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Chapter 1
Introduction
1.1 Discovery of small RNA mediated silencing path-
ways
In the last decade, our understanding of gene regulation in eukaryotes has changed dra-
matically with the awareness of small RNAmediated gene silencing pathways. The key
components of these pathways are∼ 20-30 nucleotides (nt) long single-stranded RNAs
and members of the Argonaute protein family, to which small RNAs are bound. The
small RNAs guide the Argonaute proteins to their targets, which are identified through
(partial) complementarity to the guiding small RNAs. The pathways are present in all
eukaryotes, apart from lineage-specific loss, for example in budding yeast. Histori-
cally, the first members of RNAi pathways have been discovered in the early 90s by
independent groups in different organisms. These findings converged on the discovery
of various small RNA mediated silencing pathways.
In 1998, Fire andMello discovered to their surprise, that exogenous double-stranded
RNA (dsRNA) was substantially more effective in gene silencing in Caenorhabiditis
elegans than sense or antisense strand alone [1]. This mechanism was named RNA
interference (RNAi) and because only a few molecules of dsRNA were needed for ef-
fective gene silencing. Fire and Mello proposed a catalytic amplification component
in the interference process. For their discovery that small interfering RNA (siRNA)
causes suppression of gene activity in a homology-dependent manner, Fire and Mel-
low were awarded the 2006 Nobel Prize for Physiology or Medicine.
In 1993, the first microRNA (miRNA) lin-4 was discovered as a regulator of lin-
14 in the nematode Caenorhabiditis elegans [2]. Quite surprisingly, the study found
that the lin-4 gene did not encode a protein, but a small RNA which showed antisense
complementarity to several sites in the 3’ UTR of lin-14 [2, 3]. It took another seven
years, until the second miRNA, let-7 was identified in Caenorhabiditis elegans [4].
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Once it was realized that let-7 is strongly conserved in evolution [5], the hunt for ad-
ditional small regulatory RNAs began, and soon after the list of known miRNAs has
enormously expanded [6–8].
The parallelism between the siRNA and miRNA pathway was revealed shortly af-
ter, when siRNAs of similar length as miRNAs and common pathway components such
as Dicer and Argonaute proteins were discovered in plants and animals [9–13]. This
was followed by the identification of various small RNA pathways in plants, fungi and
animals. Todate, we are aware of small RNA classes such as miRNAs, endogenous
siRNAs (endo-siRNAs) and Piwi-interacting RNAs (piRNAs), which have the ability
to regulate a broad variety of biological processes.
1.2 Argonaute proteins
The first characterized member of the Argonaute family proteins was the Drosophila
Piwi gene (P-element induced wimpy testis), which was identified for its importance
in germline stem cell division [14]. Shortly after Ago1 and Zwille were identified as
important regulators of plant development in Arabidopsis thaliana [15, 16]. Initially,
Argonautes were named after the squid-like leafs obtained from a Ago1 mutant in
Arabidopsis thaliana [15].
Currently, the Argonaute proteins are classified into three different clades [17].
The Argonaute family members or the Argonaute-like proteins are defined by their
similarity to the Arabidopsis thaliana Ago1 protein. Poteins with high similarity to
the Piwi protein in Drosophila melanogaster are named Piwi-like proteins or the Piwi
family members. The third clade consists of worm specific Argonautes (WAGOs) or
group 3 Argonautes. Indicative of their early evolutionary origin and regulatory im-
portance,Argonautes are present in most eukaryotes. Their number ranges from one
in Schizosaccharomyces pombe up to 26 in Caenorhabiditis elegans, however several
eukaryotes such as Saccharomyces cerevisiae appear to have lost the Argonaute genes.
The Argonaute-like proteins, which are involved in siRNA and miRNA pathways,
tend to be ubiquitously expressed in multicellular organisms and associate with ∼ 21-
23 nt long RNAs derived from both endogenous or exogenous source. The animal-
specific Piwi-like proteins maintain genome integrity through the piRNA and scnRNA
pathways. They are preferentially expressed in the germ line and bind ∼ 24-30 nt long
RNAs. The worm specific Argonautes are involved in secondary siRNA pathways.
Argonaute proteins adopt a bilobal structure (reviewed in [18–20]). The fist lobe
consist of the N-terminal domain which is required for protein-protein interactions and
the PAZ domain, which binds to the 3’ end of the small RNA. The second lobe consists
of the MID domain, which binds to the 5’ end of the small RNA, and the PIWI domain,
which catalyzes cleavage of target transcripts in several Argonaute members.
The N-terminal domain is required for protein-protein interactions of Piwi family
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members. In Drosophila melanogaster, HP1a has been identified to interact directly
with Piwi by binding to the N-terminal domain [21]. Quite recently, several members
of tudor domain containing proteins have been identified as interaction partners of Piwi
proteins, which require the methylation of arginine residues in the N-terminal domain
[22–26].
The PAZ domain, which is named after the three first identified Argonaute mem-
bers Piwi, Argonaute and Zwille, is a RNA-binding domain which exhibits an OB
(oligonucleotide/oligosaccharide binding) fold and has the ability to bind to the 3’ end
of either single-stranded RNA or the 3’ end overhang of double-stranded RNA in a
sequence-independent manner.
The MID domain, which is centered between the PAZ and the PIWI, contains a
pocket-like structure similar to the sugar-binding domain of the Lac repressor. This
pocket recognizes the characteristic 5’ phosphate and binds the 5’ end of the small RNA
[27,28]. In structural studies of archeal ternary guide-target-Argonaute complexes, the
base of the 5’ end is flipped and unpaired [29], which provides structural support to
the observation that the nucleotides 2-8 of the guide strand are of major importance for
target recognition [30,31]. Apart from RNA-binding, the MID domain is also involved
in protein-protein interactions by recognizing a conserved motif termed ‘Ago hook’ in
members of the GW182 family [32].
Structural studies of the C-terminal PIWI domain revealed a strong homology to
an RNase H-like fold. RNase H enzymes are endonucleases with a conserved DDH
motif which cleave RNA in a RNA-DNA duplex. Although not present in all Arg-
onaute proteins, most of them share a more degenerated DD(H/D/E/K) motif [18] and
biochemical studies demonstrated the ability of several Argonaute proteins to cleave
target RNA opposite to the 10th and 11th position of the guide RNA, which results in
a 3’ fragment carrying a 5’-phosphate and a 5’ fragment with a 3’-OH end. Argonaute
proteins which are endonucleolytically active are also called ’slicers’. In Drosophila
melanogaster, all five members of the Argonaute family exhibit slicer activity [33–36],
while in humans, slicer activity has been shown for Ago2 [37, 38]. Interestingly, most
Group 3 Argonaute proteins lack the catalytic residues, which suggests a cleavage-
independent regulatory activity [17]. Apart from being responsible for the endonucle-
olytic activity of Argonaute proteins, the PIWI domain contains the PIWI box, which
interacts with the RNase III domains of human Dicer [39].
1.3 The miRNA pathway in animals
1.3.1 Biogenesis of miRNAs
MicroRNAs (miRNAs) are ∼ 22 nt long endogenous single-stranded RNAs which de-
rive from hairpins formed by short inverted repeats. They act as guides for Argonaute
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proteins and identify their targets through Watson-Crick basepairing with their target
transcripts. MiRNAs are present in plants, animals and viruses [40], however their bio-
genesis, the target recognition of miRNAs as well as their regulatory function are quite
diverse.
In metazoa, prototypical miRNAs arise from long primary transcripts (pri-miRNAs)
or from introns from mRNAs which can give rise to several miRNAs [41]. Those tran-
scripts contain inverted repeat sequences, which fold back to form stem-loop structures.
These are recognized by the nuclear microprocessor complex, which consists of Drosha
and DGCR8/Pasha [42–45]. DGCR8/Pasha, a dsRNA binding protein, directly inter-
acts with the stem of the pri-miRNA and serves as an anchor for Drosha [46], an RNase
III enzyme, which excises the hairpin. The Drosha cut leads to a ∼ 70 nt miRNA pre-
cursor (pre-miRNA), with the RNAase III characteristic overhang of 2 nt at the 3’ end
and a 5’ monophosphate. Additionally, several miRNAs in introns, called mirtrons,
exist, which bypass the Drosha processing step [47–49]. In this case the 3’ overhang
is a direct result of the splicing process. The pre-miRNA is subsequently transported
from the nucleus to the cytoplasm by Ran-GTP and Exportin-5 [50, 51].
In the cytoplasm, another RNase III enzyme, Dicer, recognizes the miRNA pre-
cursor stem-loop and generates a ∼ 18-24 nt long dsRNA by cleaving off the loop
of the hairpin [52]. In mammals, Dicer associates with TRBP and/or PACT, and in
Drosophila melanogaster Dicer-1 interacts with Loquacious [53–57]. After unwinding
the dsRNA duplex, one strand called mature miRNA or guide strand, is incorporated
into an Argonaute protein, whereas the other strand, called passenger strand, is de-
graded [58]. The strand selection depends on the thermodynamic stability of the 5’
ends. Generally, the strand with the least stable structure at the 5’ end is incorporated
into the Argonaute proteins [59, 60]. The association of GW182 or its orthologs with
the miRNA-bound Argonaute protein is both necessary and sufficient for the formation
of the miRNA-induced silencing complex (miRISC) [61–63].
1.3.2 Target recognition
So far, several hundreds of miRNAs have been identified across the animal king-
dom [40]. Computational studies suggested that a large fraction of the transcriptome is
regulated by miRNAs [64, 65]. Although rare cases of miRNA target sites with exten-
sive complementarity between miRNA and target exist (and direct Argonaute-catalyzed
cleavage [66]), target recognition by partial complementarity is more common in meta-
zoa. The nucleotides 2-8 of miRNA, called miRNA ‘seed’, guide the miRISC to its
targets by Watson-Crick basepairing (reviewed in [67]). The target sites are preferen-
tially located in an AU-rich environment in the 3’ UTR of the target mRNA towards
the beginning or the end of long 3’ UTRs [68,69]. In case of several target sites within
one transcript, they normally act independently [70]. Nonetheless target sites located
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within short distance to each other appear to have some sort of synergetic effect [69].
Apart from canonical miRNA target sites, involving perfect basepairing with mRNA
‘seed’, atypical binding modes have been reported, where binding of the 3’ end of the
miRNA is also involved in targeting [4, 66]. In those cases, a pairing of at least 3 nt
with the positions 13-17 of the miRNA either supplements the ‘seed’ pairing, or even
compensates for a mismatch or a bulge inside the ‘seed’ region.
1.3.3 Regulatory functions of miRNAs
MiRNAs are implicated in a broad variety of biological processes in development
[2,4,71–73], cell cycle [74], metabolism [75–77] and diseases [78,79]. The inhibitory
action of miRNAs is achieved through mRNA destabilization and/or translational re-
pression. Though the precise molecular mechanisms are still debated. Most studies
indicate that repression occurs during the initiation step by preventing cap-binding,
however also several reports argue in favor of post-transcriptional mechanism like in-
hibition of elongation, premature translation termination through ribosome drop-off
or co-translational degradation of proteins (discussed in [62, 80]. The contradictory
findings, of how miRNAs inhibit translation, might be a result of experimental short-
comings or miRNA indeed inhibit translation by multiple mechanisms.
Although initial studies suggested that miRNAs inhibit translation without affect-
ing the stability of their target mRNAs, the miRNA destabilization effect is now well
established [72,81,82]. Argonaute-directed cleavage is not responsible for target degra-
dation, but rather the recruitment of deadenylation and decapping enzymes [72, 82].
Interestingly, deadenylation still occurs when transcription is globally blocked [83].
Recent large-scale studies identified several miRNA targets that were only translation-
ally repressed [84, 85]. This suggests that mRNA degradation might not be a cause of
translation inhibition and vice versa.
1.4 Endo-siRNAs in animals
1.4.1 Introduction to distinct types of endo-siRNAs
Initially, the siRNA pathway was viewed as a defense mechanism of the cell directly
against selfish and invasive RNA elements. This was supported by the observations
that disruption of the siRNA pathways in Drosophila melanogaster and Caenorhabdi-
tis elegans did not have obvious phenotypes, except for higher susceptibility to viral
infections and up-regulation of repetitive elements [86–90]. Today a broad variety of
endo-siRNAs are known, such as hairpin-siRNAs (hp-siRNAs) derived from hairpins
formed by inverted repeat structures, natural antisense siRNAs (nat-siRNAs) derived
from dsRNA formed by complementary transcripts or secondary siRNAs generated by
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RNA-dependent RNA polymerases (RdRP). Nat-siRNAs have been further classified
as cis-nat-siRNA if sense and antisense transcript are derived from either bidirectional
or antisense transcription of the same locus, or as trans-nat-siRNAs, if the two tran-
scripts originate from different genomic loci. Until recently, endo-siRNAs were well
characterized in plants [91] and fungi [92, 93] but not in animals.
1.4.2 Biogenesis of endo-siRNAs
In Caenorhabditis elegans, the targets of (exogenous) siRNAs act as templates for
the production of secondary (endogenous) siRNAs. Targeting a transcript with an ex-
ogenous siRNA leads to the recruitment of an RdRP, which synthesizes secondary
siRNAs [94, 95]. The secondary siRNAs are antisense to the target transcript and
carry a triphosphate at their 5’ end, which suggests a Dicer-independent biogene-
sis [94–96]. The targeted transcript itself acts as template for the RdRP, which produces
secondary siRNAs, which subsequently associate with the worm-specific Argonaute
members [17, 94, 95].
However, both Drosophila melanogaster and mouse lack RdRPs and the initially
repeat-associated siRNAs (rasiRNAs) turned out to be a subclass of piRNAs [97]. In
Drosophila melanogaster, so far identified endo-siRNAs originate from inter- or in-
tramolecular stem structures [98–103]. They associate with the exogenous RNAi path-
way members Dicer-2 and Ago2, however, unlike in the exogenous RNAi pathway,
some endo-siRNAs in Drosophila melanogaster require the interaction of Dicer-2 with
an isoform of Loquacious instead of R2D2 [99, 102, 104, 105]. The endo-siRNAs
showed an enrichment for both repetitive regions as well as for 3’ UTRs [98–103].
In mammals, cells normally do not tolerate long dsRNA fragments [10], but during
during early development, the interferon pathway is suppressed in oocytes and embry-
onic stem cells, and endo-siRNAs have been discovered in murine oocytes [106]. By
utilizing deep sequencing, a broad spectrum of endo-siRNAs such as cis-nat-siRNAs,
trans-nat-siRNAs and hp-siRNAs have been identified [107, 108]. Quite similar to
endo-siRNAs in fly, a high fraction of endo-siRNAs derived from repetitive loci as
well as from mRNAs. The dsRNAs giving rise to nat-siRNAs were formed by pairs
of mRNA transcripts and pseudogenes. In contrast to oocytes, hp-siRNAs are the pre-
dominant endo-siRNAs in embryonic stem cells, and pseudogene derived siRNAs have
not been found [109]. However, the abundance of endo-siRNAs seem to be quite low
in embryonic stem cells [109–111].
1.4.3 Regulatory functions of endo-siRNAs
The production of secondary siRNAs is the reason why RNAi is so effective inCaenorhab-
ditis elegans even with a very small amount of primary siRNAs.
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In contrast, the generation of endo-siRNAs in Drosophila melanogaster and mouse
is not triggered by exogenous siRNAs. Endo-siRNAs in Drosophila melanogaster are
not restricted to the germ line, and the origin of some of the endo-siRNAs from repeti-
tive loci points towards their function in silencing repetitive elements. Similarly, over-
lap of endo-siRNAs with piRNA loci in mouse oocytes has been detected. Not all
endo-siRNAs in mouse and fly are derived from repetitive loci, some are derived from
mRNAs. In fly, the transcripts giving rise to cis-nat-siRNAs enriched preferentially in
RNA- and DNA-binding proteins, and mammalian endo-siRNA targets were related
to microtubule dynamics, suggesting a more general regulatory role of endo-siRNAs
apart from repeat silencing [98–103,107,108].
1.5 The piRNA pathway
1.5.1 Introduction to the piRNA pathway
The first evidence of a repeat silencing pathway in Drosophila melanogaster was dis-
covered in 2001 [112], but it took five more years to establish a Piwi protein dependent
small RNA pathway. Primary characteristic of the ’prototypical’ piRNA pathway in
metazoa is the expression of both Piwi proteins and Piwi-interacting RNAs (piRNAs)
in the germ line or in germ line supporting tissues. Those piRNAs normally clus-
ter to distinct genomic loci. Their 5’ ends show a strong preference for uridine and
their 3’ end carries 2’ oxygen methylation. Generally, they are between 23 and 32
nt long and are generated in a Dicer-independent manner. So far, piRNA pathways
have been identified in a broad range of animals, such as mammals [106, 113–118],
zebrafish [119, 120], clawfrog [121, 122], fruit fly [35, 123, 124], silkworm [125, 126],
nematode [96, 127, 128] and flatworm [129,130].
1.5.2 Piwi proteins and their interaction partners
The founding member of the Piwi family, the Drosophila melanogaster Piwi gene,
was initially identified in a mutagenesis screen in germ line for genes involved in the
asymmetric stem cell division [14]. In Piwi mutants, not only the maintenance of
both male and female germ line stem cells is disrupted [14], but also decreased germ
cell formation and defects in oogenesis have been observed [131, 132]. The second
member of the Drosophila melanogaster Piwi family members, Aubergine (Aub), is
essential for proper germ cell formation, and the offspring of female Aub mutants
lack germ cells [133, 134]. Absence of the third Piwi member, Argonaute3 (Ago3) in
Drosophila melanogaster results in sterile females and males show defects in germ cell
maintenance [135].
The mouse Piwi family consists of three members, Miwi, Mili and Miwi2. They
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are predominantly expressed in the male germ line and are essential for spermatoge-
nesis and germ line development. Loss of each individual family member results in
infertile males with decreased testes size, whereas female mice do not show any obvi-
ous phenotype [136–139]. For Mili, the broadest expression profile has been observed,
ranging from arrested germ stem cells in the embryo from 12.5 days post-coitum (dpc)
to the round spermatids [22, 138, 140]. Miwi2 is expressed in a short time window,
ranging from 15.5 dpc up to three days after birth in arrested germ stem cells [141].
In contrast to the other two family members, Miwi is only expressed in the adult ani-
mal from meiotic spermatocytes up to the elongating spermatids stage [137]. The loss
of both Mili and Miwi2 was accompanied by spermatogenic stem cell arrest, loss of
DNA methylation marks in retrotransposons and increased expression of repetitive ele-
ments [141,142], whereas the knockout of Miwi results in a block at the early spermatid
stage [137].
In Caenorhabditis elegans, disruption of the Piwi protein Prg-1 and Prg-2 results
in fertilization defects [127, 128]. The loss of Prg-1 is accompanied by dramatical
reduction of germ cells and temperature-dependent fertility defects [128].
Several tudor domain containing proteins have been identified recently to interact
with Piwi proteins in mouse and Drosophila melanogaster [22–24, 26]. Methylation
of arginines in the N-terminal domain is required for this interaction, and is carried
out by the arginine methyltransferase PRMT5 in both fruit fly and mouse [24, 26],
Responsible for the 3’ end 2’-O methylation of piRNAs [119, 143, 144] in fruit fly
and mouse is Hen1 [145–147]. Through mutant screens in Drosophila melanogaster,
several putative piRNA pathway components have been identified in the nuage, such
as the Krimper [148], the helicases Armitage [149] and Spindle-E [148], the nucleases
Squash, Zucchini [150], Maelstrom [151] and Cutoff [152].
1.5.3 Biogenesis of piRNAs
Early studies of RNA mediated silencing pathways in male testes from Drosophila
melanogaster revealed the involvement of Aub and ∼ 24-29 nt long repeat-associated
siRNAs (rasiRNAs) in the silencing of the repetitive Stellate locus [112, 123, 153]. By
immunoprecipitation of Piwi complexes, the direct interaction between rasiRNAs and
Piwi proteins could be shown [35,124]. Therefore they were classified as piRNAs, with
rasiRNAs as a subclass derived from repetitive loci. The majority of piRNAs identified
in Drosophila melanogaster map to a small set of discrete genomic loci, ranging from
several up to hundreds of kilobases in length [97]. These piRNA clusters are located
in the heterochromatin and highly enriched in repeat-rich regions [154]. The flamenco
locus has been identified as a transposon regulatory locus, long before the discovery
of piRNAs [155]. Loss of the flamenco locus, which consists of a mix of transposable
elements, results in an increased expression of retrotransposons, defects in germ cell
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development and sterility [134, 156, 157]. Mutations in the 5’ end of the flamenco
locus disrupts the generation of piRNAs downstream of the locus, which suggests that
mature piRNAs are generated through random excision of mature piRNAs from a long
precursor transcript [134]. The excision of piRNAs from the precursor transcript is
Dicer-independent [124], and the mature piRNAs are subsequendly modified at the 3’
end [36, 124]. In contrast to Ago3 or Aub expression, the Piwi protein is not restricted
to germ cells and can be detected in the nuclei of both somatic and germ cells. The
presence of a somatic Piwi-dependent piRNA pathway has been reported recently [135,
158]. Ago3 and Aub are localized in the nuage, an amorphous structure that surrounds
the nucleus in germ cells.
In mouse, piRNAs consist of two different populations, according to the devel-
opmental stage in which they are expressed. The class of piRNAs that is expressed
before the meiotic pachytene is classified as pre-pachytene piRNAs, and is similar to
the piRNAs in Drosophila melanogaster. This piRNA population associates with both
Mili and Miwi2 and originates from genomic loci enriched in retrotransposons when
compared to the piRNA loci from the pachytene stage [154]. The sequence pool of
pre-pachytene piRNAs is dynamic. Although the fraction of transposon-derived piR-
NAs is more or less stable during development, the composition of individual trans-
poson classes changes during developmental progression [141]. Comparison of the
piRNAs bound to Mili and Miwi2 reveals that both proteins associate with transposon-
derived piRNAs, but Miwi2 shows a stronger preference for repeat-derived piRNAs
than Mili [141]. The second class of piRNAs, called pachytene piRNAs, are derived
from genomic loci with little overlap to pre-pachytene piRNA clusters [154]. They
are expressed during the pachytene stage until the haploid round spermatid stage and
interact with both Mili and Miwi [154]. A much higher fraction of pachytene piRNAs
maps uniquely to the genome compared to the pre-pachytene piRNAs [154].
The piRNAs of Caenorhabditis elegans were initially called 21U-RNAs, due to
their uracil bias at the 5’ end and their length of 21 nt [96]. They carry a 5’ monophos-
phate and a modified oxygen at their 3’ end [96]. The majority originates from two
large loci of chromosome IV, and has a consensus motif, located ∼60 nt upstream of
the mature piRNA [96]. Although the upstream motif is conserved between C. elegans
and C. briggsae [96, 128], the piRNA sequences are not conserved and the expression
of the individual piRNAs correlates with their match to the consensus motif [128]. It
has been hypothesized, that the piRNAs are transcribed individually [96], but the up-
stream motif might also act as a processing signal on posttranscriptional level [159].
RNAi screens against components of the RNAi pathway components showed depletion
of piRNAs in Prg-1, but not in Prg-2 or Dcr-1 mutants [127,128,159]. The 21U-RNAs
were identified as piRNAs by immunoprecipitation of Prg-1 and by sequencing the
associated small RNAs [127,128,159].
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1.5.4 Regulatory functions of piRNAs
It has been observed that the mature piRNA sequences themselves are poorly conserved
between closely related species, even though they are derived from syntenic regions
[113, 116, 128]. A strong positive selection and cluster acquisition has been shown
for the genomic loci of murine piRNAs, which suggests an evolutionary arms race
[160], consistent with the regulatory role. Immunoprecipitation and sequencing of the
piRNAs associated with individual Piwi family members revealed distinct species of
piRNAs. The piRNAs associated with Piwi and Aub showed a strong bias towards an U
at their 5’ end and derived preferentially from the antisense-strand of retrotransposons
[36, 134]. In contrast to that, piRNAs associated with Ago3 derived from the sense
strand of retrotransposons showed a strong bias for an A at the 10th position [36,134].
Interestingly, the 5’ ends of piRNAs associated with either Piwi and Aub overlapped
significantly with the 5’ ends of Ago3-bound piRNAs from the opposite strand by 10
nt [36, 134]. This observation together with the finding that all three Piwi proteins
in Drosophila melanogaster are able to cleave target transcripts between the 10th and
11th nt from the 5’end of the small RNA guide strand [36,145], lead to the proposal of
a piRNA amplification loop [36, 134], called ’ping-ping’ mechanism.
The amplification loop is initiated by a primary mature piRNA bound to Ago3 that
triggers cleavage of an antisense piRNA precursor transcript. This event defines the
5’ end of the secondary piRNA, which eventually associates with either Piwi or Aub.
The 3’ end of the secondary piRNA is assumed to be generated by either an exo- or
endonuclease and modified at the 3’ end, resulting in a 24-30 nt secondary piRNA. The
generation of another piRNA, which is triggered by the secondary piRNA in a similar
manner, completes the amplification loop. Distinct size preferences of piRNAs bound
to individual Piwi proteins reflect the footprint of the bound protein complex, which
protects the tail of the piRNA from the nuclease event [134].
Once the amplification loop is started, both primary and secondary piRNAs are
generated, providing the organism an adaptive immune system towards transposable
elements. What is not clear at the moment is how the initial species of piRNAs is
generated. Some solution to this problem is provided by observations that at least
some piRNAs in Drosophila are maternally deposited [161], and piRNAs have also
been reported in mouse oocytes [107,108].
Consistent with their repetitive origin, the signatures of the ping-pong mechanism
are also found in pre-pachytene piRNAs in mouse [154]. So far, it is assumed that
pachytene piRNAs consist only of primary piRNAs, and ping-pong signatures have not
yet been found [97, 141, 162]. The loci of pachytene piRNA are depleted of repetitive
elements when compared with the average repeat density of the mouse genome, and
derepression of transposons has not been reported for Miwi mutants [154]. It has been
shown that both Mili and Miwi2 act upstream of DNA methylation pathways in mouse
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[141, 142], indicating that transposons are also silenced on transcriptional level in a
piRNA-dependent manner. Nonetheless because both Miwi and Mili interact with the
cap-binding complex, they probably have a general role in translational control apart
from transposon silencing [140,163].
In general, piRNAs in Caenorhabditis elegans do not show sequence similarity to
transposons, and so far, no evidence for the ping-pong model has been observed. Their
regulatory targets have not yet been identified [127,128,159].
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Cloning and sequencing is the method of choice for small regulatory RNA
identification. Using deep sequencing technologies one can now obtain
up to a billion nucleotides—and tens of millions of small RNAs—from
a single library. Careful computational analyses of such libraries enabled
the discovery of miRNAs, rasiRNAs, piRNAs, and 21U RNAs. Given the
large number of sequences that can be obtained from each individual sam-
ple, deep sequencing may soon become an alternative to oligonucleotide
microarray technology for mRNA expression profiling. In this report we
present the methods that we developed for the annotation and expression
profiling of small RNAs obtained through large-scale sequencing. These
include a fast algorithm for finding nearly perfect matches of small RNAs
in sequence databases, a web-accessible software system for the annota-
tion of small RNA libraries, and a Bayesian method for comparing small
RNA expression across samples.
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2.1 Introduction
Though recently discovered, small RNAs appear to play a wealth of regulatory roles,
ranging from degradation of target mRNA [72, 164], translation silencing of target
mRNA [6–8], chromatin remodeling [93,165] and transposon silencing [134,154,166].
In vertebrates, the most studied class of small regulatory RNAs are the microRNAs
(miRNAs), which are produced from hairpin precursors by the Dicer endonuclease
[6–8] to block the translation of target mRNAs [167]. The discovery of the let-7
miRNA, which is perfectly conserved in sequence from worm to man [4], sparked
a great interest in the identification of additional miRNAs as well as of other regulatory
RNAs. The group of Tom Tuschl developed a protocol for isolating miRNAs which
typically yields 80−90% miRNAs in a given sample of small RNAs [168, 169], and
used it to collect small RNA expression profiles from hundreds of mammalian sam-
ples. Based on this data, we constructed an atlas of miRNA expression profiles in a
large number of mammalian tissues [170]. In parallel, high-throughput pyrosequenc-
ing [171] or sequencing-by-synthesis [172] technologies are being developed to deliver
up to a billion nucleotides in a run. With millions of miRNA sequences from a single
sample, one can obtain a very fine resolution picture of miRNA expression.
As is generally the case with high-throughput data, fast and accurate computa-
tional analysis methods are needed to uncover the information contained in these large
datasets. Here we present the methods that we have developed and used to iden-
tify novel regulatory RNAs and to analyze their expression across cells and tissues
[113,170].
2.2 Oligomap: a program for fast identification of nearly-
perfect matches of small RNAs in sequence databases
2.2.1 Problem definition
Figure 2.1 shows a sketch of the protocol for small RNA sequencing. Total RNA is
size-separated to extract sequences of the appropriate size (roughly 22 nucleotides for
miRNAs, 25-35 for piRNAs, etc.), which are subjected to adaptor ligation using a pro-
cedure that takes advantage of the presence of a 5’ phosphate and a 3’ hydroxyl group in
the RNase III products [169]. The resulting sequences are concatenated, ligated into the
T vector, cloned and sequenced. The first computational step is to retrieve the sequence
of the small RNAs from the sequenced concatamers. We accomplish this by mapping
the adaptors to the concatamer sequences using WU-BLAST (http://blast.wustl.edu).
Because the rate sequencing errors is rather high (0.01-0.03/nucleotide), and the 5’/3’
adaptors short (10-16 nucleotides), we use a set of parameters that permit the identi-
fication of short, imperfect matches between query and target sequences. These pa-
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and sequencing
Sequence reads
Figure 2.1: Protocol for small RNA sequencing.
rameters are: short initial matches between adaptor and cloned sequence (W = 4), low
score thresholds determining which of the initial alignments are to be extended (S2=50
gapS2=50), and relatively large drop in the score determining when an alignment is not
to be further extended (X=50 gapX=50). The subsequences of a concatamer that are
found between matches to 5’ and 3’ adaptors in the correct configuration are extracted
as small RNAs.
Functional annotation requires the small RNAs to be mapped to sequences of known
function and to the corresponding genome. This process has to be sensitive, meaning
that all small RNAs that do have matches within the specified quality constraints should
be mapped, and efficient, meaning that the program should not take longer than a day
to map millions of small RNAs. Variants of the Blast algorithm [173], such as WU-
BLAST (http://blast.wustl.edu) [170], Blast [96,114], or Megablast ( [174]) [175] have
been used for this purpose as well. Typically, the output of these programs is filtered
to retain only very good alignments, with very few differences between small RNAs
and targets. The programs mentioned above are in fact very general, but they have
been designed for mapping longer RNAs (such as ESTs), and in order to achieve good
performance, they use heuristics, such as initiating alignments from perfect contiguous
matches of a minimum length (”words”) between query and target sequence. Because
sequencing errors in 18-30-nucleotides long RNAs can easily reduce the length of the
contiguous matches to the target sequence, one would have to use a relatively small
word size in order to guarantee that 1-error hits are retrieved, thereby increasing the
running time of the programs. While this was not a problem when we needed to map
a few adaptors to concatamers, it became a problem when we tried to map hundreds
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of thousands of small RNAs to mammalian genomes. Moreover, if all we want to do
in the end is to identify very close matches of short RNA sequences, the complexity
of these general algorithms is not necessary. We therefore developed a special-purpose
mapping algorithm that allows us to rapidly and exhaustively identify all the perfect
and 1-error (where an error is defined to be a mismatch, insertion or deletion) matches
of large sets of small RNAs to target sequences.
2.2.2 Oligomap algorithm
A sketch of the main components of the algorithm is shown in Figure 2.2. The ap-
proach is to build a tree from the input small RNA sequences (Figure 2.2C) and then
search this tree with subsequences starting at each position of the target sequence (Fig-
ure 2.2D). Each node in the tree corresponds to a nucleotide, and each small RNA is
represented in the tree as a path that starts at the root and ends at either another internal
node or at a leaf. There are 4 possible links from a parent node to a child node, one
corresponding to each of the nucleotides. The identifier (ID) of each node encodes in-
formation about the small RNA represented by the path starting at the root and ending
at the respective node (Figure 2.2A). The search stage is performed through a number
of ”walkers” (Figure 2.2B). A walker represents a suffix of the target sequence that
ends at the current position in the target. Every time a walker visits a node that repre-
sents a small RNA, we report a match between that small RNA and the target. When
a walker ends in an internal node that does not represent a small RNA, it is removed
from the search.
2.2.3 Estimation of the resource requirements
To gain insight into the resource requirements of our algorithm, it is instructive to first
consider the simple case in which we only want to identify perfect matches between
small RNAs and a target sequence. For simplicity, let us assume that all small RNAs
have the same length L. Then every small RNA will be represented as a path from root
to a leaf in the tree and to construct the tree from N input sequences we need to visit
N ∗ L nodes. Thus, the time needed for constructing the tree is proportional to N ∗ L.
The search phase consists of following paths in this tree starting from every nucleotide
in the target. To do this, we start at the root of tree and visit the child which corresponds
to the nucleotide currently observed in the target. We then continue on this path using
the next nucleotide in the target and so on, until we either reach a leaf, or until the the
internal node does not have a child that corresponds to the current nucleotide in the
target. The length of a path that starts at a given nucleotide in the target determines the
time needed to decide whether this path specifies an input small RNA. With L being
the length of a small RNA, the upper bound on the path length is L, which for our
applications is 20 − 35. The average path length that we more typically encounter is
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Figure 2.2: Schematic representation of the mapping algorithm.
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however much shorter, as shown by the following argument. Assume that we generate
the tree from N random sequences of length L defined over an alphabet of size A.
Then the average length of a path that we will traverse starting from a given position
in the target is given by the sum is over all possible path lengths l, the length of the
path multiplied by the probability that the search will stop precisely after l steps. This
will happen when none of the N sequences inserted in the tree had the prefix of length
l+ 1 of the sequence that we are searching for, but did have the prefix of length l. The
average number of steps is thus given by:
S = L
￿
1−
￿
1− 1
AL
￿N￿
+
L−1￿
l=1
l
￿￿
1−
￿
1− 1
Al
￿N￿
−
￿
1−
￿
1− 1
Al+1
N￿￿￿
= L
￿
1−
￿
1− 1
AL
￿N￿
+
L−1￿
l=1
l
￿￿
1− 1
Al+1
N￿
−
￿
1− 1
Al
￿N￿
= L−
L￿
l=1
(1− 1
Al
)N . (2.1)
As shown in Figure 2.3, this number grows approximately logarithmically withN . For
the values of A, L and N that are typical for our applications (4, 22, 500000, respec-
tively), the average path will be approximately 9. The search time thus depends linearly
on the target size and approximately logarithmically on the number of small RNAs.
The memory requirements of this program are determined by the size of the tree
that we construct from the input small RNAs, an upper bound on this being k ∗N ∗ L,
with k a constant. An average estimate of the memory requirements can be obtained
as follows. Given a tree in which n − 1 sequences were already inserted, we want to
compute the number of new nodes that the insertion of the nth sequence will create.
When processing the nth sequence, a new node will be generated at level l in the tree if
none of the sequences observed up to that point had the same length l prefix as sequence
n. This happens with probability ￿
1− 1
Al
￿n−1
.
Thus, inserting the nth sequence will result, on average, in the insertion of
m(n) =
L￿
l=1
￿
1− 1
Al
￿n−1
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nodes. Inserting progressively a total of N sequences generates on average
M(N) =
N￿
n=1
m(n) =
N￿
n=1
L￿
l=1
￿
1− 1
Al
￿n−1
. (2.2)
Exchanging the two summations and applying the geometric series formula we obtain
M(N) =
L￿
l=1
1− ￿1− 1Al ￿N
1− ￿1− 1Al ￿ . (2.3)
Finding 1-error matches requires that we either enumerate all these variants of the
input small RNAs and insert them in the tree, or that we search the tree in such a way
that we can identify matches with 0 or 1 error. The first option requires considerable
more memory, since for every small RNA of length L we will have 8 ∗ L− 4 variants
with 1 error (see Figure 2.2F). The search time would increase comparatively little,
because the path length increases very slowly with the number of small RNAs repre-
sented in the tree. On the other hand, the second option requires little extra memory,
but has a considerably longer search time, since at each position in the target we need
to search not only for a perfect match starting at that position, but also for all the possi-
ble matches with 1 error (Figure 2.2G). This means following 8 additional search paths
from each node on the path representing a perfect match of the target to a small RNA.
To achieve a good tradeoff between memory and CPU usage, we have combined
these two strategies (Figure 2.2H): we store in the tree only the small RNAs (which
we call P small RNAs) and their 1-nucleotide deletion variants (which we call Q small
RNAs). Then, in the search process we create walkers representing target subsequences
(P walkers) and their 1-nucleotide deletion variants (which we call T walkers). The 0−
and 1-error variants of the small RNAs will be detected as follows:
1. perfect match small RNA-target: P walker stops at P small RNA
2. deletion in small RNA: P walker stops at Q small RNA
3. deletion in target: T walker stops at P small RNA
4. mismatch small RNA-target: T walker stops at Q small RNA, and looped out
nucleotides do not match
Using the same argument that we used above, we can compute the average number of
steps required to decide whether a path that starts at a given nucleotide in the target
specifies an input small RNA. The difference is that the hybrid algorithm does not use
a single walker starting from a given nucleotide in the target, but it spawns new ones
from every point along the path of a perfect walker. The probability that these stop at
a particular level l is the same as for a perfect walker, but the number of steps that they
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perform is smaller: if a T walker started at level h, it will only perform l− h+ 1 steps
up to level l. Thus, the average total number of steps performed by the P and T walkers
initiated from a given position in the target is given by
S =
L￿
h=1
￿
(L− h+ 1)
￿
1−
￿
1− 1
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￿N￿￿
+
L￿
h=1
￿
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2
−
L￿
l=1
l
￿
1− 1
Al
￿N
. (2.4)
The behavior of these functions of N are shown in Figure 2.3A for A = 4 and L =
16, 20, 24, 28, 32, 36, 40.
2.2.4 Algorithm performance in a realistic setting
To illustrate the performance of our program particularly on very large sequence datasets
for which it was designed, we used instead of small RNAs, for which large-scale data
sets are only starting to be generated, the CAGE tag data generated by the Riken Insti-
tute in Japan [176]. These are short (20-21 nucleotides) sequences from the 5’ ends of
capped mRNAs, and millions of such sequences are already available. We constructed
from this dataset 5 random subsets of sizes from 1, 000 to 512, 000 sequences, which
we then mapped to the mouse genome assembly using our program. Figure 2.3C shows
that the running time of the program increases only by a factor of 10 as the number of
sequences in the input increases by a factor of 512. Mapping half a million sequences
to the entire mouse genome takes roughly 5 hours on a 2.2 GHz AMD Opteron, using
2.3 GB of memory. We use this program to identify all close matches of small RNAs
to their corresponding genome, and to other RNAs whose function is already known.
The program can be downloaded from http://www.mirz.unibas.ch/software.shtml.
2.3 Automated annotation of small RNAs
The first aim of the analysis of a large-scale small RNA dataset is to identify all se-
quences whose function is already known. Since many genomes have been now se-
quenced and annotated to a large extent, one can frequently infer the function of a
small RNA from the annotation of the genomic region to which the small RNA maps.
This approach of course fails when the genome assembly or the genome annotation
are incomplete or incorrect. For instance, the annotation of small RNAs derived from
ribosomal RNA cannot be readily done based on the genome annotation because the
rRNA repeat unit, though available in the Genbank database (U13369 for human and
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Figure 2.3: Performance of the mapping algorithm. A: estimated average number of
steps performed by a walker as a function of the number of small RNAs represented
in the tree. Blue corresponds to the case of perfect matches only, red to perfect and
1-error matches. The alphabet size was A = 4. The small RNA length varied from
from 16 to 40, but the number of steps remains virtually unchanged for length > 28
nucleotides. B: estimated average memory requirements of the program as a function
of the number of small RNAs in the input. The small RNA length varied from 16 to 40
nucleotides. C: Physical running time and D: memory requirements of the program on
a 2.2 GHz AMD Opteron as a function of the number of small RNAs in the input. For
each input size, we selected and mapped 5 random subsets of CAGE tags.
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BK000964 for mouse), is not present in its entirety in the current assemblies of the
human and mouse genomes. Another example is the cluster of mouse embryonic miR-
NAs (mmu-mir-290 to mmu-mir-295) which is absent from the current assembly of
the mouse genome, but was present in a previous assembly [177]. For this reason we
use both the genome annotation as well as mappings of the small RNAs to transcripts
with known function to functionally annotate small RNAs. We download the genome
sequence of the species from which the small RNAs have been cloned from the UCSC
repository (http://genome.cse.ucsc.edu), from which we also obtain the annotation of
repeat elements in the genome. As sources of transcripts of known function we use the
following resources:
• miRNA - ftp://ftp.sanger.ac.uk/pub/mirbase/sequences/CURRENT/hairpin.fa.gz
• rRNA - Genbank sequence search using human/mouse/rat as species and rRNA
as “Molecule type” to filter the records
• tRNA - http://lowelab.ucsc.edu/GtRNAdb/
• sn- and sno-RNA - Genbank sequence search filtering for the appropriate “Fea-
ture Key”
• piRNA - Genbank sequence search and data from Aravin et al. [113]
• mRNA - Genbank sequence search using human/mouse/rat as species and mRNA
as “Molecule type” to filter the records.
For our recent analysis of mammalian miRNA expression [170] we additionally curated
the set of human, mouse and rat miRNAs that have been described to date, taking
special care to identify the orthologs of all known miRNAs in these three species.
After compiling these data, we can proceed to annotate small RNAs in individual
samples. The individual steps of the computational annotation and the software tools
(other than custom Perl scripts) that we use in each of them are as follows:
1. Map small RNAs to genome using oligomap (0 − /1−error matches) and WU-
BLAST (matches with ≥ 2 errors).
2. For each small RNA identify the locus/loci with minimum number of errors (mis-
match, insertion, deletions) in the small RNA-to-genome mapping.
3. Filter out too distant mappings (< 92.5% identity).
4. Map small RNAs to annotated sequences using oligomap (0−/1−error matches),
WU-BLAST (matches with ≥ 2 errors).
5. For each small RNA identify the sequences with minimum number of errors
(mismatch, insertion, deletions) in the small RNA-to-annotated sequence map-
ping.
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6. Filter out too distant mappings < 92.5% identity.
7. Assign a functional category to each small RNA based on all its best mappings.
8. Compute the number of sequences derived from each arm of each pre-miRNA.
Many small RNAs map unambiguously to sequences from one single functional
category, and their origin can therefore be easily determined. There typically are also
small RNAs that map equally well to sequences with different function, such as for
instance tRNA and genomic repeat. For these, we choose what we consider the most
likely annotation based roughly on the abundance of various types of sequences in the
cell, namely rRNA > tRNA > sn/sno-RNA > miRNA > piRNA > repeat > mRNA.
The incompleteness of databases and ambiguous mappings pose problems also in
the annotation of miRNAs. For instance, until recently, the miRNA repository miR-
Base (http://microrna.sanger.ac.uk/sequences/) only contained miRNAs from individ-
ual publications. These studies did not generally go as far as identifying the homologs
of the miRNAs that they uncovered in all sequenced genomes, and subsequent cloning
studies frequently isolated such homologs. To be able to distinguish entirely novel
miRNAs from homologs of miRNAs that were cloned previously from other species,
we use in our annotation procedure all pre-miRNAs from miRBase, irrespective of the
species. When no match to in-species precursors is found, or when a more precise
match to an out-of-species precursor is found, the out-of-species precursor is used in
the annotation of the small RNA.
In order to compare miRNA expression across samples, we need to determine the
number of clones of each individual miRNA that have been sequenced. In some cases,
a small RNA matches equally well multiple miRNA precursors, and we do not know
from which of these precursors the small RNA originated. Assuming that any of these
precursors was equally likely to give rise to the small RNA, we count each small RNA
towards all the equally-well matched precursors, with a weight that is the inverse of the
number of such precursors. We thus obtain sequence counts reflecting the expression
of mature miRNAs and of miRNA precursors, which we can compare across samples.
We have combined all of these concepts into a software system for the annotation of
small RNAs, which we used to construct a mammalian miRNA expression atlas [170].
Most recently, we have implemented this system as a web server
(http://www.mirz.unibas.ch/smiRNA-annotation/) that allows a user to annotate small
RNAs from a set of samples. The server is coupled to a database of publicly available
miRNA expression profiles (currently the miRNA atlas [170]), which we will continue
to update as more datasets become available. This enables users to analyze their own
samples, starting with the extraction of small RNAs from sequence reads, and con-
tinuing with the visualization and comparison of miRNA expression in these samples
relative to all others that are publicly available.
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Figure 2.4: Frequency distribution of miRNA counts in 2 individual samples from
frontal cortex (black) and liver (green). Most miRNAs in a given sample occur at low
frequency, with a few miRNAs having relatively high frequency.
2.4 Comparison of miRNA expression profiles
2.4.1 Clustering samples
One of the main goals of small RNA cloning is to characterize miRNA expression
across tissues and to understand the changes that take place during cell differentiation
or during pathogenic processes. One approach to these questions is to identify signif-
icant changes in miRNA expression between samples. Because in general we do not
have absolute measurements of miRNA expression, but only the relative counts of dif-
ferent miRNAs within a sample, what we can detect and quantify are changes in the
relative frequencies of miRNAs within samples. Compared to other technologies used
to measure gene expression, such as microarrays, our data consisted up to now of rela-
tively small RNA libraries, containing on the order of a thousand clones. Interestingly,
we typically find frequency distributions in which a few miRNAs are highly expressed,
occurring in hundreds of copies, while most miRNAs occur in only a handful of copies
(Figure 2.4). Given the relatively small sample sizes, the miRNA copy numbers will be
subject to large sampling noise. To identify significant changes in miRNA expression
we adopted a Bayesian probability framework.
We want to quantify the overall similarity of the miRNA expression profiles of
two samples. In each sample there is a true, but unknown, distribution of frequencies
pi for each of the miRNAs i. Let pi denote the true frequency of miRNA i in the
first sample, and let qi denote the true frequency of miRNA i in the second sample.
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The observed copy numbers ni and mi of each miRNA i in the two samples can be
considered multinomial samples from the distributions {pi} and {qi}, and for a given
set of frequencies the probability of the data is given by
P ({ni}, {mi}|{pi}, {qi}) =
￿
i
[pnii q
mi
i ] . (2.5)
We calculate the probability of the observed counts {ni} and {mi} under two models.
The first model (model “I”) assumes that the frequencies pi and qi are both unknown
and independent of each other. To calculate the likelihood LI of this model we assign
a Dirichlet prior probability to the unknown frequency distributions, i.e. a prior of the
form
P ({pi}) = Γ(kα)
￿
i
pα−1i
Γ(α)
, (2.6)
where k is the number of miRNAs and α is the pseudo-count of the Dirichlet prior, and
integrate over all possible distributions {pi} and {qi}, i.e.
LI =
￿
P ({ni}, {mi}|{pi}, {qi})P ({pi})P ({qi})dpdq, (2.7)
where the integral is over all distributions
￿
i pi =
￿
i qi = 1. The integral can be
performed analytically and we obtain
LI =
Γ(kα)2
Γ(n+ kα)Γ(m+ kα)
￿
i
Γ(ni + α)Γ(mi + α)
Γ(α)2
, (2.8)
where n is the total number of miRNAs in the first sample and m the total number of
miRNAs in the second sample.
The second model assumes that the relative frequency of any miRNA i is the same
between the two samples (”S” model), i.e. it assumes pi = qi for all i. The likelihood
LS of this model is given by
LS =
￿
P ({ni}, {mi}|{pi}, {pi})P ({pi})dp
=
Γ(kα)
Γ(n+m+ kα)
￿
i
Γ(ni +mi + α)
Γ(α)
. (2.9)
Finally, the posterior probability of the S model is given by LS/(LI +LS) and we
can use this to define a distance d = log(LI+LSLS ) between the expression profiles of
the two samples, which we can further use for the hierarchical clustering of samples of
miRNAs. Note that as the posterior probability of the S model goes to 1 the distance
goes to zero, and that as the posterior probability of the S model goes to zero, the
distance goes to infinity.
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2.4.2 Clustering miRNAs
Instead of clustering samples based on the overall expression profile of the miRNAs we
can also cluster groups of miRNAs into clusters based on the expression profiles of the
miRNAs across samples. We consider all ways in which miRNAs can be partitioned
into clusters. For each such a partition we can calculate a likelihood as follows. Let c
denote a cluster in the partition, |c| the number of miRNAs in this partition, nic the total
count of miRNAs from cluster c in sample i, and ρic the (unknown) overall frequency
of cluster c in sample i. We will again use a Dirichlet prior over the unknown cluster
frequencies ρic and calculate the likelihood of the partition by integrating over all possi-
ble distribution ρic (separately for each sample i). In addition, we will assume that each
miRNA in cluster c will have the same frequency ρic/|c| in sample i. That is, we treat
the relative frequencies of the different clusters in each of the samples as unknown
variables but demand that within each cluster all miRNAs have the same frequency.
Under this model we obtain for the likelihood
L =
￿
i
￿￿
Γ(kα)
Γ(α)k
￿
c
￿
ρic
|c|
￿α−1+nic
dρi
￿
=
￿
i
￿
Γ(kα)
Γ(ni + kα)
￿
c
￿
Γ(nic + α)
Γ(α)
|c|1−α−nic
￿￿
, (2.10)
where the first product is over all samples, the integral for each sample is over the
unknown frequencies ρic for that sample (with
￿
c ρ
i
c = 1), k is the number of clusters
in the partition k, the second product is over all k clusters in the partition, and the sum
in the exponent is over all miRNAs a that belong to cluster c.
We then cluster miRNAs hierarchically: we start with each miRNA being placed
in its own cluster, and then at every step, we consider merging two clusters together.
To decide which clusters to merge, we use the same concept as above: we denote the
partition in which the two clusters are merged as the ”S” model, and the partition in
which the two clusters are separate as the ”I” model. We then cluster at each step the
two clusters for which the likelihood ratio LS/LI is maximal. Consider two clusters c
and c￿. Using expression (2.10) we have for the likelihood ratio
LS
LI
=
￿
i
￿
|c|nic+α−1|c￿|nic￿+α−1
(|c|+ |c￿|)nic+nic￿+α−1
Γ(nic + n
i
c￿ + α)Γ(α)
Γ(nic + α)Γ(n
i
c￿ + α)
Γ(ni + kα)Γ((k − 1)α)
Γ(ni + (k − 1)α)Γ(kα)
￿
.
(2.11)
These clustering algorithms have been used in our analysis of the miRNA atlas data
[170].
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2.5 Concluding remarks
Many researchers are using small RNA cloning and sequencing to study gene expres-
sion of both small RNAs and mRNAs. The first step in the analysis of such data sets
is the mapping of small RNAs to both genome and to sequences with known func-
tion. We developed an algorithm that allows very rapid mapping of these small RNAs
assuming that only very close matches (with 0 or 1 error) are desired. We further de-
veloped a web server that applies the analysis steps that we have used in constructing
the miRNA atlas to provide a functional annotation for user-provided data sets. One of
the most typically asked questions is how small RNAs samples differ, and which of the
small RNAs are most responsible for the difference. Here we described the Bayesian
framework that we currently use in our server to identify miRNAs whose relative fre-
quency between changes most significantly between samples, taking into account the
noise inherent in the relatively small counts of these molecules in typical samples.
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MicroRNAs (miRNAs) are short RNAs that act as guides for the degrada-
tion and translational repression of protein-coding mRNAs. A large body
of work showed that miRNAs are involved in the regulation of a broad
range of biological functions, from development to cardiac and immune
system function, to metabolism, to cancer. For most of the over 500 miR-
NAs that are encoded in the human genome the functions still remain to be
uncovered. Identifying miRNAs whose expression changes between cell
types or between normal and pathological conditions is an important step
towards characterizing their function as is the prediction of mRNAs that
could be targeted by these miRNAs. To provide the community the pos-
sibility of exploring interactively miRNA expression patterns and the can-
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didate targets of miRNAs in an integrated environment, we developed the
MirZ web server, which is accessible at www.mirz.unibas.ch. The server
provides experimental and computational biologists with statistical analy-
sis and data mining tools operating on up-to-date databases of sequencing-
based miRNA expression profiles and of predicted miRNA target sites in
species ranging from Caenorhabditis elegans to Homo sapiens.
3.1 Introduction
MicroRNAs (miRNA) are a continuously growing class of small RNAs that act as
guides in the translational silencing and degradation of target mRNAs [178]. Many
miRNAs are conserved over large evolutionary distances such as between human and
worm [5]. Fundamental biological processes such as development [3,71–73], metabolism
[75–77], cardiac [179] and immune system function [180] have been shown to be reg-
ulated by miRNAs, and aberrant miRNA expression has been associated with can-
cers [78, 181].
There are various approaches to miRNA expression profiling, one of which is small
RNA sequencing. Classical cloning and sequencing of size-separated small RNAs have
been used to generate a large atlas of miRNA expression profiles [170], and this ap-
proach can be scaled up considerably through deep sequencing technologies [172].
Microarray-based expression profiling is also a popular approach, which has been used
for instance to characterize the miRNA expression cancer samples [78]. In contrast to
sequencing, microarray-based profiling does not allow identification of novel miRNAs.
Numerous approaches have also been proposed for miRNA target prediction. Be-
cause the 5’ end of miRNAs (known as “seed”) appears to be important for target
recognition, a number of tools focus on the evolutionary conservation of miRNA seed-
complementary regions in 3’UTRs [65, 68, 182, 183]. Other approaches emphasize
the energy of hybridization between miRNA and target [184–186], the expected anti-
correlation between the expression level of miRNAs and their mRNA targets [187,188],
the properties of the environment of the miRNA target site [69, 189], or combine vari-
ous features of the miRNA target site itself [190, 191].
Studies in both native expression [192] as well as transfection-induced miRNA
overexpression situations [74, 81] indicate that within a given tissue, the miRNAs that
are most strongly expressed have the largest impact on mRNA targets. For this rea-
son, deciphering the miRNA-dependent post-transcriptional regulatory layer in a given
tissue or cell type needs to start from the miRNA expression profile of that tissue or
cell type. Conversely, it is very common that one identifies differences in miRNA
expression between cells at various stages of differentiation or between normal and
malignant cells, and the natural question is what mRNAs are most likely to be affected
by the change in miRNA expression. To address these types of questions, we developed
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MirZ (www.mirz.unibas.ch), a web service that integrates two resources that we devel-
oped in the context of previous research projects: the smiRNAdb miRNA expression
atlas [170], and the ElMMo miRNA target prediction algorithm [68].
3.2 Materials and methods
3.2.1 The smiRNAdb miRNA expression atlas
smiRNAdb [170] is a unique, web-accessible and widely used resource of miRNA
profiles determined by sequencing from hundreds of Homo sapiens, Mus musculus
and Rattus norvegicus samples. The web interface of smiRNAdb features an ex-
tended repertoire of on-line analyses such as visualization and hierarchical clustering
of miRNA expression profiles, principal component analysis, comparison of miRNA
expression between two (sets of) samples with the aim of identifying the miRNAs
whose expression differs most between the samples. We used the Brenda tissue on-
tology [193, 194] as a guide in organizing the samples such that the user can readily
identify related cell lineages or normal and pathological samples derived from a given
tissue type. Our tissue hierarchy has four levels: the organ/system (e.g. hematopoi-
etic system), subsystem (e.g. lymphoid lineage), cell type (e.g. B cell), further cell
type classification (e.g. B lymphocyte). MiRNAs themselves can be analyzed inde-
pendently, grouped by their 2-7 subsequence, or grouped in precursor clusters. Two
miRNAs are placed in the same precursor cluster if their loci are within 50 kilobases
of each other in the genome, or if they share a mature form.
As an example, one may be interested in comparing miRNA expression between
effector and naive human CD4+ T-lymphocytes. SmiRNAdb features a “Sample com-
parison” tool which was specifically designed for the pairwise comparison of miRNA
(sets of) samples. The user would select to compare the sample named “hsa T-cell-
CD4-effector” to the sample named “hsa T-cell-CD4-naive”. Because the naive CD4+
T cell sample and the effector CD4+ T cell sample differ widely in the total number of
sequenced miRNAs (1374 vs 89), the precision of the miRNA frequency estimates in
the two samples will also be very different. This situation is common in sequencing-
based datasets making the identification of miRNAs whose expression is significantly
different a non-trivial problem. At the heart of the tools offered by smiRNAdb how-
ever, is a Bayesian model for computing the posterior probability that the frequency of
a miRNA in the total miRNA population differs between two (sets of) samples. We
compute this probability assuming a binomial sampling model and integrating over the
unknown miRNA frequencies in the samples. This approach — described in details in
Berninger et al. [195] — takes into account both the variability between sample sizes
and the absolute miRNA counts.
Figure 3.1 shows the results of comparing the miRNA expression profiles of naive
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vs effector CD4+ cells. The names and sizes of the samples being compared are shown
at the top of the page, followed by the log-likelihood ratio log(Psame/Pdiff) of two
models, one that assumes that the frequencies of miRNAs are the same and one that
assumes that they can be different between the samples. The log-likelihood ratio takes
positive values when the miRNA frequencies are similar and negative values when they
are different. In this case, the log-likelihood ratio is positive, indicating that overall,
the frequencies of miRNAs in these samples are more likely to have been the same.
The list of miRNAs ranked from most dissimilar to most similar expression follows.
Each row contains the name of a miRNA, the direction of regulation (up or down),
the cloning counts and frequencies in both samples, and provides a direct link to the
predicted targets of the miRNA. The model indicates that with a 18% vs 54% cloning
frequency, and despite the small size of the effector CD4+ T cell sample, miR-142-
5p is very likely to be down-regulated in effector cells. Again, this can be inferred
from the negative value of log(Psame/Pdiff) for miR-142-5p. From this page, the
user can select one or several miRNAs that came out differentially expressed and can
browse the list of predicted targets (figure 3.2). In the case of miR-142-5p, the top
10 predicted targets include four transcription factors (AFF4, ONECUT2, ZFPM2 and
ZNF148), and a kinase (PRPF4B) involved in pre-RNA splicing. These genes could
provide a starting point for experimental studies on the function of miR-142-5p in T
lymphocytes.
Since the original release of smiRNAdb, we have implemented an additional tool
for performing principal component analysis on the miRNA expression profiles, we
added more possibilities for the user to download miRNA profile data for further pro-
cessing, and we started to incorporate other publicly available small RNA sequencing
data sets from Danio rerio, Drosophila melanogaster and Caenorhabditis elegans. We
reimplemented the software that was originally written in Perl CGI to use Java Server
Faces technology and Apache / Tomcat. The computations are now performed on a
computing cluster, with job distribution managed by the Sun Grid Engine queuing sys-
tem. Finally, we enhanced the result screens of our on-line analysis tools with hyper-
links which directly take the user to the miRNA target predictions within the context
of the smiRNAdb query, i.e. preserving the selected organism, miRNAs, and tissue
(if available). Please refer to the web connectivity map in the supplementary material
for an overview of the new links between smiRNAdb and ElMMo, as well as of the
external ressources that we use in performing various analyses.
3.2.2 The ElMMo miRNA target prediction algorithm based on
comparative genomic analysis
To be able to address the question of what mRNA is most likely affected by the change
in expression of a miRNA, we coupled smiRNAdb to a PHP-based web interface to the
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ElMMo miRNA target predictions [68].
Returning to the example of the hsa-miR-142-5p miRNA which was highlighted
in section 3.2.1, the web interface allows aside from browsing the predicted targets, a
number of other queries. For instance, given an organism (Homo sapiens in this exam-
ple), the user can choose to scan for predicted miRNA target sites not only the default
set of transcripts, which is all known RefSeq [196] mRNAs in the chosen organism,
but also subsets of transcripts. The SymAtlas project [197] of the Genomics Institute
of the Novartis Research Foundation (GNF) generated microarray-based mRNA ex-
pression profiles for a wide range of tissues. These profiles are incorporated in MirZ,
giving the user the possibility to restrict target prediction to mRNAs that are expressed
in a given cell type. The web interface further allows to scan an arbitrary number of
mRNAs for up to 20 miRNAs simultaneously. Alternatively, the user can limit the
number of mRNAs to scan to 20 mRNAs and then retrieve predicted target sites in
these mRNAs for an arbitrary number of miRNAs.
MiRNAs exert their effector function through ribonucleoprotein complexes (miRNP)
that contain, aside from the guiding miRNA a member of the Argonaute family of pro-
teins. The determinants of productive miRNA-target site interactions are not entirely
known, but a large body of work [30, 182, 198–201] established that perfect comple-
mentarity of the 7–8 nucleotides from the 5’ end of the miRNA— the so-called miRNA
“seed” — is critical for target recognition. Although miRNA target sites that do not
satisfy this constraint have been described, at the genome-wide level the accuracy of
predicting such sites is low [68, 182]. Other than perfect seed complementarity, the
location of the putative target site within the 3’ UTR [68, 69, 202], structural acces-
sibility [185, 186, 203], the nucleotide composition in its vicinity [69, 189] and the
complementarity of specific positions in the miRNA 3’ end to the target site [69] have
all been reported to improve the accuracy of miRNA target prediction, yet the relative
importance of these features remains unknown. The ElMMo miRNA target prediction
method that we developed is based on a Bayesian model that only uses comparative
genomics information. Yet it has as high an accuracy as other widely used target
prediction programs that incorporate additional constraints, and measures of predic-
tive performance on a set of experimentally validated miRNA targets in Drosophila
melanogaster can be found in the article describing the ElMMo method [68]. Im-
portantly, our model does not have any free parameters, and can easily accommodate
additional species whose genome sequence becomes available.
Going back to our example, figure 3.2 shows the ElMMo predictions for miR-142-
5p in Homo sapiens. This result screen is organized in two sections: (1) a miRNA-
centric summary featuring per-miRNA target prediction statistics and a figure showing
the smiRNAdb tissues where the selected miRNAs are mostly expressed, and (2) a
mRNA-centric summary that ranks all mRNAs predicted to be targeted by the selected
miRNAs. In this later section, mRNAs are ordered by decreasing expected number
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of miRNA target sites under selective pressure, defined as the sum of all target site
posterior probabilities for the selected miRNAs. The location of the putative target
sites in the 3’UTR is also indicated.
From the result screen, the user has the possibility to zoom onto a specific tran-
script to visualize the multiple genome alignments in the regions of the predicted target
sites, and to find additional information about the targeted mRNAs from the Genbank
database of the National Center for Biomedical Information (NCBI). Our web service
also offers the possibility to run a Gene Ontology (GO) analysis searching for GO
terms that are significantly over- or under-represented in the predicted miRNA targets
through a modified version of the GeneMerge software [204]. For instance, in the
case of miR-142-5p, the most significantly enriched Biological Process GO term is
“regulation of transcription, DNA-dependent” (hypergeometric p-value < 10−10, af-
ter Bonferroni multiple testing correction), followed by two “muscarinic acetylcholine
receptor”-associated GO terms (p < 10−10). The muscarinic acetylcholine receptor
has been shown to be involved in autocrine control of cell proliferation, including the
proliferation of immune cells [205]. This type of analyses could thus provide experi-
mental scientists with clues to the function of miR-142-5p in the naive CD4+ T cells.
The current release of ElMMo features miRNA target predictions for Homo sapi-
ens,Mus musculus, Rattus norvegicus,Danio rerio, Caenorhabditis elegans andDroso-
phila melanogaster. Of these, the Mus musculus and Rattus norvegicus predictions
were not present in our initial publication [68]. Furthermore, for the remaining or-
ganisms, the current predictions are based on the genome sequences of a larger set
of species, because more fully-sequenced genomes became available since 2007. We
further based our predictions on the most recent mRNA sequences and 3’UTR annota-
tions provided by the RefSeq database [196]. Concerning the microarray profiles that
the user can use to guide miRNA target discovery in specific tissues and aside from the
Homo sapiens profiles that were used in our original ElMMo release [68], we incor-
porated similar mRNA expression profiles for Mus musculus and Rattus norvegicus.
Finally, the ElMMo web interface now informs the user about the smiRNAdb samples
in which the selected miRNAs are most strongly expressed.
3.2.3 Experimental data
The miRNA sequences that were used for miRNA sample annotation and for miRNA
target prediction were obtained from the miRBase release 12.0 [206]. For the miRNA
profiles, MirZ includes a total of 297 samples: 173 forHomo sapiens [170], 88 forMus
musculus [170], 16 for Rattus norvegicus [170], 10 forDrosophila melanogaster [123],
9 for Danio rerio [207], and 1 for Caenorhabditis elegans [96].
For miRNA target predictions, we used the most recent genome assemblies avail-
able at the University of California Santa Cruz (UCSC) [208]: hg18 for Homo sapiens,
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mm9 for Mus musculus, rn4 for Rattus norvegicus, danRer5 for Danio rerio, ce6 for
Caenorhabditis elegans and dm3 for Drosophila melanogaster. We further used the
following UCSC genome assemblies in the pairwise genome alignments: panTro2,
rheMac2, mm9, rn4, canFam2, monDom4, bosTau4 and galGal3 for Homo sapiens;
panTro2, rheMac2, hg18, rn4, canFam2, monDom4, bosTau4 and galGal3 for Mus
musculus; panTro2, rheMac2, hg18, mm9, canFam2, monDom4, bosTau3 and gal-
Gal3 for Rattus norvegicus; tetNig1, fr2 and oryLat2 for Danio rerio; caeJap1, caePb2,
caeRem3, cb3 and priPac1 for Caenorhabditis elegans; dp4, droAna3, droEre2, dro-
Gri2, droMoj3, droPer1, droSec1, droSim1, droVir3, droWil1 and droYak2 for Droso-
phila melanogaster. mRNAs for all organisms were downloaded from the RefSeq
database on January 21st 2009.
The links between sequence entities in various databases was made by mapping
them all to the Gene database of NCBI [196]. MiRNA expression profiles, microar-
ray mRNA profiles and miRNA target predictions are stored as relational databases
managed by a PostgreSQL server (www.postgresql.org).
3.3 Conclusion and future directions
Using a concrete example comparing effector to naive CD4+ T-cells, we showed how
MirZ can help isolating miRNAs that may be involved in a given biological function,
and then provide clues into which molecular pathways may be controlled by these miR-
NAs to achieve their biological function. The integration of miRNA expression profiles
with genome-wide miRNA target prediction combined with the tools we implemented
— a Bayesian model for sample comparison, multivariate exploratory statistics, GO-
term enrichment analysis — makes MirZ a powerful tool for studying miRNA-based
regulation.
Since its publication, the miRNA expression atlas has been a valuable resource to
the research community, and with the more general availability of deep sequencing
technologies, more miRNA expression data sets are expected to emerge. Being able
to explore and compare these data sets in a unified framework is highly desirable, and
we plan to further support such analyses by updating MirZ as new data sets become
available. Particularly for Drosophila melanogaster, we currently only incorporate
small-sized samples, and for Caenorhabditis elegans a whole-worm sample.
The target prediction methods also continue to evolve. In particular, additional de-
terminants of miRNA targeting specificity must exist because not all transcripts that
contain miRNA seed matches respond in a given experiment, but what these determi-
nants are is still an open question [69, 189]. If a significantly better target prediction
method emerges, this could be incorporated in our server.
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Figure 3.1: Screenshot of the web page showing the result from comparing miRNA
expression of human CD4+ effector T cells with the CD4+ naive T cells. Details are
provided in the text
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Figure 3.2: Screenshot of the web page showing the ElMMo miRNA target predictions
for miR-142-5p in all Homo sapiens RefSeq mRNAs. The target predictions results
are organized in two sections. The first section — located on the upper part of the
web page — is miRNA-centric and features miRNA target predictions statistics as well
as a figure showing the smiRNAdb tissues where the miRNA is mostly expressed.
The second, mRNA-centric section is located on the lower part of the web page and
provides a ranked list of mRNA predicted to be targeted by miR-142-5p.
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RNA transcripts are subject to posttranscriptional gene regulation involv-
ing hundreds of RNA-binding proteins (RBPs) and microRNA-containing
ribonucleoprotein complexes (miRNPs) expressed in a cell-type depen-
dent fashion. We developed a cellbased crosslinking approach to deter-
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mine at high resolution and transcriptome-wide the binding sites of cellu-
lar RBPs and miRNPs. The crosslinked sites are revealed by thymidine
to cytidine transitions in the cDNAs prepared from immunopurified RNPs
of 4-thiouridine-treated cells. We determined the binding sites and regu-
latory consequences for several intensely studied RBPs and miRNPs, in-
cluding PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our
study revealed that these factors bind thousands of sites containing defined
sequence motifs and have distinct preferences for exonic versus intronic
or coding versus untranslated transcript regions. The precise mapping of
binding sites across the transcriptome will be critical to the interpretation
of the rapidly emerging data on genetic variation between individuals and
how these variations contribute to complex genetic diseases.
4.1 Introduction
Gene expression in eukaryotes is extensively controlled at the posttranscriptional level
by RNA-binding proteins (RBPs) and ribonucleoprotein complexes (RNPs) modu-
lating the maturation, stability, transport, editing and translation of RNA transcripts
[218–220]. Vertebrate genomes encode several hundred RBPs [221], each containing
one or more domains able to specifically recognize target transcripts. Furthermore,
hundreds of microRNAs (miRNAs) bound by Argonaute (AGO/EIF2C) proteins me-
diate destabilization and/or inhibition of translation of partially complementary target
mRNAs [67]. To understand how the interplay of these RNA-binding factors affects
the regulation of individual transcripts, high resolution maps of in vivo protein-RNA
interactions are necessary [222].
A combination of genetic, biochemical and computational approaches are typically
applied to identify RNA-RBP or RNA-RNP interactions. Microarray profiling of RNAs
associated with immunopurified RBPs (RIP-Chip) [223] defines targets at a transcrip-
tome level, but its application is limited to the characterization of kinetically stable
interactions and does not directly identify the RBP recognition element (RRE) within
the long target RNA. Nevertheless, RREs with higher information content can be de-
rived computationally from RIP-Chip data, e.g., for HuR [224] or for Pumilio [225].
More direct RBP target site information is obtained by combining in vivo UV
crosslinking [226, 227] with immunoprecipitation [228, 229] followed by the isolation
of crosslinked RNA segments and cDNA sequencing (CLIP) [230]. CLIP was used to
identify targets of the splicing regulators NOVA1 [231], FOX2 [232] and SFRS1 [233]
as well as U3 snoRNA and pre-rRNA [234], pri-miRNA targets for HNRNPA1 [235],
EIF2C2/AGO2 protein binding sites [236] and ALG-1 target sites in C. elegans [237].
CLIP is limited by the low efficiency of UV 254 nm RNA-protein crosslinking, and
the location of the crosslink is not readily identifiable within the sequenced crosslinked
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fragments, raising the question of how to separate UV-crosslinked target RNA seg-
ments from background noncrosslinked RNA fragments also present in the sample.
Here, we describe an improved method for isolation of segments of RNA bound by
RBPs or RNPs, referred to as PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced
Crosslinking and Immunoprecipitation). To facilitate crosslinking, we incorporated
4-thiouridine (4SU) into transcripts of cultured cells and identified precisely the RBP
binding sites by scoring for thymidine (T) to cytidine (C) transitions in the sequenced
cDNA.We uncovered tens of thousands of binding sites for several important RBPs and
RNPs and assessed the regulatory impact of binding on their targets. These findings
underscore the complexity of posttranscriptional regulation of cellular systems.
4.2 Results
4.2.1 Photoactivatable Nucleosides Facilitate RNA-RBPCrosslink-
ing in Cultured Cells
Random or site-specific incorporation of photoactivatable nucleoside analogs into RNA
in vitro has been used to probe RBP- and RNP-RNA interactions [238,239]. Several of
these photoactivatable nucleosides are readily taken up by cells without apparent tox-
icity and have been used for in vivo crosslinking [240]. We applied a subset of these
nucleoside analogs (Figure 4.1A) to cultured cells expressing the FLAG/HA-tagged
RBP IGF2BP1 followed by UV 365 nm irradiation. The crosslinked RNA-protein
complexes were isolated by immunoprecipitation, and the covalently bound RNA was
partially digested with RNase T1 and radiolabeled. Separation of the radiolabeled
RNPs by SDS-PAGE indicated that 4SU-containing RNA crosslinked most efficiently
to IGF2BP1. Compared to conventional UV 254 nm crosslinking, the photoactivatable
nucleosides improved RNA recovery 100- to 1000-fold, using the same amount of ra-
diation energy (Figure 4.1B). We refer to our method as PAR-CLIP (Photoactivatable-
Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) (Figure 4.1C).
We evaluated the cytotoxic effects upon exposure of HEK293 cells to 100 µM
and 1 mM of 4SU or 6SG in tissue culture medium over a period of 12 hr by mRNA
microarrays. The mRNA profiles of 4SU or 6SG treated cells were very similar to those
of untreated cells, suggesting that the conditions for endogenous labeling of transcripts
were not toxic.
To guide the development of bioinformatic methods for identification of binding
sites, we first studied human Pumilio 2 (PUM2), a member of the Puf-protein family
(Figure 4.2A) known for its highly sequence-specific RNA binding [241].
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4.2.2 Identification of PUM2 mRNA Targets and Its RRE
PUM2 protein crosslinked well to 4SU-labeled cellular transcripts (Figure 4.2B). The
crosslinked segments were converted into a cDNA library and Solexa sequenced [242].
The sequence reads were aligned against the human genome and EST databases. Reads
mapping uniquely to the genome with up to one mismatch, insertion or deletion were
used to build clusters of sequence reads (Figure 4.2C). We obtained 7523 clusters orig-
inating from about 3000 unique transcripts, 93% of which were found within the 3’
untranslated region (UTR) in agreement with previous studies [243]. All sequence
clusters with mapping and annotation information are available online
(http://www.mirz.unibas.ch/restricted/clipdata/RESULTS/index.html).
PhyloGibbs analysis [244] of the top 100 most abundantly sequenced clusters, as
expected, yielded the PUM2 RRE, UGUANAUA [245] (Figure 4.2D). Unexpectedly,
over 70% of all sequence reads that gave rise to clusters showed a T to C mutation
compared to the genome. Ranking of sequence read clusters according to the frequency
of T to C mutation further enriched for the PUM2 RRE indicating that the T to C
mutation is diagnostic of sequences interacting with the RBP. The T to C changes
were not randomly distributed: the T corresponding to U7 of the RRE mutated at
higher frequency compared to the Ts corresponding to U1 and U3 (Figure 4.2E). Our
analyses suggest that the reverse transcriptase specifically misincorporated dG across
from crosslinked 4SU residues and that local amino acid environment also affected
crosslinking efficiency. Uridines proximal to the RRE also exhibited an increased T
to C mutation frequency, indicating that crosslinks also form in close proximity to an
RRE and that our method even captured PUM2 binding sites that did not have a U7 in
its RRE.
4.2.3 Identification of QKI RNA Targets and Its RRE
To further validate our method, we applied it to the RBP Quaking (QKI), which con-
tains a single heterogeneous nuclear ribonucleoprotein K homology (KH) domain (Fig-
ures 4.3A,B). The RRE ACUAAYwas determined by SELEX [246], but in vivo targets
are largely undefined. Mice with reduced expression of QKI show dysmyelination and
develop rapid tremors or “quaking” 10 days after birth. Previous studies suggested that
QKI participates in pre-mRNA splicing, mRNA export, mRNA stability and protein
translation [247].
PhyloGibbs analysis of the 100 most abundantly sequenced clusters yielded the
RRE AYUAAY (Figures 4.3C,D), similar to a motif identified by SELEX [246]. We
found approximately 6000 clusters mapping to 2500 transcripts. Close to 75% of these
clusters were derived from intronic sequences, supporting the hypothesis that QKI is a
splicing regulator [247] and 70% of the remaining exonic clusters fall into 3’ UTRs.
Mutation analysis of the clustered sequence reads showed that the T correspond-
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ing to U2 in AUUAAY was frequently altered to C whereas the T corresponding to
U3 in AUUAAY or ACUAAY remained unaltered (Figure 4.3E). Crosslinking of 4SU
residues located in immediate vicinity to the RRE was mostly responsible for exposing
the motif with C2, showing that crosslinking inside the recognition element is not a
precondition for its identification. Hence, the discovery of RREs is unlikely to be pre-
vented by sequence-dependent crosslinking biases as long as deep enough sequencing
captures these interaction sites at and nearby the RRE.
4.2.4 T to C Mutations Occur at the Crosslinking Sites
To better characterize the T to C transition observed in crosslinked RNA segments, we
UV 365 nm crosslinked oligoribonucleotides containing single 4SU substitutions to
recombinant QKI (Figures 4.3F,G). The crosslinking efficiency varied 50-fold and mir-
rored the results of the mutational analysis (Figure 4.3G). The least effective crosslink-
ing was observed for placement of 4SU at position 3 of the QKI RRE (4SU9), and
the most effective crosslinking was found at position 2 of the QKI RRE (4SU10); the
crosslinking efficiency for two positions outside of the RRE (4SU2 and 4SU4) was in-
termediate. Neither of these substitutions affected RNA-binding to recombinant QKI
protein as determined by gel-shift analysis, whereas mutations of the recognition ele-
ment weakened the binding between 2.5- and 9-fold.
Next, we sequenced libraries prepared from noncrosslinked as well as QKI-protein-
crosslinked oligoribonucleotides containing 4SU at indicated positions (Figure 4.3F).
The fraction of sequence reads with T to C changes obtained from nonirradiated 4SU-
containing oligoribonucleotides varied between 10 and 20%, and increased to 50%
to 80% upon crosslinking. The variation of the degree of T to C changes in the
crosslinked samples is most likely determined by background of noncrosslinked olig-
oribonucleotides. Presumably, the T to C transition frequency is increased upon crosslink-
ing as a direct consequence of a chemical structure change of the 4SU nucleobase upon
crosslinking to protein amino acid side chains, resulting in altered stacking or hydrogen
bond donor/acceptor properties directing the preferential incorporation of dG rather
than dA during reverse transcription. At the doses of 4SU applied to cultured cells,
about 1 out of 40 uridines was substituted by 4SU as determined by HPLC analysis
of the nucleoside composition of total RNA. Assuming a 20% T to C conversion rate
for a noncrosslinked 4SU-labeled site, we estimated that the average T to C conver-
sion rate of 40-nt sequence reads derived from background noncrosslinked sequences
will be near 5%. Clusters of sequence reads with average T to C conversion above
this threshold, irrespective of the number of sequence reads, most certainly represent
crosslinking sites. The ability to separate signal from noise by focusing on clusters
with a high frequency of T to C mutations rather than clusters with the largest number
of reads, represents a major enhancement of our method over UV 254 nm crosslinking
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methods.
To assess whether the transcripts identified by PAR-CLIP are regulated by QKI, we
analyzed the mRNA levels of mock-transfected and QKI-specific siRNA-transfected
cells with microarrays. Transcripts crosslinked to QKI were significantly upregulated
upon siRNA transfection, indicating that QKI negatively regulates bound mRNAs (Fig-
ure 4.3H), consistent with previous reports of QKI being a repressor [247].
4.2.5 Identification of IGF2BP Family RNA Targets and Its RRE
We then applied PAR-CLIP to the FLAG/HA-tagged insulin-like growth factor 2 mRNA-
binding proteins 1, 2, and 3 (IGF2BP1-3) (Figures 4.4A,B), a family of highly con-
served proteins that play a role in cell polarity and cell proliferation [248]. These pro-
teins are predominantly expressed in the embryo and regulate mRNA stability, transport
and translation. They are re-expressed in various cancers [249, 250] and IGF2BP2 has
been associated with type-2 diabetes [251]. The IGF2BPs are highly similar and con-
tain six canonical RNA-binding domains, two RNA recognition motifs (RRMs) and
four KH domains (Figure 4.4A). Therefore, target recognition for this protein family
appears complex, with only a small number of coding and noncoding RNA targets
being known so far. A precise definition of the RREs is missing [248].
The three IGF2BPs recognized a highly similar set of target transcripts, suggesting
similar and redundant functions. PhyloGibbs analysis of the clusters derived from mR-
NAs (Figure 4.4C) yielded the sequence CAUH (H = A, U, or C) as the only consensus
recognition element (Figure 4.4D), contained in more than 75% of the top 1000 clusters
for IGF2BP1, 2 or 3. In total, we identified over 100,000 sequence clusters recognized
by the IGF2BP family that map to about 8,400 protein-coding transcripts. The annota-
tion of the clusters was predominantly exonic (ca. 90%) with a slight preference for 3’
UTR relative to coding sequence (CDS). The mutation frequency of all sequence tags
containing the element CAUH (H = A, C, or U) showed that the crosslinked residue was
positioned inside the motif, or in the immediate vicinity (Figure 4.4E). The consensus
motif CAUH was found in more than 75% of the top 1000 targeted transcripts, fol-
lowed in more than 30% by a second motif, predominantly within a distance of three to
five nucleotides. In vitro binding assays showed that nucleotide changes of the CAUH
motif decreased, but did not abolish the binding affinity (Figure 4.4F).
To test the influence of IGF2BPs on the stability of their interacting mRNAs, as re-
ported previously for some targets [248], we simultaneously depleted all three IGF2BP
family members using siRNAs and compared the cellular RNA from knockdown and
mock-transfected cells on microarrays. The levels of transcripts identified by PAR-
CLIP decreased in IGF2BP-depleted cells, indicating that IGF2BP proteins stabilize
their target mRNAs. Moreover, transcripts that yielded clusters with the highest T to C
mutation frequency were most destabilized (Figure 4.4G), indicating that the ranking
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criterion that we derived based on the analysis of PUM2 and QKI data generalizes to
other RBPs.
For comparison to conventional and high-throughput sequencing CLIP [230, 231],
we also sequenced cDNA libraries prepared from UV 254 nm crosslinking. Of the
8,226 clusters identified by UV 254 nm crosslinking of IGF2BP1, 4,795 were found
in the PAR-CLIP dataset. Although UV 254 nm crosslinking identified the identical
segments of a target RNA as PAR-CLIP, the position of the crosslink could not be
readily deduced, because no abundant diagnostic mutation was observed.
4.2.6 Identification of miRNATargets by AGO and TNRC6 Family
PAR-CLIP
To test our approach on RNP complexes, we selected the protein components mediat-
ing miRNA-guided target RNA recognition. In animal cells, miRNAs recognize their
target mRNAs through base-pairing interactions involving mostly 6–8 nucleotides at
the 5’ end of the miRNA (the so called “seed”) [67]. Target sites were thought to be
predominantly located in the 3’ UTRs of mRNAs, and computational miRNA target
prediction methods frequently resort to identification of evolutionarily conserved sites
that are located in 3’ UTRs and are complementary to miRNA seed regions [67, 252].
We isolated mRNA fragments bound by miRNPs from HEK293 cell lines stably
expressing FLAG/HA-tagged AGO or TNRC6 family proteins [192]. The AGO IPs re-
vealed two prominent RNA-crosslinked bands of 100 and 200 kDa, representing AGO,
and likely TNRC6 and/or DICER1 protein. The TNRC6 IPs showed one prominent
RNA-crosslinked protein of 200 kDa (Figure 4.5A).
From clusters (Figure 4.5B) formed by at least 5 PAR-CLIP sequence reads and
containing more than 20% T to C transitions, we extracted 41 nt long regions centered
over the predominant T to C transition or crosslinking site. The length of the crosslink-
centered regions (CCRs) was selected to include all possible registers of miRNA/target-
RNA pairing interactions relative to the crosslinking site.
PAR-CLIP of individual AGO proteins yielded on average about 4000 clusters that
overlapped, supporting our earlier observation that AGO1-4 bound similar sets of tran-
scripts [192]. We therefore combined the sequence reads obtained from all AGO ex-
periments, which yielded 17,319 clusters of sequence reads at a cut-off of 5 reads.
These clusters distributed across 4647 transcripts with defined GeneIDs, correspond-
ing to 21% of the 22,466 unique HEK293 transcripts that we identified by digital gene
expression (DGE).
PAR-CLIP of individual TNRC6 proteins yielded on average about 600 clusters
that also overlapped substantially, again consistent with our observation that TNRC6
family proteins bind similar transcripts [192]. We therefore combined all sequence
reads from all TNRC6 experiments, yielding 1865 clusters and CCRs. More than 50%
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of these TNRC6 CCRs fell within 25 nt of an AGO CCR, and 26% overlapped by at
least 75%, indicating that AGO and TNRC6 members bind to the same sites.
4.2.7 Comparison of miRNAProfiles fromAGOPAR-CLIP to Non-
crosslinked miRNA profiles
To relate the potential miRNA-target-site–containing CCRs to the endogenously ex-
pressed miRNAs, we determined the miRNA profiles from total RNA isolated from
HEK293 cells, and miRNAs isolated from noncrosslinked AGO1-4 IPs by Solexa se-
quencing [242], and compared them to the profile from the miRNAs present in the
combined AGO1-4 PAR-CLIP library. miRNA profiles obtained from total RNA and
IP of the four AGO proteins in noncrosslinked cells correlated well (Figure 4.5C) sup-
porting our observation that AGO1-4 bind the same targets [192]. The most abundant
among the 557 identified miRNAs and miRNAs* were miR-103 (7% of miRNA se-
quence reads), miR-93 (6.5%), and miR-19b (5.5%). The 25 and 100 most abundant
miRNAs accounted for 72% and 95% of the total of miRNA sequence reads, respec-
tively. Comparison of the miRNA profile derived from the combined AGO PAR-CLIP
library with the combined noncrosslinked libraries showed a good correlation (Spear-
man correlation coefficient of 0.56, Figure 4.5C).
Importantly, in the AGO PAR-CLIP library, the majority of miRNA sequence reads
derived from prototypical miRNAs [170] displayed T to C conversion near or above
50%. The T to C conversion was predominantly concentrated within positions 8 to 13
(Figure 4.5D), residing in the unpaired regions of the AGO protein ternary complex
[29]. Five of the 100 most abundant miRNAs in HEK293 cells lack uridines at position
8–13, yet only 2 of those miRNAs, miR-374a and b, showed no crosslinking, because
uridines at residues 14 and higher can still be crosslinked. This frequency of crosslinks
was substantially lower in the miRNAs whose expression did not correlate between
AGO-IP and AGO PAR-CLIP samples compared to the miRNAs whose expression
correlated well.
4.2.8 mRNAs Interacting with AGOs Contain miRNA Seed Com-
plementary Sequences
Independent of any pairing models for miRNAs and their targets, we first determined
the enrichment of all 16,384 possible 7-mers within the 17,319 AGO CCRs, relative
to random sequences with the same dinucleotide composition. The most significantly
enriched 7-mers, except for a run of uridines, corresponded to the reverse complement
of the seed region (position 2–8) of the most abundant HEK293miRNAs, and they were
most frequently positioned 1–2 nt downstream of the predominant crosslinking site
within the CCRs (Figure 4.6A). This places the crosslinking site near the center of the
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AGO-miRNA-target-RNA ternary complex, where the target RNA is proximal to the
Piwi/RNase H domain of the AGO protein [29]. The polyuridine motif lies within the
region of target RNA that may be able to basepair with the 3’ half of miRNA loaded into
AGO proteins [29, 253]. Therefore, these stretches of uridine may contribute directly
to miRNA-target RNA hybridization or, as has been suggested previously, they may
represent an independent determinant of miRNA targeting specificity [69, 254].
To further examine the positional dependence of target RNA crosslinking, we aligned
the CCRs containing 7-mer seed complements to the 100 most abundant miRNAs
and plotted the position-dependent frequency of finding a crosslinked position (Fig-
ure 4.6B). This identified two additional crosslinking regions, which correspond to the
unpaired 5’ and 3’ ends of the target RNA exiting from the AGO ternary complex, in-
dicating that the window size of 41 nt centered on the predominant crosslink position
always included the miRNA-complementary sites.
We then computed the number of occurrences of miRNA-complementary sequences
of various lengths in the CCRs and calculated their enrichment. The most significant
enrichment was generally obtained with 8-mers that were complementary to miRNA
seed regions (pos. 1–8). Inspection of the region between 3 nt upstream and 9 nt
downstream of the predominant crosslinking site reveals that approximately 50% of
the CCRs contain 6-mers corresponding to one of the top 100 expressed miRNAs, with
a 1.5-fold enrichment over random 6-mers. Given that 6-mers still showed some de-
gree of excess conservation in comparative genomics studies [68, 182] and that our
analysis was focused on a narrow window directly downstream of the crosslinking site,
our results suggest that the majority of the CCRs represent bona fide miRNA binding
sites. Furthermore, the number of miRNA seed complements for all known miRNAs
correlated well with the expression levels of miRNAs found in HEK293 cells, and less
well with miRNA profiles of other tissue samples.
The nucleotide composition of CCRs that contained at least one 7-mer seed comple-
mentary to one of the top 100 expressed miRNA showed a slightly elevated U-content
(approx. 30% U) compared to those CCRs not containing seed matches, which was
expected from previous bioinformatic analyses of functional miRNA-binding sites.
4.2.9 Noncanonical and 3’ End Pairing of miRNAs to their mRNA
Targets Is Limited
Structural and biochemical studies of the ternary complex of T. thermophilus Ago,
guide and target indicated that small bulges and mismatches could be accommodated
in the seed pairing region within the target RNA strand ( [29]). We therefore searched
for putative target RNA binding sites that did not conform to the model of perfect
miRNA seed pairing, but rather contained a discontinuous segment of sequence com-
plementarity to either target or miRNA with a minimum of 6 base pairs. We only
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considered pairing patterns if they were significantly enriched in CCRs compared to
dinucleotide randomized sequences, and if the CCRs containing them did not at the
same time contain perfectly pairing seed-type sites. We identified 891 CCRs with mis-
matches and 256 with bulges in the seed region. Mismatches occurred most frequently
across from position 5 of the miRNA as G-U or U-G wobbles, U-U mismatches and
A-G mismatches (A residing in the miRNA). Therefore, it appears that only a small
fraction of the miRNA target sites that we isolated (less than 6.6%), contained bulges
or loops in the seed region.
To assess the role of auxiliary base pairing outside of the seed region, we selected
CCRs that contained a 7-mer seed match to one of the 100 most abundant miRNAs.
Supporting earlier computational results [69], we also detected a weak signal for con-
tiguous 4-nt long matches to positions 13–15 of the miRNA (Figure 4.6C).
4.2.10 miRNABinding Sites in CDS and 3’ UTRDestabilize Target
mRNAs to Different Degrees
The majority (84%) of AGO CCRs originated in exonic regions, with only 14% from
intronic, and 2% from undefined regions. Of the exonic CCRs, 4% corresponded to 5’
UTRs, 50% to CDS, and 46% to 3’ UTRs (Figure 4.6D).
Evidence of widespread binding of miRNAs to the CDS was reported before [182,
255]. However, miRNAs are believed to predominantly act on 3’ UTRs [67], with rel-
atively few reports providing experimental evidence for miRNA-binding to individual
5’ UTRs or CDS [255–259].
To obtain evidence that AGO CCRs indeed contain functional miRNA-binding
sites, we blocked 25 of the most abundant miRNAs in HEK293 cells (Figure 4.5C) by
transfection of a cocktail of 2’-O-methyl-modified antisense oligoribonucleotides and
monitored the changes in mRNA stability by microarrays (Figure 4.7A). Consistent
with previous studies of individual miRNAs [69], the magnitude of the destabilization
effects of transcripts containing at least one CCR depended on the length of the seed-
complementary region and dropped from 9-mer to 8-mer to 7-mer to 6-mer matches
(Figure 4.7B). We did not find evidence for significant destabilization of transcripts
that only contained imperfectly paired seed regions.
Next, we examined whether the change in stability of CCR-containing transcripts
correlated with the number of binding sites. We found that multiple sites were more
destabilizing compared to single sites (Figure 4.7C), and that multiple binding sites
may also reside within a single 41-nt CCR. Both of these findings are in agreement
with previous observations [69].
Then we analyzed the impact on stability for transcripts with CCRs exclusively
present either in the CDS or the 3’ UTR; there were not enough transcripts to assess
the impact of CCRs derived from the 5’ UTR. CDS-localized sites only marginally
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reduced mRNA stability (Figure 4.7D), independent of the extent of seed pairing. To
gain more insights into miRNA binding in the CDS, we examined the codon adapta-
tion index (CAI) [260] around crosslinked seed matches, and found that the sequence
environment of crosslinked seed matches differed from that of noncrosslinked seed
matches in the CAI. The bias in codon usage extended for at least 70 codons up- as
well as downstream of the crosslinked seed matches (Figure 4.7E), which also corre-
lates well with the marked increase in the A/U content around the binding sites that
would lead to a codon usage bias. It was recently reported that miRNA regulation in
the CDS was enhanced by inserting rare codons upstream of the miRNA-binding site,
presumably due to increased lifetime of miRNA-target-RNA interactions as ribosomes
are stalled [261]. These observations suggest that transcripts with reduced translational
efficiency form at least transient miRNP complexes amenable to UV crosslinking.
The abundance of mRNAs expressed in HEK293 cells varied over 5 orders of mag-
nitude as shown by DGE profiling. When we related the expression level of CCR-
containing transcripts with the magnitude of transcript stabilization after miRNA inhi-
bition, we found that miRNAs preferentially act on transcripts with low and medium
expression levels (Figure 4.7F). Highly expressed mRNAs appear to avoid miRNA
regulation [190], at least for those miRNAs expressed in HEK293 cells. However, we
cannot fully rule out that the weaker response of highly abundant targets may be due
to lower affinity and reduced occupancy of miRNA binding sites in highly abundant
transcripts.
Earlier studies defining miRNA target regulation were carried out by transfection
of miRNAs into cellular systems originally devoid of these miRNAs [81, 84, 85]. We
transfected miRNA duplexes corresponding to the deeply conserved miR-7 and miR-
124 into FLAG/HA-AGO2 cells, performed PAR-CLIP, and also recorded the effect
on mRNA stability upon miR-7 and miR-124 transfection by microarray analysis.
Transcripts containing miR-7- or miR-124-specific CCRs were destabilized, especially
when CCRs were located in the 3’ UTR.
4.2.11 Context Dependence of miRNA Binding
Not every seed-complementary sequence in the HEK293 transcriptome yielded a CCR,
thereby providing an opportunity to identify sequence context features specifically con-
tributing to miRNA target binding and crosslinking. For seed-complementary sites that
were crosslinked and those that were not crosslinked, we computed the evolutionary
selection pressure by the ElMMo method [68], the mRNA stability scores by Tar-
getScan context score [69], and sequence composition and structure measures for the
regions around the miRNA seed complementary sites. The feature that distinguished
most crosslinked from noncrosslinked seed matches was a 25% lower free energy re-
quired to resolve local secondary structure involving the miRNA-binding region, as-
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sociated with a 6% increase in the A/U content within 100 nt around the seed-pairing
site. These differences were similar for sites located in the CDS and 3’ UTRs. Com-
pared to noncrosslinked sites, crosslinked sites are under stronger evolutionary selec-
tion (ElMMo) and in sequence contexts facilitating miRNA-dependent mRNA degra-
dation (TargetScan context score).
The location of AGO CCRs within transcript regions was nonrandom and 7-mer or
8-mer sites within the 3’ UTR were preferentially located near the stop codon or the
polyA tail in transcripts with relatively long 3’ UTRs (more than 3 kb). The location
of CCRs in the CDS was biased toward the stop codon for the transfected miR-7 and
124, but not for the endogenous miRNAs.
Finally, we wanted to examine how miRNA targets defined by PAR-CLIP com-
pared in regulation of target mRNA stability to those predicted by ElMMo [68], Tar-
getScan context score [69], TargetScan Pct [65] and PicTar [262]. In each case, we se-
lected the same number of highest-scoring sites containing a 7-mer seed-complement
to the top 5 expressed miRNAs (let-7a, miR-103, miR-15a, miR-19a, and miR-20a).
The analysis was limited to 3’ UTR sites due to restriction by the prediction meth-
ods. The effect on mRNA stability, as assessed by miRNA antisense inhibition, was
overall equivalent for transcripts harboring CCRs compared to transcripts predicted by
ElMMo, TargetScan context score, TargetScan Pct and PicTar.
4.3 Discussion
Maturation, localization, decay and translational regulation of mRNAs involve for-
mation of complexes of RBPs and RNPs with their RNA targets [218, 219]. Several
hundred RBPs are encoded in the human genome, many of them containing combi-
nations of RNA-binding domains which are drawn from a relatively small repertoire,
resulting in diverse structural arrangements and different specificities of target RNA
recognition [263]. Furthermore hundreds of miRNAs function together with AGO and
TNRC6 proteins to destabilize target mRNAs and/or repress their translation [67]. Col-
lectively, these factors and their presumably combinatorial action constitute the code
for posttranscriptional gene regulation. Here we describe an approach to directly iden-
tify transcriptome-wide mRNA-binding sites of regulatory RBPs and RNPs in live
cells.
4.3.1 PAR-CLIPAllows High-ResolutionMapping of RBP andmiRNA
Target Sites
We showed that application of photoactivatable nucleoside analogs to live cells facili-
tates RNA-protein crosslinking and transcriptome-wide identification of RBP and RNP
binding sites. We concentrated on 4SU after it became apparent that the crosslinking
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sites in isolated RNAs were revealed upon sequencing by a prominent transition from
T to C in the cDNA prepared from the isolated RNA segments. Compared to regular
UV 254 nm crosslinking in the absence of photoactivatable nucleosides, our method
has two distinct advantages. We obtain higher yields of crosslinked RNAs using simi-
lar radiation intensities, and more importantly, we can identify crosslinked regions by
mutational analysis. Studies using conventional UV 254 nm CLIP have not reported
the incidence of deletions and substitutions [230,231,236,237], except for recent work
by Grannemann et al. on the U3 snoRNA that showed an increase of deletions at the
RBP binding site [234]. Our own analysis indicates that mutations in sequence reads
derived from UV 254 nm CLIP were at least one order of magnitude less frequent than
T to C transitions observed in PAR-CLIP.
From an experimental perspective, it is important to note that crosslinked RNA
segments, irrespective of the methods of isolation, are always contaminated with non-
crosslinked RNAs, as shown by consistent identification of rRNAs, tRNAs, and miR-
NAs. Compared to crosslinked RNA fragments, these unmodified RNA molecules
are more readily reverse transcribed, which underscores the need for separation of
crosslinked signal from noncrosslinked noise. We now provide a method that accom-
plishes this critical task.
4.3.2 Context Dependence of 4SU Crosslink Sites
It is conceivable that binding sites located in peculiar sequence environments, e.g.,
those completely devoid of U, may exist and cannot be captured using 4SU-based
crosslinking. However, such sites are extremely rare. Only about 0.4% of 32-nt long
sequence segments, representative of the length of our Solexa sequence reads, are U-
less, corresponding to an occurrence of one such segment in every 8 kb of a transcript.
Nonetheless, to provide a means to resolve such unlikely situations, we explored
the use of other photoactivatable nucleosides, such as 6SG to identify IGF2BP1 bind-
ing sites. We found a good correlation between the sequence reads obtained from a
given gene with 4SU and 6SG (Pearson correlation coefficient 0.65). Moreover, the se-
quence read clusters, representing individual binding sites, overlapped strongly: 59%
out of the 47,050 6SG clusters were also identified with 4SU, despite of the fact that
the environment of IGF2BP1 binding sites was strongly depleted for guanosine. Inter-
estingly, the sequence reads obtained after 6SG crosslinking were enriched for G to A
transitions, pointing to a structural change in 6SG analogous to the situation in PAR-
CLIP with 4SU. Because 6SG appears to have lower crosslinking efficiency compared
to 4SU, we recommend to first use 4SU and then resort to 6SG when the data indicates
that the sites of interest are located in sequence contexts devoid of uridines. It is impor-
tant to point out that neither of these photoactivatable nucleotides appears to be toxic
under our recommended conditions.
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4.3.3 miRNA Target Identification
When applying PAR-CLIP to isolate miRNA-binding sites, we were surprised to find
nearly 50% of the binding sites located in the CDS. However, miRNA inhibition ex-
periments showed that miRNA binding at these sites only caused small, yet significant
mRNA destabilization. In spite of the difference in their efficiency of triggering mRNA
degradation, CDS and 3’ UTR sites appear to have similar sequence and structure fea-
tures. The sequence bias around CDS sites is associated with an increased incidence of
rare codon usage, which could in principle reduce translational rate, thereby providing
an opportunity for transient miRNP binding and regulation. Similar observations were
made previously using artificially designed reporter systems [261].
The use of the knowledge of the crosslinking site allowed us to narrowly define
the miRNA-binding regions for matching the site with the most likely miRNA en-
dogenously co-expressed with its targets, and to assess noncanonical miRNA-binding
modes. We were able to explain the majority of PAR-CLIP binding sites by con-
ventional miRNA-mRNA seed-pairing interactions [69], yet found that about 6% of
miRNA target sites might best be explained by accepting bulges or mismatches in the
seed pairing region, similar to the interaction between let-7 and its target lin-41 [264]
and those recently observed in biochemical and structural studies of T. thermophilus
Ago protein [29, 253].
4.3.4 The mRNA Ribonucleoprotein Code and Its Impact on Gene
Regulation
We were able to identify all of the crosslinkable RNA-binding sites present in about
9,000 of the top-expressed mRNA in HEK293 cells representing approximately 95%
of the total mRNAmolecules of a cell. One of the surprising outcomes of our study was
that each of the examined RBPs or miRNPs bound and presumably controlled between
5 and 30% of the more than 20,000 transcripts detectable in HEK293 cells. These re-
sults demonstrate that a transcript will generally be bound and regulated by multiple
RBPs, the combination of which will determine the final gene-specific regulatory out-
come. Exhaustive highresolution mapping of RBP– and RNP–target-RNA interactions
is critical, because it may lead to the discovery of specific combination of sites (or mod-
ules) that may control distinct cellular processes and pathways. To gain further insights
into the dynamics of mRNPs it will be important to also map the sites of RNA-binding
factors, such as helicases, nucleases or polymerases, where the specificity determinants
are poorly understood. The precise identification of RNA interaction sites will be ex-
tremely useful for interrogating the rapidly emerging data on genetic variation between
individuals and whether some of these variations possibly contribute to complex ge-
netic diseases by affecting posttranscriptional gene regulation.
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4.4 Experimental Procedures
4.4.1 PAR-CLIP
Human embryonic kidney (HEK) 293 cells stably expressing FLAG/HA-tagged IGF2BP1-
3, QKI, PUM2, AGO1-4, and TNRC6A-C [192] were grown overnight in medium
supplemented with 100 µM 4SU. Living cells were irradiated with 365 nm UV light.
Cells were harvested and lysed in NP40 lysis buffer. The cleared cell lysates were
treated with RNase T1. FLAG/HA-tagged proteins were immunoprecipitated with
anti-FLAG antibodies bound to Protein G Dynabeads. RNase T1 was added to the
immunoprecipitate. Beads were washed and resuspended in dephosphorylation buffer.
Calf intestinal alkaline phosphatase was added to dephosphorylate the RNA. Beads
were washed and incubated with polynucleotide kinase and radioactive ATP to label
the crosslinked RNA. The protein-RNA complexes were separated by SDS-PAGE and
electroeluted. The electroeluate was proteinase K digested. The RNA was recovered
by acidic phenol/chloroform extraction and ethanol precipitation. The recovered RNA
was turned into a cDNA library as described [242] and Solexa sequenced. The ex-
tracted sequence reads were mapped to the human genome (hg18), human mRNAs and
miRNA precursor regions. For a more detailed description of the methods, see the
Extended Experimental Procedures. For a video presenting the procedure please visit
http://www.jove.com/index/Details.stp?ID=2034.
4.4.2 Oligonucleotide Transfection and mRNA Array Analysis
siRNA, miRNA and 20-O-methyl oligonucleotide transfections of HEK293 T-REx Flp-
In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen)
as described by the manufacturer. Total RNA of transfected cells was extracted using
TRIZOL following the instructions of the manufacturer. The RNA was further pu-
rified using the RNeasy purification kit (QIAGEN). 2 µg of purified total RNA was
used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to
manufacturer’s protocol. Biotinylated cRNA targets were cleaned up, fragmented, and
hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix). For details of the
analysis, see Bioinformatics section in the Supplementary Material.
4.4.3 Generation of Digital Gene Expression (DGEX) Libraries
1 µg each of total RNA from HEK293 cells inducibly expressing tagged IGF2BP1 be-
fore and after induction was converted into cDNA libraries for expression profiling by
sequencing using the DpnII DGE kit (Illumina) according to instructions of the man-
ufacturer. For details of the analysis, see Bioinformatics section in the Supplemental
Information.
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Figure 4.1: PAR-CLIP Methodology. (A) Structure of photoactivatable nucleo-
sides. (B) Phosphorimages of SDS-gels that resolved 5’-32P-labeled RNA–FLAG/HA-
IGF2BP1 immunoprecipitates (IPs) prepared from lysates from cells that were cul-
tured in media in the absence or presence of 100 µM photoactivatable nucleoside
and crosslinked with UV 365 nm. For comparison, a sample prepared from cells
crosslinked with UV 254 nm, was included. Lower panels show immunoblots probed
with an anti-HA antibody. (C) Illustration of PAR-CLIP. 4SU-labeled transcripts were
crosslinked to RBPs and partially RNase-digested RNA-protein complexes were im-
munopurified and size-fractionated. RNA molecules were recovered and converted
into a cDNA library and deep sequenced. 57
Figure 4.2: RNA Recognition by PUM2 Protein. (A) Domain structure of PUM2
protein. (B) Phosphorimage of SDS-gel of radiolabeled FLAG/HA-PUM2-RNA com-
plexes from nonirradiated or UV-irradiated 4SU-labeled cells. The lower panel shows
an anti-HA immunoblot. (C) Alignments of PAR-CLIP cDNA sequence reads to corre-
sponding regions in the 3’ UTR of ELF1 and HES1 Refseq transcripts. The number of
sequence reads (# reads) and mismatches (errors) are indicated. Red bars indicate the
PUM2 recognition motif and red-letter nucleotides indicate T to C sequence changes.
(D) Sequence logo of the PUM2 recognition motif generated by PhyloGibbs analysis
of the top 100 sequence read clusters. (E) T to C positional mutation frequency for
PAR-CLIP clusters anchored at the 8-nt recognition motif from all motif-containing
clusters. The dashed line represents the average T to C mutation frequency within
these clusters.
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Figure 4.3: RNA Recognition by QKI Protein. (A) Domain structure of QKI protein.
(B) Phosphorimage of SDS-gel resolving radiolabeled RNA crosslinked to FLAG/HA-
QKI IPs from nonirradiated or UV-irradiated 4SU-labeled cells. The lower panel shows
the anti-HA immunoblot. (C) Alignments of PAR-CLIP cDNA sequence reads to the
corresponding regions in the 3’ UTRs of the CTNNB1 and HOXD13 transcripts. Red
bars indicate the QKI recognition motif and red-letter nucleotides indicate T to C se-
quence changes. (D) Sequence logo of the QKI recognition motif generated by Phy-
loGibbs analysis of the top 100 sequence read clusters. (E) T to C positional mutation
frequency for PAR-CLIP clusters anchored at the AUUAAY (left panel) and ACUAAY
(right panel) RRE; Y = U or C. The dashed line represents the average T to C mutation
frequency within these clusters.
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Figure 4.3: RNA Recognition by QKI Protein. (F) Sequences of synthetic 4SU-
labeled oligoribonucleotides with QKI recognition motifs, derived from a sequence
read cluster aligning to the 3’ UTR of HOXD13 shown in (C) 4SU-modified residues
are underlined. (G) Phosphorimage of SDS-gel resolving recombinant QKI protein
after crosslinking to radiolabeled synthetic oligoribonucleotides shown in (F). (H) Sta-
bilization of QKI-bound transcripts upon siRNA knockdown. Two distinct siRNA du-
plexes (1, orange traces and 2, black traces) were used for QKI knockdown and changes
in transcript stability relative to mock transfection were inferred from microarray anal-
ysis. Shown are the distributions of changes upon siRNA transfection for transcripts
that did (dashed lines) or did not (solid lines) contain QKI PAR-CLIP clusters. The p-
values obtained in the Wilcoxon rank-sum test comparing the changes in targeted and
nontargeted transcripts are indicated.
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Figure 4.4: RNA Recognition by the IGF2BP Protein Family. (A) Domain struc-
ture of IGF2BP1-3 proteins. (B) Phosphorimage of an SDS-gel resolving radiolabeled
RNA crosslinked to FLAG/HA-IGF2BP1-3 IPs. The lower panel shows anti-HA im-
munoblots. (C) Alignments of IGF2BP1 PAR-CLIP cDNA sequence reads to the cor-
responding regions of the 3’ UTRs of EEF2 and MRPL9 transcripts. Red bars indi-
cate the 4-nt IGF2BP1 recognition motif and nucleotides marked in red indicate T to
C sequence changes. (D) Sequence logo of the IGF2BP1-3 RRE generated by Phy-
loGibbs analysis of the top 100 sequence read clusters. (E) T to C positional muta-
tion frequency for PAR-CLIP clusters anchored at the 4-nt recognition motif from all
motif-containing clusters. The dashed line represents the average T to C mutation fre-
quency within these clusters. (F) Phosphorimage of native PAGE resolving complexes
of recombinant IGF2BP2 protein with wild-type (left panel) and mutated target olig-
oribonucleotide (right panel). Sequences and dissociation constants (Kd) are indicated.
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Figure 4.4: RNA Recognition by the IGF2BP Protein Family. (G) Destabilization
of IGF2BP-bound transcripts upon siRNA knockdown. A cocktail of three siRNA
duplexes targeting IGF2BP1, 2, and 3 was used, as well as a mock transfection and
changes in transcript stability were monitored by microarray analysis. Distributions of
transcript level changes for IGF2BP1-3 PAR-CLIP target transcripts versus nontargeted
transcripts are shown. IGF2BP1-3 target sequences were ranked and divided into bins.
The p-values indicate the significance of the difference between the changes of target
versus nontarget transcripts, as given by the Wilcoxon rank-sum test and are corrected
for multiple testing.
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Figure 4.5: AGO Protein Family and TNRC6 Family PAR-CLIP. (A) Phospho-
rimage of SDS-gels resolving radiolabeled RNA crosslinked to the FLAG/HA-AGO1-
4 and FLAG/HA-TNRC6A-C IPs. The lower panel shows the immunoblot with an
anti-HA antibody. (B) Alignment of AGO PAR-CLIP cDNA sequence reads to the
corresponding regions of the 3’ UTRs of PAG1 and OGT. Red bars indicate the 8-nt
miR-103 seed complementary sequence and nucleotides marked in red indicate T to
C mutations. (C) miRNA profiles from RNA isolated from untreated HEK293 cells,
noncrosslinked FLAG/HA-AGO1-4 IPs, and combined AGO1-4 PAR-CLIP libraries.
The color code represents relative frequencies determined by sequencing. miRNAs in-
dicated in red were inhibited by antisense oligonucleotides for the transcriptome-wide
characterization of the destabilization effect of miRNA binding. (D) T to C positional
mutation frequency for miRNA sequence reads is shown in black, and the normalized
frequency of occurrence of uridines within miRNAs is shown in red. The dashed red
line represents the normalized mean U frequency in miRNAs.
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Figure 4.6: AGO PAR-CLIP Identifies miRNA Seed-Complementary Sequences
in HEK293 Cells (A) Representation of the 10 most significantly enriched 7-mer se-
quences within PAR-CLIP CCRs. T/C indicates the predominant T to C transition
within clusters of sequence reads. (B) T to C positional mutation frequency for clusters
of sequence reads anchored at the 7-mer seed complementary sequence (pos. 2–8 of
the miRNA) from all clusters containing seed-complementary sequences to any of the
top 100 expressed miRNAs in HEK293 cells. The dashed line represents the average
T to C mutation frequency within the clusters. (C) Identification of 4-nt base-pairing
regions contributing to miRNA target recognition. CCRs with at least one 7-mer seed
complementary region to one of the top 100 expressed miRNAs were selected. The
number of 4-nt contiguous matches in the CCRs relative to the 5’ end of the match-
ing miRNA was counted. (D) Analysis of the positional distribution of CCRs. The
number of clusters annotated as derived from the 5’ UTR, CDS or 3’ UTR of target
transcripts is shown (green bars). Yellow bars show the expected location distribution
of the crosslinked regions if the AGO proteins bound without regional preference to
the target transcript.
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Figure 4.7: Relationship between Various Features of miRNA/Target RNA In-
teractions and mRNA Stability. (A) FLAG/HA-AGO2-tagged HEK293 cells were
transfected with a cocktail of 25 2’-O-methyl modified antisense oligoribonucleotides,
inhibiting miRNAs marked in red in Figure 4.5C, or mock transfected, followed by mi-
croarray analysis of the change of mRNA expression levels. (B) Transcripts contain-
ing CCRs were categorized according to the presence of n-mer seed complementary
matches and the distributions of stability changes upon miRNA inhibition are shown
for these categories. The stability change for transcripts harboring CCRs without iden-
tifiable miRNA seed-complementary regions is also shown. The p values indicate the
significance of the difference between the transcript level changes of transcripts con-
taining CCRs versus transcripts without CCRs, as given by the Wilcoxon rank-sum test
and are corrected for multiple testing. (C) Transcripts were categorized according to
the number of CCRs they contained. (D) Transcripts were categorized according to the
positional distribution of CCRs. Only transcripts containing CCRs exclusively in the
indicated region are used.
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Figure 4.7: Relationship between Various Features of miRNA/Target RNA Inter-
actions and mRNA Stability. (E) Codon adaptation index (CAI) for transcripts con-
taining 7-mer seed complementary regions (pos. 2-8) in the CDS for the miR-15,
miR-19, miR-20, and let-7 miRNA families. The red and the black lines indicate the
CAI for seed-complementary sequence containing transcripts bound and not bound by
AGO proteins determined by AGO PAR-CLIP. (F) LOESS regression of total tran-
script abundance in HEK293 cells (log2 of sequence counts determined by digital gene
expression (DGE)) against fold change of transcript abundance (log2) determined by
microarrays after transfection of the miRNA antagonist cocktail versus mock transfec-
tion of AGO-bound and unbound transcripts.
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Loss of microRNA (miRNA) pathway components negatively affects dif-
ferentiation of embryonic stem (ES) cells, but the underlying molecu-
lar mechanisms remain poorly defined. Here we characterize changes in
mouse ES cells lacking Dicer (Dicer1). Transcriptome analysis ofDicer−/−
cells indicates that the ES-specific miR-290 cluster has an important reg-
ulatory function in undifferentiated ES cells. Consistently, many of the
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defects in Dicer-deficient cells can be reversed by transfection with miR-
290 family miRNAs. We demonstrate that Oct4 (also known as Pou5f1)
silencing in differentiating Dicer−/− ES cells is accompanied by accu-
mulation of repressive histone marks but not by DNA methylation, which
prevents the stable repression of Oct4. The methylation defect correlates
with downregulation of de novo DNA methyltransferases (Dnmts). The
downregulation is mediated by Rbl2 and possibly other transcriptional re-
pressors, potential direct targets of miR-290 cluster miRNAs. The defec-
tive DNA methylation can be rescued by ectopic expression of de novo
Dnmts or by transfection of the miR-290 cluster miRNAs, indicating that
de novo DNA methylation in ES cells is controlled by miRNAs.
5.1 Introduction
Short 20-25-nucleotide (nt) RNAs have emerged recently as important sequence-specific
regulators of gene expression in eukaryotes [178, 265–267]. Short RNAs are pro-
duced from long double-stranded RNA (dsRNA) and miRNA precursors, which are
processed by the RNase III family enzymes Drosha and Dicer to yield mature effector
molecules, small interfering RNAs (siRNAs) and miRNAs [178, 265–268]. MiRNAs
are the dominant class of short RNAs in mammalian cells, from which several hun-
dred different miRNAs have been identified and implicated in the regulation of many
cellular processes [41,269]. Mammalian miRNAs typically base-pair imperfectly with
the 3’ untranslated region (3’ UTR) of target mRNAs and induce their translational
repression or degradation [270, 271]. The eight 5’ terminal nucleotides form the criti-
cal miRNA region for target mRNA recognition. This region, generally referred to as
the ’seed’, hybridizes nearly perfectly with the target to nucleate the miRNA-mRNA
interaction [182,201]. Most computational methods of miRNA target prediction incor-
porate this constraint [252].
ES cells are pluripotent cells derived from the inner cell mass of blastocysts. De-
pending on the culture conditions, ES cells can differentiate into various cell types
[272]. The Oct4, Sox2 and Nanog transcription factors form a core circuit respon-
sible for the transcriptional control of ES cell renewal and pluripotency [273, 274].
Mouse ES cells contain numerous miRNAs, including a cluster of six miRNAs (miR-
290 through miR-295) that share a 5’-proximal AAGUGC motif [177, 275]. The clus-
ter (for brevity referred to as the miR-290 cluster) is specific to ES cells [177]. Its
expression increases during preimplantation development [276] and remains high in
undifferentiated ES cells, but decreases after ES cell differentiation [177]. Genes and
pathways regulated by the miR-290 cluster are unknown.
The loss of Dicer in mouse ES cells results in miRNA depletion [277, 278] and
causes differentiation defects in vivo and in vitro [277]. Dicer−/− cells make no con-
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tribution to chimeric mice and fail to generate teratomas in vivo. In vitro, Dicer−/−
cells form embryoid body (EB)-like structures, but there is little morphological evi-
dence of differentiation. Expression of Oct4, a characteristic marker of pluripotent ES
cells, is only partially decreased in mutant EBs after day 5 of differentiation, and ex-
pression of endodermal and mesodermal markers is not detectable [277]. Similarly,
the loss of Dgcr8, a protein required specifically for miRNA maturation, causes partial
downregulation of pluripotency markers during retinoic acid (RA)-induced differenti-
ation [60].
In this work, we investigated the molecular mechanisms underlying the inability of
Dicer−/− ES cells to differentiate. We found that silencing of the Oct4 pluripotency
factor is properly initiated in differentiating Dicer−/− ES cells, but it is not followed
by de novo DNA methylation of the promoter. Consistent with this, we observed that
levels of de novo DNA methyltransferases are downregulated in Dicer−/− cells in an
miR-290 cluster-dependent manner. Thus, our data indicate that the de novo DNA
methylation in differentiating ES cells is regulated by ES-specific miRNAs from the
miR-290 cluster.
5.2 Results
5.2.1 Transcriptome analysis of Dicer−/− ES cells
To study the roles of miRNAs in gene regulation in ES cells, we profiled the transcrip-
tomes of Dicer−/− and Dicer+/− ES cells using Affymetrix microarrays. We found
a similar number of transcripts that were upregulated (2,551; P-value < 0.001) and
downregulated (2,578; P-value< 0.001) upon the loss of Dicer (Figure 5.1a). Analysis
of core pluripotency regulators, as well as different differentiation markers, indicated
that Dicer−/− cells retain characteristics of undifferentiated ES cells.
The binding of miRNAs to the 3’ UTR of mRNAs commonly results in degra-
dation of mRNA targets. Numerous studies have reported significant enrichment of
sequences complementary to miRNA seeds in 3’ UTRs of mRNAs that are upreg-
ulated in miRNA knockdowns, or downregulated upon overexpression of miRNAs
[77,81,279].We searched for sequence motifs that are enriched in the 3’ UTRs of tran-
scripts upregulated in the Dicer−/− ES cells and that could explain the mRNA expres-
sion changes. The three motifs that were most significantly enriched (Figure 5.1b) were
all complementary to the seed region of embryonic miRNAs [206]: miR-291a-3p, miR-
291b-3p, miR-294 and miR-295 in the case of the first and second motifs (GCACUUU
and AGCACUU), and miR-302 in the case of the third motif (GCACUUA). The seed
region of miR-302 differs from that of miR-290 cluster members only in the first nu-
cleotide. The enrichment of the GCACUUA motif may imply that miR-302 has an
important role in regulating mRNA expression in ES cells. Alternatively, it may indi-
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Figure 5.1: Transcriptome analysis of Dicer−/− embryonic stem (ES) cells (a)
M [log2(fold change)] vs. A [average log2(expression level)] plot for Dicer−/− vs.
Dicer+/− ES cells. Each dot represents a transcript. Significant expression changes
(P-value <0.001, n = 3) are shown in red. (b) Heptamer (7-mer) motif analysis of
upregulated transcripts indicates enrichment in motifs complementary to the seed of
miR-290 cluster miRNAs. Motifs whose frequency in the 3’ UTRs of upregulated
transcripts is significantly different from the frequency in the entire set of 3’ UTRs are
in shown in red. (c) Correlation between the occurrence of sequence motifs and the
change in mRNA expression. Transcripts were divided into five sets on the basis of
their change in expression in Dicer−/− compared with Dicer−/− ES cells as follows:
strong down, more than 2-fold downregulation; down, 1.2-fold to 2-fold downregu-
lation; not changed, 1.2-fold downregulation to 1.2-fold upregulation; up, 1.2-fold to
2-fold upregulation; strong up, more than 2-fold upregulation.
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cate that miRNAs prefer target sites with an A residue opposite the 5’-most nucleotide
of the miRNA, as has been proposed before [182]. Because the same motif is also most
significantly enriched in the 3’ UTRs of mRNAs that are downregulated upon transfec-
tion with miR-290 cluster miRNAs (see below), we favor the second explanation. We
also note that the ubiquitously expressed oncogenic miRNAs of the miR-17/20/93/106
cluster share extensive similarity at their 5’ end with the embryonic miRNAs and could
also contribute to mRNA regulation in ES cells. As shown in Figure 5.1c, the fre-
quency of the top three motifs decreased gradually from the mRNAs that are most
strongly upregulated in Dicer−/− cells to the mRNAs that are strongly downregulated.
We examined expression of the miR-290 cluster primary transcript using available
microarray data [280]. Quantification of the primary transcript indicated that expres-
sion of the cluster occurs zygotically and reaches the highest level in the blastocyst. No-
tably, accumulation of the miR-290 cluster transcript was downregulated in Dicer−/−
ES cells, indicating a possible feedback control of its expression by the cluster or other
miRNAs. Array analysis of miRNA levels in Dicer+/− and Dicer−/− ES cells using
Exiqon arrays revealed that, as expected [170,177], miR-290 cluster miRNAs are abun-
dantly expressed in ES cells, and miR-290 cluster and other miRNA levels are reduced
in Dicer−/− cells.
5.2.2 Identification of primary miR-290 cluster targets
To increase the accuracy of the miRNA target prediction, we compared the transcrip-
tome profile of Dicer−/− ES cells (transfected with a nonspecific siRNA as a control)
with that of Dicer−/− ES cells transfected with the siRNA-like form of miRNAs of
the miR-290 cluster (Figure 5.2a). Applying the same heptamer motif analysis used
above, we found a few motifs enriched in transcripts that were downregulated after
miR-290 cluster miRNA transfection. Among them are motifs complementary to seeds
of miR-290 cluster miRNAs, identical to the top three motifs identified above (Figure
5.2b). Analysis of both array experiments showed a good inverse correlation between
transcript-level changes inDicer−/− cells (compared to Dicer+/− cells) andDicer−/−
cells transfected with miR-290 cluster miRNAs (compared to control Dicer−/− cells)
(Figure 5.4a). The correlation holds for mRNAs that carry the miR-290 cluster seed-
matching sequences in their 3’ UTR, as well as for those that do not (Figure 5.4b,c).
The correlation for mRNAs lacking seed-matching sequences anywhere in the tran-
script was as good as that shown in Figure 5.4c. These data suggest that not only
primary miRNA effects, but also many secondary gene-expression changes controlled
by miR-290 cluster miRNAs, are reversible in Dicer−/− ES cells.
To predict primary miR-290 cluster targets, we used data from both sets of mi-
croarray experiments. We intersected the lists of transcripts that showed a significant
change (P-value <0.001) in the expected direction in the Dicer−/− cells compared to
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Figure 5.2: Transcriptome analysis of Dicer−/− embryonic stem (ES) cells (a) MA-
plot for Dicer−/− ES cells transfected with the miR-290 cluster versus Dicer−/− ES
cells transfected with nonspecific siRNA as control, significant expression changes
are shown in red. (b) Heptamer motif analysis of downregulated transcripts in the
miR-290 cluster-transfected Dicer−/− cells. Many significantly enriched motifs are
complementary the seeds of the miR-290 cluster miRNAs. The motifs complementary
to the seed of siRL did not show any enrichment, indicating that there was a minimal
off-target effect.
Figure 5.3: De novo DNA methyltransferases (Dnmts) are downregulated in
Dicer−/− embryonic stem (ES) cells and their expression is rescued by miR-
290 cluster miRNAs (a) Expression of DNA methyltransferases in undifferentiated
Dicer+/− and Dicer- /- cells as analyzed by Affymetrix microarrays. The probe sets
detecting mRNAs encoding different DNA methyltransferases are indicated. Mean
expression (s.d.; n = 3) in Dicer+/− cells was set to one. Signals from probe sets de-
tecting Dnmt3a, Dnmt3b and Dnmt3l were significantly downregulated in Dicer−/−
cells (two-tailed t-test P-values, from left to right: 0.0001, 0.0006, 0.0093, 0.0022 and
0.0010). (b) Western blot analysis of Dnmt1, Dnmt3a and Dnmt3b levels in ES cells
cultured in the presence of either leukemia inhibitory factor (LIF) or retinoic acid (RA)
for 3 d. α-Tubulin was used as a loading control. Quantification of western blots shown
in b and d and in Figure 3f by image densitometry revealed a 3.0-fold to 5.6-fold change
in the level of Dnmt3a2 and a 2.0-fold to 4.4-fold change in the levels of Dnmt3b1/b6
between conditions of low and high expression of the proteins.
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Figure 5.3: De novo DNA methyltransferases (Dnmts) are downregulated in
Dicer−/− embryonic stem (ES) cells and their expression is rescued by miR-290
cluster miRNAs (c) The miR-290 cluster miRNAs induce accumulation of mRNAs
encoding Dnmt3a, Dnmt3b and Dnmt3l in Dicer−/− ES cells. Mean values (s.d.; n
= 3) observed for the siRL-transfected cells (a nonspecific control) were set to one.
The P-values, from left to right, were: 0.0102, 0.0008, 0.0021, 0.0010 and 0.0009.
(d) Dnmt3a2 and Dnmt3b expression 3 d after transfection with siRL, miR-290 clus-
ter or miR-291a-3p. Ponceau staining served as a loading control. (e) Upregulation
of Dnmt3a2 and Dnmt3b1/6 (quantified by RT-qPCR) in response to transfection of
either all miR-290 cluster miRNAs or miR-291a-3p into Dicer−/− ES cells. Mean
expression values (s.d.; n = 3) were normalized to glyceraldehyde-3-phosphate dehy-
drogenase (Gapdh) and are shown relative to corresponding siRL samples, whose ex-
pression values were set to one (dashed line). (f) Dicer loss affects transcription from
the Dnmt3b promoter. Firefly luciferase (FL) reporters containing Dnmt3b promoter
fragments were co-transfected to Dicer+/− and Dicer−/− ES cells together with the
pRL-TK control reporter. Mean FL activity values (s.e.m., n 3) in Dicer+/− ES cells
were set to one. The P-values, from left to right, were: 0.0192, 0.0391, 0.0238 and
0.0230.
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Figure 5.4: Relationship between the expression change in the Dicer−/− vs.
Dicer+/− (x-axis) and miR-290s-transfected vs. siRL-transfected Dicer−/− ES
cells (y-axis) Each dot corresponds to a single transcript, and the panels represent: (a)
all transcripts; (b) transcripts with at least one 7-mer match to one of the 1-8 posi-
tions of the miRNAs of the 290 cluster in their 3’ UTRs; (c) transcripts with no 7-mer
match to any of the miRNAs of the 290 cluster in their 3’ UTRs. The spearman rank
coefficients are indicated in each panel.
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Dicer+/− cells (upregulation) and in the miR-290 cluster-transfected Dicer−/− cells
compared to control siRNA-transfected Dicer−/− cells (downregulation). The list was
then filtered to keep only the transcripts whose 3’ UTRs had at least one match to the
GCACUU hexamer, which is common to all significantly enriched heptamers. The re-
sulting list of predicted targets contained 253 mRNAs. However, it is likely that the
number of targets is even larger, as not all expressed mRNAs are detectable by mi-
croarrays and some genes may be regulated at the protein rather than the transcript
level.
5.2.3 Indirect control of de novo methyltransferases by miRNAs
Inspection of microarray data indicated that expression of de novo DNA methyltrans-
ferase genes Dnmt3a, Dnmt3b and Dnmt3l was significantly downregulated in undif-
ferentiated Dicer−/− ES cells (Figure 5.3a). Protein levels of Dnmt3a2, Dnmt3b1
and Dnmt3b6 were also lower in Dicer−/− cells, whereas the ubiquitously expressed
isoform of Dnmt3a, Dnmt3a1 ( [281]), remained unchanged (Figure 5.3b). Notably,
expression of de novo DNA methyltransferases could be rescued, at both mRNA and
protein levels, upon transfection of all miR-290 cluster miRNAs or miR-291a-3p alone
(Figure 5.3c-e). Similar downregulation of all three Dnmt3 genes upon loss of Dicer
and their upregulation in response to transfection of miR-290 cluster miRNAs indi-
cated that miRNAs may regulate the expression of Dnmt3 genes indirectly, possibly by
controlling the activity of a common transcriptional repressor. This possibility is sup-
ported by the observations that Dnmt3a2, Dnmt3b and Dnmt3l contain similar TATA-
less GC-rich promoters, are regulated by SP1-SP3 transcription factors, and are highly
expressed in blastocysts and ES cells but are downregulated during differentiation into
somatic lineages [281–284]. To corroborate the possibility of transcriptional regula-
tion, we compared the activity of firefly luciferase (FL) reporters containing Dnmt3b
promoter regions of different lengths. Activity of the reporters was significantly lower
in Dicer−/− than in Dicer+/− ES cells (Figure 5.3f), arguing that the Dnmt3b pro-
moter is markedly repressed in cells lacking Dicer and suggesting that downregulation
of Dnmt3 genes in Dicer−/− ES cells may occur at the level of transcription.
Among the predicted primary targets of the miR-290 cluster, we identified several
annotated [285] transcriptional repressors that are upregulated during embryonic differ-
entiation after the blastocyst stage [284]. They include genes for the basic Kruppel-like
factor Klf3, the nuclear receptor Nr2f2, the zinc-finger proteins Zmynd11 and Zbtb7,
and retinoblastoma-like 2 (Rbl2) (Figure 5.5a,b). Several other observations make
Rbl2 a plausible candidate for the miR-290 cluster-regulated transcriptional repressor
of de novo DNA methyltransferases. The Rbl2 3’ UTR contains conserved potential
binding sites for miR-290 cluster miRNAs (Figure 5.5c), and Rbl2 mRNA is down-
regulated upon transfection of all miR-290 cluster miRNAs or miR-291a-3p alone into
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Dicer−/− ES cells (Figure 5.5b,d). Rbl2 repressor was recently shown to associate
with the DNMT3B promoter in human glioblastoma cells ( [286] and Discussion). In
mouse ES cells, Rbl2 is expressed at low levels, and during neuronal differentiation its
expression correlates inversely with the expression of the miR-290 cluster and de novo
DNA methyltransferases (F.M. and D. Sch”ubeler, Friedrich Miescher Institute, un-
published results). We used RNA interference to obtain more direct evidence that Rbl2
indeed regulates the expression of de novo DNA methyltransferases. Transfection of
siRNAs against Rbl2 resulted in a marked increase ofDnmt3a2 andDnmt3b expression
at both mRNA and protein levels (Figure 5.5e,f). Taken together, these data argue in
favor of Rbl2 as a target of the miR-290 cluster that acts as a repressor, downregulating
the expression of de novo DNA methyltransferases.
Figure 5.5: Retinoblastoma-like protein 2 (Rbl2) regulates the expression of
Dnmt3a2 and Dnmt3b (a) Levels of Rbl2 mRNA are upregulated in Dicer−/− cells
as indicated by analysis of Affymetrix arrays. The probe sets detecting expression of
Rbl2 are indicated. Mean expression values (±s.d.; n = 3) in Dicer+/− cells were set
to one. The P-values from left to right are 0.0010 and 0.0023. (b) Transfection of miR-
290 miRNAs into Dicer−/− ES cells downregulates the level of Rbl2 mRNA. Cells
were transfected for 24 h with either a mixture of the miR-290 cluster miRNAs or with
siRL (small interfering RNA against Renilla luciferase mRNA). Mean expression val-
ues (±s.d.; n = 3) in siRL-transfected cells were set to one. The P-values from left to
right were 0.0135 and 0.1082.
5.2.4 Defective DNA methylation of Oct4 in Dicer−/− cells
To investigate in more detail the differentiation defects in Dicer−/− cells and the pos-
sible role of the miR-290 cluster, we examined expression of Oct4, the core pluripo-
tency regulator of ES cells. When differentiation was induced with 100 nM RA in the
absence of leukemia inhibitory factor (LIF), the mRNA and protein levels of Oct4 de-
creased similarly in Dicer−/− and control cells at day 3 (Figure 5.6a). The expression
level of the orphan nuclear receptor gene Gcnf, an early repressor of Oct4, Nanog and
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Figure 5.5: Retinoblastoma-like protein 2 (Rbl2) regulates the expression of
Dnmt3a2 and Dnmt3b (c) Schematic representation of the localization of predicted
binding sites for AAGUGC seed-containing miRNAs in the 3’ UTR of Rbl2 mRNA.
Predicted binding sites that contain GU base pairs in the seed and those without GU
base pairs in the seed are marked with white and black triangles, respectively. (d)
Downregulation of Rbl2 in response to transfection of Dicer−/− ES cells with either
all miR-290 cluster miRNAs or miR-291a-3p. For other details see Figure 5.3e. (e)
Effect of Rbl2 knockdown on Dnmt3a2 and Dnmt3b mRNA levels. Cells were trans-
fected with siRNAs against Rbl2 (siRbl2) or with siRL as a control. For other details
see Figure 5.3e. (f) Western blot analysis of Dnmt3a2 and Dnmt3b expression 1 d, 2 d
or 3 d after siRbl2 transfection. Expression after transfection of siRL (3 d) is shown as
a control. Ponceau staining served as a loading control.
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other pluripotency markers [287], was upregulated to the same extent in Dicer+/− and
Dicer−/− cells after 1 d of RA treatment (Figure 5.6b). We could also detect accu-
mulation of repressive histone marks at the Oct4 promoter (Figure 5.6c,d), indicating
that the initiation of Oct4 silencing was not strongly perturbed. However, repression
of Oct4 at day 6 of differentiation was clearly stronger in Dicer+/− ES cells (Figure
5.6e). When RA was removed at day 6 and the cells were cultured in the presence
of LIF for an extra 4 d, the Oct4 mRNA levels in Dicer−/− cells increased to ap-
proximately 40% of the initial level, whereas Oct4 expression remained repressed in
Dicer+/− cells (Figure 5.6e). A similar pattern of expression was observed for Nanog.
Incomplete and reversible silencing of Oct4 in RA-treated Dicer−/− ES cells is
notably similar to findings demonstrating that the stable silencing of Oct4 is dependent
on a correct de novo methylation of DNA [288, 289]. Therefore, we used bisulfite se-
quencing to analyze the methylation status of theOct4 promoter during the RA-induced
differentiation. In Dicer+/− ES cells, DNA methylation was already detectable af-
ter 3 d of differentiation; it increased further at day 6 and remained high following
the withdrawal of RA. In marked contrast, the Oct4 promoter failed to undergo DNA
methylation in differentiating Dicer−/− cells (Figure 5.6f).
To address the possibility that impaired maintenance of DNA methylation is re-
sponsible for the observed methylation defect, we analyzed several typically hyper-
methylated sequences and found no loss of their methylation in undifferentiated or
differentiated Dicer−/− ES cells. Furthermore, expression of the maintenance DNA
methyltransferase Dnmt1 was not affected either by the loss of Dicer or upon transfec-
tion of miR-290 cluster miRNAs into Dicer−/− ES cells (Figure 5.3a-c), suggesting
that maintenance of DNA methylation is not impaired in Dicer−/− ES cells.
5.2.5 Rescue of de novo DNA methylation of Oct4 by miRNAs
We tested whether ectopic expression of Dnmt3a2, Dnmt3b and Dnmt3l, or transfec-
tion with miR-290 cluster miRNAs, is sufficient to rescue the defective Oct4 promoter
methylation. Co-transfection of Dicer−/− ES cells with constructs expressing all three
methyltransferases from a heterologous promoter restored the de novo DNA methyla-
tion in Dicer−/− cells treated with RA for 3 d (Figure 5.7a). Transfection of Dicer−/−
ES cells with miR-290 cluster miRNAs had a similar effect (Figure 5.7a). These results
indicate that the observed Oct4 promoter methylation defect is due to the repressed ex-
pression of de novo DNA methyltransferases in Dicer−/− ES cells.
To address whether the DNA methylation defect is more general, we analyzed the
methylation status of two testis-specific genes, Tsp50 and Sox30, which are silenced
in ES cells and undergo de novo DNA methylation during differentiation (F.M. and D.
Sch”ubeler, unpublished results). Dicer+/− but not Dicer−/− ES cells showed limited
DNA methylation at Tsp50 and Sox30 promoters, even in the undifferentiated state.
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Figure 5.6: Oct4 expression during differentiation of Dicer+/− and Dicer−/− em-
bryonic stem (ES) cells (a) Western blot analysis of Oct4 levels in Dicer+/− and
Dicer−/− cells cultured in the presence of either leukemia inhibitory factor (LIF) or
retinoic acid (RA) for 3 d. (b) Similar upregulation of the orphan nuclear receptor
gene Gcnf expression in Dicer+/− and Dicer−/− cells in response to RA. Expression
was estimated by RT-qPCR. The values, normalized to glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) expression, represent means (±s.e.m.; n ≥ 3). Expression in
control Dicer+/− cells at the 0 d time point was set as one. (c,d) Accumulation of
repressive histone marks at the Oct4 promoter. Dicer+/− and Dicer−/− cells, cultured
in the presence of LIF, RA for 3 d (RA, 3 d) or RA for 6 d (RA, 6 d), were used for
chromatin immunoprecipitation (ChIP) analysis using antibodies against dimethylated
histone H3 lysine 9 (H3K9me2; c) and trimethylated histone H3 lysine 27 (H3K27me3;
d). The enrichment values represent means (±s.e.m.; n ≥ 3).
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Figure 5.6: Oct4 expression during differentiation of Dicer+/− and Dicer−/− em-
bryonic stem (ES) cells (e) RT-qPCR analysis of Oct4 expression during RA-induced
differentiation at 0 d, 1 d, 3 d or 6 d, and after returning the cells to the LIF-containing
medium for up to an additional 4 days (2 d after, 4 d after). Oct4 expression was nor-
malized to Gapdh as in b (n ≥ 3). (f) Analysis of CpG methylation of the Oct4 core
promoter (positions -212 to -8) during differentiation, followed by 2 d or 4 d culture in
the presence of LIF. Each row of dots represents CpGs in one sequenced clone. Black
dots represent methylated CpGs and white dots represent unmethylated CpGs. Sites for
which the methylation status was uncertain are in gray. The cells used were the same
as those used for the experiment shown in e. Average percentages of the methylated
CpG sites are indicated.
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Differentiation of Dicer+/− but not Dicer−/− cells was accompanied by additional
DNA methylation. Nevertheless, the DNA-methylation changes at Tsp50 and Sox30
promoters were less pronounced than those observed at the Oct4 locus, and the de novo
DNA methylation of Tsp50 and Sox30 promoters was not uniformly distributed along
analyzed sequences.Ectopic expression of de novo DNA methyltransferases affected
the accumulation of DNA methylation during differentiation, whereas transfection of
miR-290 cluster miRNAs resulted in increased DNA methylation at the 3’ portion of
the Tsp50 sequence but had no appreciable effect at the Sox30 promoter. Taken to-
gether, the data suggest that the defect in de novo methylation in Dicer−/− ES cells
may be of more global character.
Dicer−/− ES cells grow substantially more slowly than Dicer+/− ES cells [278],
and we found that transfection of miR-290 cluster miRNAs into Dicer−/− ES cells
partially rescues the growth phenotype (Figure 5.7b), possibly by regulating expres-
sion of p21, an established repressor of cell-cycle progression [290]. To eliminate the
possibility that the observed changes of Oct4 DNA methylation are a consequence of
different proliferation rates rather than a specific miR-290 cluster-mediated regulation,
we tested whether the proliferation rate of ES cells has an effect on the onset of de novo
DNA methylation and the expression levels of the Dnmt3 enzymes.
To reduce proliferation of Dicer+/− ES cells to a rate similar to that of Dicer−/−
ES cells (Figure 5.7b), cells were treated with rapamycin, an inhibitor of mammalian
target of rapamycin (TOR). Rapamycin reduces the proliferation of mouse ES cells
without significantly affecting their cell-cycle profile [292], making the growth prop-
erties of rapamycin-treated Dicer+/− ES cells comparable to that of Dicer−/− cells
[278]. In Dicer+/− cells grown in the presence of rapamycin, DNA methylation read-
ily accumulated at the Oct4 promoter after 3 d of RA treatment (Figure 5.7a). Like-
wise, decreased proliferation had no significant effect on the expression of Dnmt3a2 or
Dnmt3b1/6. Furthermore, restoration of Oct4 promoter methylation by ectopic expres-
sion of de novo DNA methyltransferases occurred without an increase in the prolifera-
tion rate of Dicer−/− ES cells (Figure 5.7a,b). Taken together, these data demonstrate
that the Oct4 promoter methylation defect is not caused by the slower proliferation of
Dicer−/− ES cells but is dependent on the miR-290 cluster miRNAs.
5.3 Discussion
Our data indicate that miRNAs bearing the AAGUGC seed, largely represented by the
miR-290 cluster, are the functionally dominant miRNAs in mouse ES cells. In fact,
the miR-290 cluster miRNAs were able to reverse many of the defects due to loss of
Dicer when transfected into ES cells. We also found that de novo DNA methylation in
differentiating ES cells is controlled by the miR-290 cluster and that this regulation is
required for stable repression of Oct4. We propose that, in undifferentiated ES cells,
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Figure 5.7: Deficient de novo DNA methylation of the Oct4 promoter in Dicer−/−
embryonic stem (ES) cells can be rescued by expression of de novo DNA methyl-
transferases (Dnmts) or by transfection of miR-290 cluster miRNAs Analysis of
CpG methylation in four different Oct4 regions. The scheme identifies positions of
bisulfite-sequenced regions with respect to the Oct4 transcription start site. SP1-GCNF
depicts characterized transcription factor binding sites in the Oct4 promoter. PE-1A
and PE-1B show positions of previously characterized 1A and 1B sequences in the
proximal enhancer and DE-2A is the position of 2A sequence in the distal enhancer.
(for the detailed Oct4 promoter annotation, see [291] and references therein). Repre-
sented from top to bottom: untransfected Dicer+/− and Dicer−/− cells; Dicer−/−
cells co-transfected with plasmids expressing EGFP-Dnmt3a2, EGFP-Dnmt3b and
EGFP-Dnmt3l; Dicer−/− cells transfected with miR-290 cluster mimics; Dicer−/−
cells transfected with siRL (small interfering RNA against Renilla luciferase mRNA);
and Dicer+/− cells treated with rapamycin. Both Dicer+/− and Dicer−/− ES cells
were differentiated for 3 d with RA in the absence of LIF. For other details, see Figure
5.6f, the data originate from experiments independent of that shown in Figure 5.6f.
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Figure 5.7: Deficient de novo DNA methylation of the Oct4 promoter in Dicer−/−
embryonic stem (ES) cells can be rescued by expression of de novo DNA methyl-
transferases (Dnmts) or by transfection of miR-290 cluster miRNAs Effects of dif-
ferent treatments on proliferation of Dicer+/− and Dicer−/− ES cells. Equal numbers
of undifferentiated Dicer−/− and Dicer+/− cells were transfected with miR-290 clus-
ter miRNAs, siRL or a mix of plasmids expressing Dnmt3a2, Dnmt3b and Dnmt3l.
Alternatively, cells were grown in the presence of rapamycin. Average number of cells
is shown relative to the number of cells present at day 1 after transfection. (±s.d.; n=3).
the miR-290 cluster miRNAs suppress a transcriptional repressor that targets genes
encoding de novo DNA methyltransferases. The predicted primary targets of the miR-
290 cluster include several transcriptional repressors, and we identified Rbl2 as a factor
contributing to repression of Dnmt3 genes.
The expression of approximately one-quarter of predicted primary miR-290 clus-
ter targets in ES cells is high in the oocyte but reduced in the blastocyst and somatic
cells (data not shown). This resembles the situation in zebrafish, where the zygotic
AAGUGC seed-containing miR-430 miRNAs control the maternal mRNA degrada-
tion [72]. However, murine maternal mRNAs are largely degraded before zygotic
genome activation [280], hence before the miR-290 cluster expression. Moreover, the
transition between maternal and zygotic gene expression is much slower in mammals
than in the zebrafish [293]. Thus, the miR-290 cluster and related miRNAs restrict em-
bryonic expression of genes that are highly expressed in the oocyte rather than having
an extensive role in the rapid elimination of maternal transcripts. However, miR-290
cluster miRNAs and miR-430 may share some conserved roles in development, as the
mouse homologs of zebrafish lft1 and lft2, important regulators of mesoderm formation
and targets of miR-430 ( [294]), are found among ∼250 predicted primary targets of
miR-290 cluster miRNAs.
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Figure 5.8: A model for a role of miRNAs in de novo DNA methylation in embry-
onic stem (ES) cells Dnmt, DNA methyltransferase; Rbl2, retinoblastoma-like protein
2; WT, wild type.
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Themicroarray analysis also identified several transcripts that showed inverse changes
in the Dicer knockout and miR-290 cluster rescue microarray experiments, but con-
tained no matches to the seed of miR-290 cluster miRNAs. These are probably sec-
ondary targets whose expression is regulated by the primary targets of the miRNAs.
Notably, the microarray analysis indicated that many secondary effects, probably brought
about by the primary targets, are reversible despite the fact that the Dicer−/− ES cell
line was established a relatively long time ago.
Both primary and secondary targets probably contribute to the reduced prolifera-
tion rate of Dicer−/− ES cells, which can be partially rescued by transfecting miR-290
cluster miRNAs. Notably, one of the predicted primary targets of the miR-290 cluster is
p21 (also known as Cdkn1a), a cyclin-dependent kinase inhibitor that has been shown
to repress cell-cycle progression [295]. It is well established that control of p21 expres-
sion is achieved through negative transcriptional regulators [290]. Our data argue for
an additional layer of control of p21 expression by miRNAs carrying the AAGUGC
seed sequence. p21 mRNA has three GCACUU motifs in its 3’ UTR, two of which
are conserved across mammals. p21 mRNA is upregulated more than three-fold in
Dicer−/− ES cells, and this misregulation can be corrected by transfection of miR-290
cluster miRNAs. Thus, upregulation of p21 could be one of the mechanisms causing
the slower-growth phenotype. Although in ES cells miRNAs carrying the AAGUGC
seed sequence are primarily represented by miR-290 cluster miRNAs, other related
miRNAs, such as the oncomirs of the miR-17/19/106 cluster [181], could regulate
expression of p21 in other tissues. Notably, the reverse complement of AAAGUGC
(positions 2-8 in miR-17-5p) was one of the motifs that was highly enriched in 3’
UTRs of transcripts upregulated in human HEK293 cells depleted of Dicer or the arg-
onaute protein AGO2 ( [279]). At the same time, these cells grew more slowly, and the
p21 transcript was upregulated. As miR-17/19/106 miRNAs are fairly ubiquitously ex-
pressed [170], they may provide another way to modulate expression of the p21 tumor
suppressor, with a predictable outcome for cellular growth.
The category of secondary targets includes de novoDNAmethyltransferases, which
are downregulated inDicer−/− ES cells and upregulated upon miR-290 cluster miRNA
transfection. Our data suggest that reduced expression of Dnmt3 genes in Dicer−/−
ES cells is the cause of de novo DNA-methylation defects observed during differentia-
tion. Decreased expression of Dnmt3a2 and Dnmt3b, correlating with defective DNA
methylation, has been described in mouse XX ES cells [296], arguing that even incom-
plete depletion of Dnmt3 enzymes may be limiting for proper de novo DNA methyla-
tion. Dnmt3a, Dnmt3b and possibly Dnmt3l may function as a complex [289]. Hence,
even partial downregulation of each of them may strongly affect DNA methylation.
We investigated whether the proliferation rate itself affects Dnmt3 expression and
de novo DNAmethylation. We found that Dnmt3 expression and de novo DNAmethy-
lation are not impaired when the growth of control Dicer+/− ES cells is reduced by
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rapamycin. As the rapamycin-treated wild-type and Dicer−/− ES cells have compara-
ble cell-cycle profiles and similarly slow proliferation rates [278,292], it is unlikely that
the altered growth rate of Dicer−/− ES cells is responsible for decreased Dnmt3 gene
expression and the loss of de novo DNA methylation during differentiation. Further-
more, ectopic expression of de novo DNA methyltransferases rescued de novo DNA
methylation without an apparent effect on proliferation of Dicer−/− cells. Because
de novo DNA methylation proceeds normally inrapamycin-treated Dicer+/− ES cells,
which show minimal proliferation during 3 d of RA-induced differentiation, it is un-
likely that clonal effects in the cell culture would significantly distort the results of
DNA-methylation analysis.
We propose that the transcription of Dnmt3 genes is regulated in ES cells by a
repressor protein whose mRNA is a target of miR-290 cluster miRNAs (Figure 5.8).
Loss of the miR-290 cluster miRNAs in Dicer−/− cells would cause the upregulation
of the repressor, followed by the downregulation of de novo DNA methyltransferases.
This type of Dnmt3 regulation may be restricted to ES cells, as the levels of Dnmt3
mRNAs are not affected in HEK293 cells with knockdown of Dicer or Argonaute pro-
teins [279]. A suitable candidate for the repressor that targets Dnmt3 genes is Rbl2,
whose mRNA has all the features of a primary miR-290 cluster target. Consistent with
our model, knockdown of Rbl2 in Dicer−/− cells had a positive effect on Dnmt3a2
and Dnmt3b expression. Rbl2 is a tumor suppressor that is capable of repressing E2f4
target genes as a part of the DREAM repressor complex [286]. Notably, the expression
profile of human Dnmt3b during the cell cycle (low in G1 and G0 and upregulated in S
phase) is similar to that of the E2f4 target genes repressed by Rbl2 [286]. RBL2 and the
DREAM complex were recently shown to associate physically with the Dnmt3b pro-
moter in human glioblastoma cells [286], suggesting that RBL2 can directly repress
transcription of Dnmt3 genes. Certainly, as the miR-290 cluster controls expression of
a number of transcriptional repressors, Rbl2 may not be the only regulator of de novo
DNA methylation in ES cells. Fabbri et al. [297] have recently reported that the miR-
29 family of miRNAs (miR-29s) can directly target Dnmt3a and Dnmt3b mRNAs and
repress synthesis of de novoDNAmethyltransferases in human lung cancer cells. miR-
29 miRNAs are expressed in mouse ES cells and downregulated upon loss of Dicer, but
our data argue against a major role of these miRNAs in controlling Dnmt3a/b mRNA
or protein levels in mouse ES cells.
One of the functions of de novo DNA methylation during ES cell differentiation is
the stable silencing of the pluripotency program. Our data indicate that, although the
initial phase of transcriptional repression of Oct4 seems to be undisturbed, the de novo
DNA methylation of the Oct4 promoter is severely impaired during differentiation of
Dicer−/− cells. These results are consistent with the observation that stable silencing
of Oct4 is dependent on correct de novo methylation of DNA [288, 289]. The defect
in de novo DNA methylation may not be confined to Oct4, as Nanog, another core
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pluripotency factor, showed a similar expression profile. In addition, the promoters of
Tsp50 and Sox30, two testis-specific genes that are silent in ES cells and acquire de
novo DNA methylation during differentiation, also failed to undergo DNA methyla-
tion in Dicer−/− cells. DNA-methylation data from these two loci are less conclusive,
possibly resulting from slower kinetics of accumulation of methylation at these loci,
exacerbated by a transient nature of the rescue with miR-290 cluster miRNAs. Never-
theless, accumulation of DNA methylation at these promoters is consistent with that of
Oct4, suggesting a more general defect in de novo DNA methylation in Dicer−/− ES
cells.
The defects in de novo DNA methylation in Dicer−/− ES cells may contribute
decisively to the loss of the ability to differentiate in vitro and in vivo. Notably,
Dnmt3a−/− Dnmt3b−/− double-mutant ES cells retain an undifferentiated morphol-
ogy, and their late passages fail to form teratomas in nude mice [298]. The defects in
de novo DNA methylation may also underlie the variable levels of centromeric DNA
methylation reported for different Dicer−/− ES lines [277,278], because the loss of de
novo DNA methyltransferases results in gradual DNA demethylation during prolonged
culture [298].
In summary, our analysis of gene expression in mouse Dicer−/− ES cells indicates
that many of the observed transcriptome changes that occur upon loss of Dicer can be
attributed to miRNAs, particularly to those of the miR-290 cluster. We have identified
∼250 candidate primary targets of the AAGUGC seed-containing miRNAs, and we
also identified many genes that they regulate indirectly. Most notably, we demonstrated
that de novo DNA methylation is defective in Dicer−/− ES cells, and that this is due
to the indirect control of expression of the de novo DNA methyltransferases by the
miR-290 cluster. The established link between miR-290 cluster miRNAs and de novo
DNA methylation in ES cells indicates that miRNAs may contribute substantially to
the epigenetic control of gene expression.
5.4 Methods
Cell culture.
Dicer heterozygous (+/-; line D4) and Dicer-deficient (-/-; line 27H10) ES cells (re-
ferred to as Dicer+/− and Dicer−/−, respectively) were kindly provided by G. Han-
non, Cold Spring Harbor Laboratory, Cold Spring Harbor, NewYork, USA [278]. They
were maintained on gelatin-coated plates with DMEM supplemented with 15% (w/v)
FCS, sodium pyruvate, β-mercaptoethanol, nonessential amino acids and LIF. Differ-
entiation of ES cells was carried out in the absence of LIF and the presence of 100 nM
RA. When indicated, cells were cultured for 4 d in the presence of 25 nM rapamycin
(200 µM stock of rapamycin dissolved in ethanol). Control cells were grown in the
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presence of ethanol at equivalent concentration. For differentiation in the presence of
rapamycin, the cells were cultured for 1 d with rapamycin and LIF followed by 3 d
without LIF and with 100 nM RA and 25 nM rapamycin.
Plasmids.
The control reporter constructs encoding firefly (FL) or Renilla (RL) luciferase (pGL3-
FF and pRL-TK, respectively) were described earlier [279]. FL reporters under the con-
trol ofDnmt3b promoter fragments (p3b-1102/+93-FF, p3b-1981/+93-FF, p3b-4997/+93-
FF and p3b-7886/+93-FF) and constructs encoding the EGFP-tagged de novo DNA
methyltransferases (pCag-EGFP-Dnmt3a2, p-Cag-EGFP-Dnmt3b and p-Cag-EGFP-
Dnmt3L) were kindly provided by K. Ura, Osaka University Graduate School ofMedicine,
Osaka, Japan [299,300].
Transfection of reporter constructs.
At least three independent transfection experiments in triplicate were done in each
case. For luciferase assays, Dicer−/− cells were transfected in six-well plates with
500 ng of indicated FL reporter constructs and 50 ng of pTK-RL as a control, using
Lipofectamine 2000 reagent (Invitrogen). All luciferase assays were performed 24 h
after transfection.
Other transfections.
Other transfections were performed using theMouse ES cell Nucleofection Kit (Amaxa
Biosystems) and program A23 of Nucleofector I apparatus (Amaxa Biosystems). Ap-
proximately 3×106 Dicer−/− cells were used per transfection and the cells were plated
immediately after electroporation. Transfections of siRNAs were performed according
to the manufacturer’s instructions, using 300 pmol of siRNA against RL mRNA (siRL)
(Eurogentec), 50 pmol of siGENOME smartPOOL siRNAs against Rbl2 (Dharmacon),
50 pmol of each of the mmu-mir-290, mmu-mir-291a-3p, mmu-mir-292-3p, mmu-
mir-293, mmu-mir-294 and mmu-mir-295 miRNA mimics (Dharmacon), or 300 pmol
of mmu-mir-291a-3p, together with 2 µg of pCX-EGFP50, which served as control
for transfection efficiency. For rescue of de novo DNA methylation by a mixture of
pCag-EGFP-Dnmt3a2, pCag-EGFP-Dnmt3b and pCag-EGFP-Dnmt3L plasmids, the
Dicer−/− cells were co-transfected with 7 µg of each of these plasmids, using the Nu-
cleofector I apparatus. The EGFP-expressing cells were collected using a MoFlow cell
sorter (Dako Cytomation) after 3 d of culture in the presence of 100 nM RA and the
absence of LIF.
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Chromatin immunoprecipitation.
Chromatin immunoprecipitations (ChIPs) were performed as described previously [301].
Dicer+/− and Dicer−/− ES cells, either undifferentiated or treated for 3 d with RA,
were cross-linked by adding formaldehyde directly to the medium to a final concen-
tration of 1% (w/v) at room temperature. The reaction was stopped after 8 min by
adding glycine to a final concentration of 0.15 M. Cell lysates were sonicated to gen-
erate 300-1,500-bp DNA fragments. After preclearing the samples with Protein A
Agarose (Upstate), the immunocomplexes were formed using anti-H3K9me2 or anti-
H3K27me3 antibodies (Upstate). Immunocomplexes were collected with 30 µl of Pro-
tein AAgarose (Upstate). The purified DNA and a 1:100 dilution of the respective input
DNA were used as templates for quantitative real-time PCR (RT-qPCR), using the ABI
Prism 7000 Sequence Detection System (Applied Biosystems), Platinum SYBR Green
qPCR SuperMix (Invitrogen) and primers specific for the glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) and Oct4 promoters. Obtained values were first normalized to
the respective input DNA and further to the enrichment at the Gapdh promoter where
these modifications do not accumulate. Annealing of all primers was done at 55 ◦C.
Bisulfite sequencing.
Bisulfite sequencing was performed using the Epitect Bisulfite sequencing kit (Qiagen)
according to the manufacturer’s conditions. Up to 2 µg of genomic DNA was used as
a starting material. PCR amplification conditions were as described [301].
Statistical analysis.
Analysis of microarray data and motifs, including statistical methods, is described in
detail in the Supplementary Methods. All remaining statistical analysis used two-tailed
t-tests.
Real-time quantitative RT-PCR (RT-qPCR)
Total RNA from ES cells was extracted using the Absolutely RNAMiniprep Kit (Strata-
gene). A Thermoscript RT-PCR kit (Invitrogen) was used for the cDNA synthesis re-
action with 1 µg template RNA and 250 pmol of oligo(dT)20 primer, incubated for 1
h at 55 ◦C. Subsequently, cDNA was used as a template for RT-qPCR with the ABI
Prism 7000 Sequence Detection System and Platinum SYBR Green qPCR SuperMix,
using gene-specific primers. For Dnmt3 enzymes, splice-variant-specific primers were
used. Sequences of primers are provided in Supplementary Table 4. Annealing of all
primers was done at 55 ◦C. Relative expression levels were calculated using the for-
mula 2−(∆Ct), where ∆Ct is Ct(geneofinterest) − Ct(GAPDH) and Ct is the cycle at
which the threshold is crossed. For time course experiments, the expression level at
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day 0 in Dicer+/− ES cells or in siRL-transfected Dicer−/− cells was always set as 1
and expression levels at other time points were normalized to it.
Western blotting.
Cells were lysed in lysis buffer (30 mM Tris-HCl, pH 7.5, containing 150 mM NaCl, 1
mMMgCl2, 0.5% (v/v) Nonidet P-40, 1 mM DTT and protease inhibitors) and kept on
ice for 10 min. Equal amounts of the lysed proteins were separated on polyacrylamide-
SDS gels, blotted on polyvinylidene fluoride membrane and probed with the follow-
ing primary antibodies: anti-Oct4 (Santa Cruz, dilution 1:2,000), anti-α-tubulin (5.2.1
Sigma, 1:10,000), anti-Dicer [D349 ( [302]), 1:5,000], anti-Dnmt1 (Abcam, 1:500),
anti-Dnmt3a (Imgenex, 1:250), anti-Dnmt3b (Imgenex, 1:250) and anti-RNA-polymerase
II (Covance, 1:500). This was followed by incubation with secondary horseradish
peroxidase-coupled antibodies. Detection was performed with ECL or ECL+ kits
(Amersham).
Luciferase assays.
Luciferase assays were performed using the Dual-Luciferase Reporter Assay kit (Promega)
according to the manufacturer’s instructions. FL activity was normalized to RL activ-
ity expressed from pRL-TK. Normalized FL activity in cells transfected with pGL3-FF
was always set as one.
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5.5 Parts of the Supplementary Methods
5.5.1 Microarray data analysis
BioConductor Affymetrix package of the R software was used to import the CEL files
from the Affymetrix Mouse Genome 430 2.0 Array. Probe set intensities were then
background-corrected, adjusted for non-specific binding and quantile normalized with
the GCRMA algorithm [303]. GCRMA-normalized microarray data were deposited in
the GEO database (GSE7141 and GSE8503).
To extract a non-redundant set of transcripts for subsequent analyses of 3’-UTR
sequences, probe sets with s or x tags, which map to multiple transcripts from differ-
ent genes, were discarded. Then, the Affymetrix annotation from December 2006 was
used to obtain the corresponding reference sequence (RefSeq [304]) for each probe set.
When the Affymetrix array contained probe sets for alternative RefSeq transcripts for
the same gene, we only used the RefSeq transcript with the median length 3’-UTR.
Through this procedure, we obtained an n-to-1 probe set to RefSeq transcript mapping.
For transcripts that had multiple probe sets, we discarded those that were deficient, as
indicated by their very low variance across a set of unrelated experiments performed
with different cell types using the same platform (Affymetrix Mouse Genome 430 2.0).
Finally, the log2 intensities of the probe sets corresponding to a given transcript were
averaged to obtain a transcript level measurement. We used Limma [305] to estimate
the fold change and the corresponding p-value in the three replicate experiments for
each condition.
To identify those motifs whose frequency in up-regulated (in Dicer−/−) or down-
regulated (in Dicer−/−) ES cells transfected with miRNA mimics of the miR-290 fam-
ily) 3’-UTRs is significantly different relative to the frequency in the entire set of 3’-
UTRs, we extracted the set of transcripts up-regulated in the Dicer−/−) cells (p-value
< 0.001) and computed the relative frequency of all 7-mers in the 3’-UTRs of these
transcripts compared with the entire set of 3’-UTRs represented on the microarray. For
each 7-mer, we then plotted the log2(number of occurrences in up-regulated 3’-UTRs)
on the x-axis, and the enrichment in up-regulated 3’-UTRs compared to the entire set
of 3’-UTRs on the y-axis (Fig. 5.1b,e). We then used a Bayesian model that we pre-
viously introduced for comparing miRNA frequencies between samples [170]. Briefly,
we estimate the posterior probabilities of the model that assumes that the frequency of a
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given motif is different between two sets of transcripts (call this ”different” model), and
the model that assumes that the frequency is the same (call this ”same” model), given
the observed counts m and n of the motif among M and N total motifs in the two sam-
ples. We selected as significant those motifs that were enriched in the up-regulated or
down-regulated set, respectively, with a posterior probability of the ”different” model
> 0.99
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MicroRNAs (miRNAs) are small endogenous RNAs that typically imper-
fectly base pair with 3’ untranslated regions (3’ UTRs) and mediate trans-
lational repression and mRNA degradation. Dicer, which generates small
RNAs in the miRNA and RNA interference (RNAi) pathways, is essen-
tial for meiotic maturation of mouse oocytes. We found that 3’ UTRs of
transcripts upregulated in Dicer1−/− oocytes are not enriched in miRNA
binding sites, implicating a weak impact of miRNAs on the maternal tran-
scriptome. Therefore, we tested the ability of endogenous miRNAs to me-
diate RNA-like cleavage or translational repression of reporter mRNAs. In
contrast to somatic cells, endogenous miRNAs in oocytes poorly repressed
translation of mRNA reporters, whereas their RNAi-like activity was much
less affected. Reporter mRNA carrying let-7-binding sites failed to local-
ize to P body-like structures in oocytes. Our data suggest that miRNA
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function is downregulated during oocyte development, an idea supported
by normal meiotic maturation of oocytes lacking Dgcr8, which is required
for the miRNA but not the RNAi pathway (Suh et al. [306]). Suppressing
miRNA function during oocyte growth is likely an early event in repro-
gramming gene expression during the transition of a differentiated oocyte
into pluripotent blastomeres of the embryo.
6.1 Results and Discussion
6.1.1 Minimal Impact of MicroRNAs on Mouse Oocyte Transcrip-
tome
The eight 5’-terminal nucleotides of a microRNA (miRNA) form a “seed,” which hy-
bridizes nearly perfectly with the target mRNA and nucleates the miRNA-mRNA inter-
action [182]. Whereas enrichment of motifs complementary to seeds of highly active
miRNAs has been observed in 3’ untranslated regions (3’ UTRs) of mRNAs whose
relative abundance is increased (hereafter referred to as upregulated) upon depletion of
Dicer1 [72,279,307], transcriptome analysis ofDicer1−/− metaphase II (MII) eggs did
not identify any miRNA-related motifs [308]. Because transcriptome remodeling dur-
ing meiosis [309] could mask upregulation of primary miRNA targets, we performed an
analysis of fully grown germinal vesicle-intact (GV) Dicer1−/−oocytes. Microarray
profiling revealed a comparable number of upregulated (489, p < 0.001) and down-
regulated (628, p < 0.001) transcripts (Figure 6.1A). The magnitude of these changes
was ∼ 5 times smaller when compared to other studies of Dicer1−/−-depleted mam-
malian cells [279,307]. In fact, the loss of Dicer1 in the oocyte caused a transcriptome
change comparable to the effect of a single miRNA in embryonic stem (ES) cells (Fig-
ure 6.1A) [307].
We searched for heptamer motifs enriched in 3’ UTRs of transcripts that were
upregulated in the Dicer1−/− oocytes and that could explain the mRNA expression
changes. One of the four motifs most significantly enriched was complementary to
the seed of miR-1195 (GAACUCA, Figure 6.1B). This motif, however, is likely not
associated with miRNA function, because miR-1195 was absent in deep sequencing of
small RNAs from mouse oocytes [107]. Likewise, none of the predicted miR-1195 tar-
gets in the miRBase [206] was upregulated in the Dicer1−/− oocytes. Sylamer [310],
an alternative approach to analyze miRNA signals in 3’ UTRs, showed that none of
the high-scoring motifs and none of the top five miRNA-related heptamers match seed
regions of miRNAs with a cloning frequency in oocytes > 0.1%.
We also examined motifs related to abundant miRNAs in transcriptomes ofDicer1−/−
oocytes and ES cells. These motifs, which were selected based on deep sequencing
data [107, 111], represent binding sites for more than half of all miRNAs cloned from
95
these cells. Interestingly, none of the motifs (including those for the let-7 family, which
represents sim30% of maternal miRNAs [107,276]) showed any enrichment or any sta-
tistical bias in 3’ UTRs of transcripts upregulated inDicer1−/− oocytes. This contrasts
with Dicer1−/− ES cells, where the most significant motifs match a family of highly
abundant miRNAs (∼25% of cloned miRNAs [111]), and several motifs corresponding
to other abundant miRNAs also showed enrichment and deviation from the statistical
background (Figure 6.1C).
Our data suggest limited miRNA-associated mRNA degradation in the oocyte and
do not support the notion that miRNAs extensively modulate gene expression in oocytes
[276, 311]. Our analysis of 3’ UTRs of transcripts upregulated in Dicer1−/− oocytes
does not provide evidence that the upregulation is associated with miRNA function via
seed-mediated interaction with 3’ UTRs. Likewise, we observed no significant enrich-
ment of miRNA-associated motifs in 3’ UTRs of intrinsically unstable mRNAs [312]
and mRNAs degraded during meiosis [107]. Although miRNA binding sites were as-
sociated with specific transcript isoforms during meiotic mRNA degradation [313], it is
unclear whether this observation reflects miRNA effects. It is possible that none of the
maternal miRNAs is functionally dominant, and therefore none generates a strong sig-
nal, but this does not explain the low number of upregulated transcripts in Dicer1−/−
oocytes. Alternatively, miRNA-mediated mRNA degradation is not robust, and the
transcriptome change reflects the loss of endogenous small interfering RNAs (endo-
siRNAs). We found that 42 of 489 upregulated but only 6 of the 628 downregulated
transcripts inDicer1−/− oocytes perfectly base pair with endo-siRNAs [108]. Because
siRNA-guided cleavage by small RNAs requires less than complete base pairing and
can occur without a perfect seed complementarity [314], it is plausible that inhibition of
the RNAi pathway is the major cause of transcriptome changes in Dicer1−/− oocytes.
The idea that low activity of miRNA-mediated mRNA degradation is responsible
for the absence of a miRNA signature in Dicer1−/− oocytes is supported by Suh et
al. [306], who analyzed the maternal loss of Dgcr8, a component of the microproces-
sor complex involved in miRNA biogenesis. Dgcr8–/– oocytes show the same deple-
tion of miRNAs as Dicer1−/− oocytes, yet the transcriptome of Dgcr8−/− oocytes is
more similar to the wild-type, and mice with Dgcr8−/− oocytes are fertile, showing
no meiotic spindle defects reported for Dicer1−/− and Ago2−/− oocytes. Therefore,
the sterile phenotype of Dicer1−/− oocytes [276,308] is likely due to misregulation of
genes controlled by endo-siRNAs [107].
6.1.2 Endogenous miRNAs Poorly Repress Cognate mRNAs
To understand the function of maternal miRNAs, we used three sets of reporter mR-
NAs carrying binding sites for the endogenous miRNAs let-7a and miR-30c. let-
7 is the most abundant miRNA family in the oocyte (∼ 30% of maternal miRNAs
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[107, 108, 276]). The miR-30 family is less abundant; it represents ∼8% of mater-
nal miRNAs, as suggested by reverse transcriptase-polymerase chain reaction (RT-
PCR) [276]. The deep-sequencing data suggest a lower abundance (∼w2.4% [107]),
but such estimates are prone to errors [315]. To assess let-7 activity during oocyte
growth and meiotic maturation, we used firefly luciferase reporters (Figure 6.2A) car-
rying a lin-41 fragment with two natural bulged let-7 binding sites (FL-2xlet-7), which
were mutated in the control (FL-control) [316]. Because fully grown GV oocytes and
MII eggs are transcriptionally quiescent, we microinjected in vitro-synthesized mR-
NAs instead of plasmid reporters. First, we compared let-7-mediated repression of FL-
2xlet-7 mRNA microinjected into meiotically incompetent oocytes with repression of
the FL-2xlet-7 plasmid or synthetic FL-2xlet-7 mRNA transfected into NIH 3T3 cells.
FL-2xlet-7 expression was reduced by ∼40% relative to FL-control in oocytes (Figure
6.2B). Although this was less than repression of FL-2xlet-7 reporters in NIH 3T3 cells
(∼50%, Figure 6.2B), it showed that reporter mRNA is repressed by endogenous let-7
in small, growing oocytes.
When FL-2xlet-7 mRNA was microinjected into fully grown GV oocytes, we ob-
served inefficient let-7 repression, which was also found upon meiotic maturation (Fig-
ure 6.2C). This was unlikely due to insufficient amounts of endogenous let-7 miRNA
because delivering the FL-2xlet-7 mRNA with a 50 molar excess of let-7a miRNA did
not, in contrast to NIH 3T3 cells, improve reporter repression. Likewise, a 50 molar
excess of let-7a antagomir did not increase FL-2xlet-7 expression in oocytes but did in
NIH 3T3 cells.
To explore further let-7 function in oocytes, we obtained another set of reporters
(Figure 6.3A), which contained three bulged let-7 sites (RL-3xB let-7) or a single per-
fectly complementary let-7 site (RL-1xP let-7) downstream of the Renilla luciferase
coding sequence [317]. These two reporters are repressed to the same extent in dif-
ferent cell lines, but by different mechanisms [279]. The RL-1xP let-7 is cleaved by
AGO2 loaded with let-7 in the middle of the duplex. The bulged sites of RL-3xB let-
7 mediate translational repression and subsequent mRNA degradation. To extend the
analysis to other miRNAs, we produced a similar set of reporters for miR-30c (Figure
6.3A).
Our results showed that repression of all miRNA-targeted reporters was reduced
during oocyte growth (Figures 6.3B–D) despite a 3- and 5-fold increase in the amount
of miR-30 and let-7, respectively, during oocyte growth [276]. This repression was pre-
sumably miRNA mediated because reporters harboring mutated miRNA binding sites
(RL-3xM let-7 and RL-4xM miR-30) were not repressed (Figures 6.3B–D). Repres-
sion of perfectly complementary reporters was always significantly greater than that
of their bulged versions, contrasting with data from cell lines where bulged reporters
were repressed either more or equally as well [279]. This finding suggests that RNAi-
like cleavage by miRNAs loaded on the AGO2-RISC complex is less affected during
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oocyte growth than translational repression, which is typical for most natural mam-
malian miRNA targets. Target site accessibility probably partially influences reduced
repression of all reporters; our data show that siRNAs target 3’UTR sequences less ef-
ficiently in the oocyte when compared to somatic cells or siRNAs targeting the coding
sequence.
The miR-30 reporter was consistently better repressed than the let-7 reporter. This
finding was unexpected because let-7 family constitutes ∼30% of maternal miRNAs,
whereas miR-30 mRNAs are several times less abundant [107, 276]. An additional
miR-30 binding site in the bulged miR-30 reporter could explain its better repression
relative to the bulged let-7 reporter. However, this cannot explain differences between
RL-1xP let-7 and RL-1xP miR-30 reporters. This difference may stem from secondary
structures of miRNA binding sites or may reflect yet-unknown let-7-specific regulation.
Repression of the RL-4xB miR-30 reporter could involve miRNA-mediated trans-
lational repression, miRNA-mediated mRNA degradation, or a combination of both.
Thus, we microinjected fully grown GV oocytes with the RL-4xB miR-30 reporter and
assayed for luciferase activity and the relative amount of Luc mRNA (Figures 6.4A,B).
Whereas RL-1xP miR-30 mRNAwas reduced at protein and mRNA levels as expected,
RL-4xB miR-30 luciferase activity was reduced ∼50%, whereas there was negligible
reduction in the amount of Luc mRNA. This observation suggests that the remain-
ing miRNA-mediated translational repression is uncoupled from mRNA degradation
in fully grown GV oocytes. Therefore, we tested whether miRNA-targeted mRNAs
localize to P bodies, cytoplasmic foci involved in miRNA-mediated mRNA degrada-
tion [316, 317]. We visualized let-7-targeted and nontargeted mRNAs via a MS2-YFP
binding strategy [316]. Whereas the let-7-targeted and nontargeted reporters were uni-
formly distributed in the oocyte cytoplasm, only the reporter harboring functional let-7
miRNA binding sites was targeted to P bodies in NIH 3T3 cells (Figure 6.4C). This
result is consistent with the loss of P bodies during oocyte growth [318].
Taken together, our data present a puzzling paradox: although mouse oocytes pro-
duce abundant RNA-induced silencing complex (RISC)-loaded miRNAs, their mRNA
targets are poorly repressed. Uncoupling the loaded RISC from translational repres-
sion, however, may be an elegant solution for selective inhibition of the miRNA path-
way in the oocyte because the RNAi and miRNA pathways have common components,
e.g., Dicer and AGO2. Reducing miRNA activity during oocyte growth may have two
roles. First, the low activity of miRNA-mediated mRNA degradation, perhaps linked
to the absence of P bodies, may contribute to mRNA stability and accumulation in
growing oocytes. Second, downregulation of the miRNA pathway may be required
for oocyte-to-zygote transition. Abundant maternal miRNAs, such as let-7, are found
in somatic cells [170]. Efficient reprogramming of somatic cells into pluripotent stem
cells requires large remodeling of miRNA expression, including downregulation of
“somatic” miRNAs like let-7 (reviewed in [319]). Therefore, reducing miRNA activity
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may be associated with acquisition of developmental competence, and miRNAs may
not be required until the zygotic genome activation is completed and the pluripotency
program, which also controls miRNA expression [320], is established. From this per-
spective, suppression of maternal miRNA function during oocyte growth may be the
first event in reprogramming the differentiated oocyte into pluripotent blastomeres of
the embryo.
6.1.3 Experimental Procedures
Animals and Oocytes
Fully grown GV Dicer1–/– oocytes were obtained from 3A8 Dicer1 conditional mice
as previously described [308]. Meiotically incompetent oocytes; fully grown, GV-
intact cumulus-enclosed oocytes; and MII eggs were collected, microinjected, and cul-
tured as described [321–324]. All animal experiments were approved by the Institu-
tional Animal Use and Care Committee and were consistent with National Institutes of
Health guidelines.
mRNAMicroarray Analysis
RNA was isolated from 25 fully grown GV-intact mouse oocytes and amplified as pre-
viously described [280,325]. Oocytes for each sample were collected from an individ-
ual mouse, and four samples were generated for each group. Biotinylated complemen-
tary RNA (cRNA) was fragmented and hybridized to the Affymetrix MOE430 v2 chip,
which contains∼45,000 probe sets. All arrays yielded hybridization signals of compa-
rable intensity and quality. Original CEL files were processed, and 3’ UTR heptamer
analysis was performed as described previously [279,307].
Reporter mRNA Preparation and Microinjection
Meiotically incompetent oocytes and fully grown GV oocytes were injected as de-
scribed [324]. The same concentration of reporter mRNA was achieved in both stages
by microinjecting incompetent oocytes with ∼1.7 pl and fully grown GV oocytes with
three times that amount (i.e., ∼5 pl), because the volume of the meiotically incompe-
tent oocytes used in these studies is about one-third of the fully grown GV oocyte. Five
pl contained ∼ 105 molecules of the reporter. Reporter mRNAs were microinjected at
the following concentrations: FL-2xlet-7 and FL-control reporter cRNA for let-7 at 0.2
µg/µl with spiked Renilla luciferase mRNA at 0.05 µg/µl; RL-C, RL-1xP, RL-3xB, and
RL-3xM for let-7 reporter at 0.05 µg/µl with spiked firefly luciferase mRNA at 0.05
µg/µl; RL-C, RL-1xP, RL-4xB, and RL-4xM for miR-30 reporter at 0.05 µg/µl with
spiked firefly luciferase mRNA at 0.05 µg/ml; let-7 reporter with 12xMS2-YFP bind-
ing sites and MS2-YFP at 1 µg/µl each; let-7 mimic or antagonist at 50:1 molar ratio
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to FL-2xlet-7 reporter mRNA. After microinjection, oocytes were cultured overnight
in CZB containing 2.5 µM milrinone (to maintain meiotic arrest of meiotically com-
petent oocytes) or CZB without milrinone (for meiotically incompetent oocytes) in an
atmosphere of 5% CO2 in air at 37◦C before they were processed for RT-PCR analysis,
luciferase assay, or immunocytochemistry.
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Figure 6.1: Transcriptome analysis of Dicer1−/− Oocytes. (A) M [log2(fold
change)] vs. A [average log2(expression level)] plot for the Dicer1−/− versus
Dicer1+/+ fully grown germinal vesicle oocytes. Each dot represents a transcript.
Significant expression changes (p < 0.001 computed from four replicate experiments)
are shown in red. (B) Heptamer motif analysis of upregulated transcripts. The motifs
whose frequency in the 3’ untranslated regions (3’ UTRs) of upregulated transcripts
is significantly different from the frequency in the entire set of 3’ UTRs are shown in
red. One of the significantly enriched motifs is complementary to positions 1–7 of the
miR-1195.
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Figure 6.1: Transcriptome analysis of Dicer1−/− Oocytes. (C) Comparison of hep-
tamer motif analyses of Dicer1–/– oocytes (left) and embryonic stem (ES) cells (right,
horizontally inverted); most-relevant motifs complementary to seeds of most-abundant
microRNAs (miRNAs) in both cell types are highlighted. The most-abundant miR-
NAs in the oocyte and ES cells are shown in red and blue text, respectively. Note
that none of the motifs corresponding to abundant maternal miRNAs is enriched more
than 1.1 times in 3’ UTRs of transcripts upregulated in Dicer1–/– oocytes, whereas all
four motifs corresponding to miRNAs abundant in ES cells are enriched in Dicer1–/–
ES cells. Posterior probability analysis shows a high significance (1.000) only for the
GCACUUU motif. However, posterior probability for the other three motifs corre-
sponding to ES cell miRNAs was one to three orders of magnitude higher than all
other motifs, which scored within the statistical background (∼ 10−5 ). Abundance
(%) of miRNAs related to individual motifs in both cell types is indicated next to each
motif. Dashed lines mark 1.0- and 1.1-fold motif enrichment.
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Figure 6.2: FL-2xlet-7 Reporter Analysis. (A) Schematic drawing of reporters used
in experiments presented in Figure 6.2. (B) Relative firefly luciferase reporter activity
in NIH 3T3 cells and growing oocytes. NIH 3T3 cells were transfected with reporter
plasmids or mRNAs, and small, growing oocytes obtained from 13-day-old mice were
microinjected with reporter mRNAs as described in the Experimental Procedures. Fire-
fly luciferase reporter activities were normalized to the coinjected Renilla luciferase
control and are shown relative to FL-control, which was set to one. The experiment
was performed three times, and similar results were obtained in each case. Shown are
data (mean ± standard error of the mean [SEM]) from one experiment. (C) Relative
firefly luciferase reporter activity in growing oocytes obtained from 13-day-old mice,
fully grown GV oocytes, and oocytes matured to metaphase II (MII). Data are pre-
sented as the mean ± SEM from six independent experiments. *p < 0.05, **p < 0.01
compared to control by analysis of variance.
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Figure 6.3: Renilla Luciferase let-7 and miR-30 Reporter Analysis. (A) Schematic
drawing of reporters used in experiments presented in Fig. 6.3. (B-D). Relative Renilla
luciferase reporter activities in growing oocytes (B), fully grown GV oocytes (C), and
MII eggs (D). In vitro-produced reporter mRNAs were microinjected as described in
the Experimental Procedures. Renilla luciferase reporter activities were normalized to
coinjected firefly luciferase control and are shown relative to RL-C control, which was
set to one for each studied miRNA. The experiment was performed three times, and
similar results were obtained in each case. Shown are data (mean ±6 SEM) from one
experiment. *p < 0.05, **p < 0.01 compared to control by analysis of variance.
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Figure 6.4: Repressed Bulged Luciferase Transcripts Are Not Degraded and Do
Not Localize to P Bodies. (A) Schematic of the miR-30 reporters. (B). Oocytes
were microinjected with miR-30 reporter mRNAs, shown in (A), and after 1 day of
culture, the relative reporter mRNA abundance was measured by quantitative reverse
transcriptase-polymerase chain reaction, and reporter mRNA translation efficiency was
monitored by the dual luciferase assay. Renilla luciferase reporter activities were nor-
malized to coinjected firefly luciferase control and are shown relative to RL-C control,
which was set to one. The experiment was performed three times, and similar results
were obtained in each case. Shown are data (mean ± SEM) from one experiment. *p
< 0.05, **p < 0.01 compared to control by analysis of variance. (C) mRNA harboring
a let-7-binding sequence fails to localize to P bodies in oocytes. Schematic depic-
tion of reporters bound and not bound by endogenous let-7 is shown on the top of the
figure. Below are confocal images showing cytoplasmic localization of correspond-
ing reporter mRNAs. NIH 3T3 cells (top) were transfected with the corresponding
reporter plasmids, and fully grown GV oocytes (bottom) were microinjected with in
vitro-transcribed mRNAs as described in the Experimental Procedures. Cotransfected
(coinjected) YFP-MS2 fusion protein containing nuclear localization signal is retained
in the cytoplasm upon binding to reporter transcripts, thus visualizing their localiza-
tion [316]. White arrowheads depict P bodies visualized by let-7-targeted reporter
mRNA in NIH 3T3 cells. Scale bars represent 20 µm.
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7.1 Introduction
During the last years, members of the Argonaute protein family have been identified
as key players in small RNA guided silencing pathways. The members of the Piwi
clade of Argonautes are predominantly expressed in germ cells and the association
with a small RNA population distinct of miRNAs has been shown for various ani-
mals [35, 113, 114, 124, 127–129, 159]. These small RNAs, called piwi-interacting
RNAs (piRNAs) which range from about 23 to 31 nt in length and show a bias for
uracil at the 5’ end. They are organized in clusters that represent distinct genomic
loci. The infertile phenotypes observed in mouse and fruit fly carrying mutations of
Piwi proteins suggested an important role of piRNAs and Piwi proteins in germ cell
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development, and later their involvement in silencing retrotransposons has been re-
vealed [134, 154]. The post-transcriptional silencing of retrotransposon transcripts is
achieved by a piRNA amplification mechanism called ping-pong mechanism [36,134].
In the ping-pong mechanism, piRNAs complementary to retrotransposons guide Piwi
proteins to cleave retrotransposon transcripts. The cleavage of the target transcript oc-
curs at the bond between the nucleotides which are opposite to the nucleotides 10 and
11 of the piRNA. This cleavage defines the 5’ end of the secondary piRNA that is
generated from the transposon transcript. After the 3’ end is generated through nucle-
ase cleavage and 2’-O methylation, the secondary piRNA itself is loaded into a Piwi
protein and guides the cleavage of new primary piRNA precursors. This results in the
production of piRNAs from the same loci from which the initial piRNAs were derived.
So far, most studies on piRNAs analyzed sequence reads whose length was in the range
of prototypical piRNAs (23-31 nucleotides), therefore masking out potential interme-
diates and/or byproducts of the amplification loop that were outside of this range. Such
products could arise during the processing steps that generate both 5’ and 3’ ends of
piRNAs and may leave detectable traces in deep sequencing libraries. This was in fact
suggested by Murchison et al. who sequenced small RNAs of 18-30 nucleotides from
platypus testes and observed that a high proportion of RNAs that were derived from
piRNA loci was short relative to prototypical piRNAs. However, apart from their ge-
nomic origin those small RNAs have not been further characterized [117]. We decided
to reanalyze this data set to further characterize the nature of these small RNAs and to
search for processing products of the ping-pong cycle.
7.2 Results
After obtaining and mapping the small RNAs from this data set against the platypus
genome, we determined genome-wide the relative distances between the 5’ coordi-
nates of perfect and uniquely mapping sequences from opposite strands (see Methods).
When two sequences from opposite strands have the same 5’ coordinate, this distance
would be 0, whereas the primary and secondary piRNAs that are related through the
ping-pong mechanism give a signature distance of 9 nucleotides. To prevent our re-
sults from being dominated by a few very abundantly sequenced clusters, we counted
the pairs of sense-antisense sequences as follows. Given a sense read with copy num-
ber cs and an antisense read with copy number ca we count towards the distance la− ls
the minimum of the two copy numbers. Here ls is the genome coordinate of the sense
sequence and la the genome coordinate of the antisense sequence. For example, if we
have 3 sequences starting on the sense strand at position ls and 7 sequences on the
antisense strand at position la, we counted 3 observed ’pairs’ at distance la − ls.
As expected, we detected a strong signal for the ping-pong amplification cycle (see
Fig. 7.1a), that is we found a high frequency of sense-antisense pairs with a distance of
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9 between 5’ ends. Surprisingly, we also detected a signal corresponding to a difference
of 28 nt between the 5’ ends, which has not been reported before (see Fig. 7.1a). Note
that in this analysis we did not consider solely sequences whose length was in the
range of prototypical piRNAs (23-31 nt). Because previous analyzes of piRNAs only
used relatively long sequences (longer than 23 nucleotides) and did not report the peak
at 28 nucleotides, we separated the sequences in different sets based on their length
and repeated the analysis. Indeed, restricting the analysis to sequences longer than 23
nucleotides (the piRNA range) revealed only the peak at 9 nucleotides (P9). The peak at
28 (P28) became apparent when we analyzed sequences of disparate lengths, with one
long sequence in the range of a prototypical piRNA, and a smaller (≤ 23 nt) sequence
on the opposite strand (see Figure 7.1b). Further analysis revealed that mostly 19 nt
long sequences contributed to the short member of the pair (see Fig. 7.1a).
By inspecting some examples of pairs that gave P28 we noticed that in the P28
duplex the pairing between the 19 nt-long sequence and the long piRNA sequence
started at the 11th nt from the 5’ end of the long sequence, as if the 3’ end of the 19
nt-long sequence were defined by the ping-pong mechanism. Therefore, we decided
to address systematically the question of whether the P28 and P9 co-occurred. The
regions of overlap between sense and antisense pairs that gave rise to the P9 and the
P28 peaks were anchored at the middle of the interval defined by the 5’ ends of the
sense-antisense pairs. We then performed cross-correlation analysis of those positions
(see Methods). We obtained two symmetrical peaks at -9 and 10, which suggested that
the middle of the P28 interval occurs preferentially either 9 nt downstream or 10 nt
upstream of the middle of the P9 interval (see Fig. 7.1c,d). By separately analyzing
the cases in which the short sequence of a P28-defining pair occurred on the plus and
on the minus strand, we determined that the peak at -9 corresponded to cases in which
the short sequence was on the plus strand and the peak at 10 to cases in which the short
sequence was on the minus strand. Cross-correlation therefore showed that sense-
antisense pairs with a distance of 9 between 5’ ends indeed to co-occur with sense-
antisense pairs with a distance of 28 between 5’ ends, with an arrangement shown in
Fig. 7.1e. That is, there are two long piRNA sequences from opposite strands that
overlap by 10 nucleotides, characteristic for the ping-pong mechanism, and a 19 nt-
long sequence which is located upstream of one of the two piRNAs (see Fig. 7.1e).
Reasoning that a meaningful processing pattern would be conserved across species,
we analyzed a number of other publicly available data sets that were generated from
a variety of species, such as mouse, fruit fly, zebrafish and flatworm. Unfortunately,
piRNA studies in these species focused on the relatively long piRNA fraction of the
total RNA. That is, only the band believed to contain sequences longer than about 20
nucleotides was sequenced. Because we expected the 19 nucleotide long reads to be
much sparser in these species, we included in our analysis not only uniquely mapped
sequences, but also sequences that mapped somewhat repetitively, i.e. with less than 10
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loci. Of course, in this case, we weighted the copy number of a sequence coming from
a given locus by the number of loci to which the sequence maps. We further focused
on pairs formed by 19 nt-long sequences and prototypical piRNAs, and we did not
sought evidence for the P9 peak characteristic of the ping-pong mechanism. In some
of these species evidence for the existence of the ping-ping mechanism was already
provided [119, 130, 134, 154]. Indeed, we found weak evidence for the P28 pattern
in mouse, fruit fly, zebrafish and flatworm (see Fig. 7.2), but not in nematodes (data
not shown). The nematodes are the only ones among the studied species for which no
evidence for ping-pong amplification of piRNAs has been reported [159] to date. This
suggests conserved mechanism for the generation of 19 nt sequences during piRNA
biogenesis.
7.3 Discussion
A reanalysis of the piRNA sequence reads in five species surprisingly revealed that
the signature of the ping-pong mechanism is accompanied by 19 nt long sequences
upstream of piRNAs. The biogenesis of these 19-mers is still elusive. Although we
cannot exclude that they emerge during the production of primary piRNAs, because
their production appears to be associated with the production of what appear to be
piRNA-guided cleavage fragments of Piwi proteins, we speculate that the 3’ ends of
these 19-mer sequences are most likely generated during the same cleavage event that
produces the 5’ ends of the secondary piRNAs. What defines the 5’ end of these 19-
mers is yet unknown. Our current hypothesis is that a 5’→3’ exonuclease, which stops
when it reaches a double-stranded complex formed by the primary piRNA and the
future 19-mer fragment or when it reaches the Piwi protein (that holds the piRNA-
target duplex), is responsible for the formation of the 5’ ends of these sequence.
It is unclear whether these 19-mers have a specific function or are simply by-
products of piRNA biogenesis. If they are incorporated into Piwi proteins, they would
allow the ping-pong mechanism to move on the transcript, instead of being limited to
the location defined by the primary piRNA because the cleavage that would be guided
by the 19-mer would occur at a different position in the transcript relative to the cleav-
age that is induced by the secondary piRNA located immediately downstream of the
19-mer. Even as degradation products, understanding how the 5’ ends of these se-
quences are generated will shed further light into the piRNA biogenesis. Finally, be-
cause currently we cannot define precisely what a piRNA is (other than using as criteria
the length of the sequence and its association with the Piwi proteins), the P28 and P9
patterns used in conjunction may allow us to more precisely identify true piRNAs in
deep sequencing samples of small RNAs.
In order to follow up on these ideas, we would like to know how abundant the 19
nt sequences are in testis lysate and immunoprecipitated Piwi proteins compared with
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primary and secondary piRNAs. This is because, as we already noticed, none of the
data sets that are publicly available and we analyzed were generated optimally to allow
us to identify the 19-mers. Towards this end we will isolate total RNA from mouse
testes and we will perform deep sequencing of the small RNA fraction in the range
of 15-40 nucleotides. To investigate whether the 19-mers may function as piRNAs,
we will also determine whether they carry a 2’-O methylation at their 3’ ends. We
hope that these studies will open new avenues in the identification of factors that are
responsible for piRNA biogenesis.
7.4 Methods
7.4.1 Sequence annotation
From the GEO database (http://www.ncbi.nlm.nih.gov/geo/) we obtained the follow-
ing publicly available data sets that were obtained in previous studies [23,24,117,119,
120, 130, 134, 141, 154, 158, 326, 327]: GSM266831 and GSM266832 for platypus,
GSM405492, GSM406408, GSM405490, GSM405493 and GSM406409 for flatworm,
GSM319953, GSM319955, GSM319956, GSM319957, GSM319959, GSM319960,
GSM433288, GSM433290, GSM433292, GSM433294, GSM400967, GSM400968
and GSM179088 for mouse, GSM171830, GSM171831, GSM315420, GSM315421,
GSM315422, GSM315423 and GSM315424 for zebrafish and GSM154618, GSM154620,
GSM154621, GSM154622, GSM231091, GSM378200, GSM379050, GSM379052,
GSM379054, GSM379056, GSM379058, GSM379060, GSM379061, GSM379063
and GSM379065 for fruit fly.
After downloading the data sets, the adaptors were trimmed according to [195],
and afterwards all sequences of minimum length 15 nt were aligned against the corre-
sponding genomes with oligomap [195]. For platypus, zebrafish, fruit fly and mouse,
we obtained the genome assemblies ornAna1, danRer7, dm3 and mm9 from the UCSC
genome website (http://genome.cse.ucsc.edu) and the genome assembly version 3.1 for
flatwormwas obtained from the genome center at washington university (genome.wustl.edu).
After mapping the reads to the respective genomes we only use those that mapped
to less than 10 loci in the case of mouse, zebrafish, fruit fly and flatworm, and only
sequences that mapped uniquely in the case of platypus.
7.4.2 Position Correlations
We wanted to assess the correlation between the locations of the 5’ ends of sequences
deriving from opposite strands. We measured the distance∆ between the 5’ ends for a
given locus as follows:
pairs(∆)+− =
￿
min(weight+(xi), weight
−(xi +∆)) (7.1)
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where weight+a (x) is the sum over all of sequences that have their 5’ end on the plus
strand at a particular position x of the sequence copy number divided by the number
of genomic loci corresponding to the sequence. This measurement focuses only on
the distance between the 5’ ends and the length of the sequences is ignored. The 10
nucleotide overlap between the 5’ ends of sequences from opposite strands that are gen-
erated by the ping-pong mechanism corresponds to ∆=9. The results of this computa-
tion can be interpreted quite intuitively, it just indicates how often a particular distance
has been observed in the entire set of reads. On the other hand, our measure is more
conservative than that proposed by Olson et al. [328], who multiplied the counts of
sequences overlapping from sense and antisense strands, thereby putting more weight
on distances observed in genomic loci with a large number of reads.
For the systematic analysis of the relative position of the two peaks that we iden-
tified in the ’pairs’ analysis, we used cross-correlation analysis (matlab fuction cross-
corr). First, we identified the sequence reads that give rise to P28 and P9 patterns,
respectively. For each of these patterns, we generated independently a vector in which
the index was the genomic location of the nucleotide that was located midway between
the 5’ end of the sequence on the plus strand and the 5’ end of the sequence on the
minus strand, and the entries were the numbers of pairs associated with a given ge-
nomic location. We then applied cross-correlation analysis between the two vectors in
a window of length 50. This resulted in two peaks, one at -9 and the other at 10. We
then repeated this analysis using the same vector for P9, but two different vectors for
P28. One of these vector was constructed from pairs containing the 19-mer on the plus
strand and the other from pairs containing the 19-mer on the minus strand. With the
first vector we obtained only the peak at -9 and with the second vector only the peak at
10.
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Figure 7.1: Novel processing pattern revealed by overlapping tags. (a) Overlap
analysis of sequences from opposite strands inside the piRNA clusters. On the x-axis,
the 5’ offset of sequences deriving from opposite strands is shown, and on the y-axis,
the number of detected ’pairs’. The analysis was carried out for several sets (defined by
the length of reads taken into account) of perfectly and uniquely mapping sequences.
For the blue line all sequences of length 15-40 nt were taken into account. The red
line corresponds to sequences in the range of prototypical piRNAs (23-31 nt). For the
green line, pairs were only counted, if the sequences on one strand were in the range
of piRNAs (23-31 nt) and those on the opposite strand below that range (15-22 nt).
In black, only pairs generated by a 19 nt long sequence on the one strand, and 23-31
nt long sequences on the other strand were taken into account. The peak at 9 (P9) is
specific to a set of sequences in the piRNA range, and the peak at 28 (P28) comes
from pairs in which one sequence is long and the other is short. In b the corresponding
duplexes are shown. (b) On the top, the duplex corresponding to the peak at 9 is
shown. Here, the opposite strand sequences overlap by 10 nt with a distance of 9
between 5’ ends, which is characteristic for the ping-pong mechansim. The nucleotide
located midway between the two 5’ ends, which is used for the cross-correlation in c,
is colored in green. The two duplex corresponding to the peak at 28 are shown below.
The ’center’ of the duplex is marked green.
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Figure 7.1: Novel processing pattern revealed by overlapping tags. (c) Cross-
correlation analysis was applied on the loci responsible for the peak at 9 against the
loci responsible for the peak at 28. The cross-correlation was made between the ’cen-
ters’ of the regions giving rise to the P9 and P28 peaks as shown in b. Taking all sites
together, two preferential locations of the ’centers’ are found (blue). By separating
the locations of the peaks of 28 based on the strand on which the 19-mer contributing
to the P28 pattern occurred, the two peaks were disentangled. For brown we used P28
patterns in which the short sequence was found on the plus strand. For red we used P28
patterns in which the short sequence was found on the minus strand. (d) A Venn dia-
gram showing the co-occurrence of P9 and P28 patterns. All locations on the genome
that gave rise to P9 or P28 patterns were taken into account. The intersection shows
that a substantial proportion of cases of P9 pattern co-occur with the P28 pattern.
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Figure 7.1: Novel processing pattern revealed by overlapping tags. (e) The du-
plexes, which occur if the P28 and P9 patterns co-occur are shown. The 19 nt sequence
is colored in red. The top duplex corresponds to the distance of -9 of the two ’cen-
ters’, the bottom one to the distance of 10. Note, the ping-pong pairs stay at the same
location, only the 19 nt sequence changes place in a point symmetrical manner.
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Figure 7.2: Occurrence of the novel processing pattern is conserved The presence
of the novel processing pattern is shown for mouse, fruit fly, zebrafish and flatworm.
The analysis was restricted to pairs formed by 23-31 nt sequences on the one, and 19
nt sequences on the other strand. Only sequences mapping to less than 10 genomic loci
were taken into account. The position of the P28 pattern is marked with red.
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Chapter 8
Conclusions
Presented in the chapters before was the work carried out to characterize small regu-
latory RNAs as well as their processing products and targets from large-scale datasets.
We have developed an annotation pipeline, which allows both the annotation of small
RNAs obtained from deep-sequencing runs, as well as the identification of small RNAs
whose expression changes between different conditions or cell types. The initial step
of this analysis is the identification of the genomic loci from which the sequence reads
emerge and their careful classification into different functional RNA categories, which
is crucial for further interpretations of the obtained data. We have connected our anno-
tation pipeline with the Elmmo miRNA target predictions and made them available as a
web server for the scientific community. This provides the user with statistical analysis
and data mining tools on miRNA expression profiles and predicted miRNA target sites
in several species. This in turn allows the user to focus on promising miRNA targets.
Interestingly, the statistical tools which are used for the expression profile comparisons
turned out to be applicable for the motif enrichment analyzes in the PURE-CLIP and
Dicer−/− studies.
Although the additional information which is gained by the intersection between
predicted miRNA targets and miRNA expression profiles results is a big improvement
over target predictions alone, the experimental validation of miRNA targets still re-
mains. In collaboration with the group of Thomas Tuschl at Rockefeller University, we
have developed a method which allows identification of miRNA target sites directly
from deep-sequencing data. This approach, which employs crosslinking of mRNAs
and immunoprecipitation of Argonaute protein complexes, makes use of photoreactive
4-thiouridines, which are incorporated into nascent transcripts. To our surprise, we
not only detected a strong motif enrichment which corresponded to the high abundant
miRNAs, but also that those motifs occured predominantly 1-2 nt downstream of the
crosslink site, suggesting that the crosslink occurs precisely opposite to the 9th and
10th position of the miRNA.
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In collaboration with the groups of Witold Filipowicz and Petr Svoboda we ex-
plored the functional consequences of loss of Dicer on early development. The transi-
tion from oocyte to embryo is accompanied by a extensive transcriptome remodelling.
Maternally inherited transcripts are degraded after fertilization and new transcripts are
generated at the onset of transcription. Dicer−/− in murine embryonic stem cells re-
vealed an important role for miRNAs. Our analysis suggested that the members of
the miR-290 cluster have a major impact on the transcriptome, and through combina-
tion of experiments and computational transcriptome analysis we were able to identify
primary and secondary targets of the miR-290 cluster.
In clear contrast, the loss of Dicer in oocytes did not point towards a disruption of
the miRNA pathway. Consistent with this, we did not detect a signal for miRNA in
the microarray analysis. Instead, we identified ∼ 10 % of the up-regulated genes as
targets of endo-siRNAs. This suggests that miRNAs do not extensively modulate the
gene expression in oocytes and disruption of the endo-siRNA pathway is responsible
for the misregulation of genes observed in Dicer−/− oocytes.
Finally, the analysis of piRNA reads revealed the presence of 19-mer sequences up-
stream of ping-pong amplified piRNAs. This pattern, which turned out to be conserved
among species with ping-pong amplification, might be useful for the understanding
of piRNA biogenesis. It does not only provide a starting point for biochemical ex-
periments but also offers a criterion together with the already known piRNA pattern
to identify ping-pong events in deep sequencing samples of small RNAs. Process-
ing analysis similar to ours identified tasiRNAs and methylation patterns in plants as
well as the ping-pong mechanism in Drosophila melanogaster. Hence, it is tempting
to speculate that processing analyses in the age of deep-sequencing data might reveal
more valuable biological insights.
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